1 | * D.3.6.2.1 - valore : Every 4 weeks dosing of 200 mg | - | - | - | - | [1] 41 41 |
2 | * D.3.6.2.1 - valore :Every 4 weeks dosing of 400 mg | - | - | - | - | [1] 41 41 |
3 | 0 mg Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 44 44 |
4 | 0 mg tropicamide | [1] Tropicamide Tropicamide | [1] D00397
D00397
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 |
5 | 0,25 mg RPC1063 | - | - | - | - | [1] 96 96 |
6 | 0,5 mg Fingolimod | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
7 | 0,5 mg Prevenar i.m. | - | - | - | - | [1] 51 51 |
8 | 0,5 mg seasonal influenza vaccine i.m. | - | - | - | - | [1] 51 51 |
9 | 0.04 mg Lu AE04621 | - | - | - | - | [1] 6 6 |
10 | 0.08 mg Lu AE04621 | - | - | - | - | [1] 6 6 |
11 | 0.2 mg Lu AE04621 | - | - | - | - | [1] 6 6 |
12 | 0.25 mg RPC103 | - | - | - | - | [1] 97 97 |
13 | 0.25 mg RPC1063 | - | - | - | - | [3] 13 13, 96, 97 |
14 | 0.3 mg tropicamide | [1] Tropicamide Tropicamide | [1] D00397
D00397
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 |
15 | 0.4 mg Lu AE04621 | - | - | - | - | [1] 6 6 |
16 | 0.5 mg budesonide effervescent tablet for orodispersible use | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
17 | 0.5 mg RPC1063 | - | - | - | - | [2] 13 13, 97 |
18 | 0.6 mg Lu AE04621 | - | - | - | - | [1] 6 6 |
19 | 0.8 mg Lu AE04621 | - | - | - | - | [1] 6 6 |
20 | 0109-0012A 100 mg/ml | - | - | - | - | [1] 46 46 |
21 | 0109-0012A 25 mg/ml | - | - | - | - | [1] 46 46 |
22 | 0109-0012A 50 mg/ml | - | - | - | - | [1] 46 46 |
23 | 1 mg budesonide effervescent tablet for orodispersible use | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
24 | 1 mg QD to 15 mg QD PF-06649751 | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
25 | 1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
26 | 1 mg RPC1063 | - | - | - | - | [2] 13 13, 97 |
27 | 1 mg tropicamide | [1] Tropicamide Tropicamide | [1] D00397
D00397
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 |
28 | 1 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 |
29 | 1.0 mg Lu AE04621 | - | - | - | - | [1] 6 6 |
30 | 1.0 mg rasagiline mesylate | [1] Rasagiline Rasagiline | [2] D08469
D08469
,
D10829
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
31 | 1.0 mg RPC103 | - | - | - | - | [1] 97 97 |
32 | 1.0 mg RPC1063 | - | - | - | - | [1] 97 97 |
33 | 1.2 mg Lu AE04621 | - | - | - | - | [1] 6 6 |
34 | 1.2 mg ZGN-440 for injectable suspension | - | - | - | - | [1] 193 193 |
35 | 1.8 mg ZGN-440 for injectable suspension | - | - | - | - | [1] 193 193 |
36 | 10 mg | - | - | - | - | [1] 96 96 |
37 | 10 mg Natura-alpha capsule | - | - | - | - | [1] 97 97 |
38 | 10 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 |
39 | 10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP) | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
40 | 10% Metronidazole Ointment (Synonym: METRONIDAZOLE250 MG) | [1] Metronidazole Metronidazole (Synonym: Metronidazole 250 mg) | [1] D00409
D00409
(Name: METRONIDAZOLE250 MG) | - | - | [1] 96 96 |
41 | 10-mg dose of E5501 2G tablet | - | - | - | - | [1] 63 63 |
42 | 10-mg dose of E5501 cyclodextrin oral solution | - | - | - | - | [1] 63 63 |
43 | 10-mg dose of E5501 lipid-based oral | - | - | - | - | [1] 63 63 |
44 | 10-mg dose of E5501-P21% powder | - | - | - | - | [1] 63 63 |
45 | 100 mg | - | - | - | - | [1] 97 97 |
46 | 100 mg AP1189 | - | - | - | - | [2] 46 46, 222 |
47 | 100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC | - | - | - | - | [1] 299 299 |
48 | 100 mg ELX /50 mg TEZ /75 mg IVA FDC | - | - | - | - | [1] 299 299 |
49 | 100 mg ELX/50 mg TEZ /75 mg IVA FDC | - | - | - | - | [1] 299 299 |
50 | 100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination | - | - | - | - | [1] 299 299 |
51 | 100 mg LX3305 QD | - | - | - | - | [1] 46 46 |
52 | 100 mg TEZ/150 mg IVA FDC | - | - | - | - | [1] 299 299 |
53 | 100 mg VX-445 /50 mg TEZ/75 mg IVA FDC | - | - | - | - | [1] 299 299 |
54 | 100 mg VX-445/50 mg TEZ /75 mg IVA FDC | - | - | - | - | [1] 299 299 |
55 | 100 mg/m2 dose | - | - | - | - | [1] 299 299 |
56 | 100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | [1] 299 299 |
57 | 100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | [1] 299 299 |
58 | 100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC | - | - | - | - | [1] 299 299 |
59 | 100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC | - | - | - | - | [1] 299 299 |
60 | 100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | [1] 299 299 |
61 | 100-mg VX-445 /50-mg TEZ/75-mg | - | - | - | - | [1] 299 299 |
62 | 100-mg VX-445/50-mg TEZ/75-mg IVA FDC | - | - | - | - | [1] 299 299 |
63 | 12 mg/kg GSK2402968 | - | - | - | - | [1] 113 113 |
64 | 120 mg sodium nitrite inhalation solution | [1] Nitrite Nitrite | - | - | - | [1] 86 86 |
65 | 14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration | - | - | - | - | [3] 13 13, 96, 97 |
66 | 15 mg fampridine-SR (4-aminopyridine, 4-AP) | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
67 | 15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
68 | 15 mg QD PF-06649751 | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
69 | 15 mg sodium nitrite inhalation solution | [1] Nitrite Nitrite | - | - | - | [1] 86 86 |
70 | 15 or 45 mg | - | - | - | - | [1] 67 67 |
71 | 150 mg double-blinded secukinumab | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
72 | 150 mg GSK1265744B | - | - | - | - | [1] 265 265 |
73 | 150 mg Induction/Chronic | - | - | - | - | [1] 97 97 |
74 | 150 mg LX3305 QD | - | - | - | - | [1] 46 46 |
75 | 150 mg open-label secukinumab | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
76 | 150-mg IVACAFTOR | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
77 | 2 mg perampanel | [1] Perampanel Perampanel | [1] D08964
D08964
| [4] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | [16] Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 6 6 |
78 | 2 x 10 mg Natura-alpha capsules | - | - | - | - | [1] 97 97 |
79 | 20 mg | - | - | - | - | [1] 97 97 |
80 | 20 mg BID of PF-02545920 | - | - | - | - | [1] 8 8 |
81 | 20 mg fampridine-SR (4-aminopyridine, 4-AP) | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
82 | 20 mg GA | - | - | - | - | [1] 13 13 |
83 | 20 mg MitoQ | - | - | - | - | [1] 13 13 |
84 | 20 mg sildenafil citrate by mouth | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
85 | 20 mg/ml Treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
86 | 200 mg BIA 6-512 | [1] BIA BIA | - | - | - | [1] 6 6 |
87 | 200 mg LX3305 QD | - | - | - | - | [1] 46 46 |
88 | 200 mg/m2 dose | - | - | - | - | [1] 299 299 |
89 | 25 mg BIA9 1067 | - | - | - | - | [1] 6 6 |
90 | 25 mg Ongentys | [1] Opicapone Opicapone | [1] D10825
D10825
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
91 | 25 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 |
92 | 250 mg CK-2017357 | - | - | - | - | [2] 2 2, 11 |
93 | 250 mg LX3305 BID | - | - | - | - | [1] 46 46 |
94 | 250 mg LX3305 QD | - | - | - | - | [1] 46 46 |
95 | 3 mg [14C]-A4250 capsule | - | - | - | - | [3] 93 93, 297, 338 |
96 | 3 mg Melatonin | [1] Melatonin Melatonin (Synonym: Melatonin Rapid Release Gelcaps 5 mg) | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
97 | 3 mg QD to 15 mg QD PF-06649751 | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
98 | 3 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
99 | 3 mg tropicamide | [1] Tropicamide Tropicamide | [1] D00397
D00397
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 |
100 | 3 mg/kg GSK2402968 | - | - | - | - | [1] 113 113 |
101 | 30 or 60 mg | - | - | - | - | [1] 67 67 |
102 | 30 or 90 mg | - | - | - | - | [1] 67 67 |
103 | 300 mg double-blinded secukinumab | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
104 | 300 mg LX3305 QD | - | - | - | - | [1] 46 46 |
105 | 4 mg perampanel | [1] Perampanel Perampanel | [1] D08964
D08964
| [4] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | [16] Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 6 6 |
106 | 4 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 |
107 | 4.5 mg Naltrexone | [1] Naltrexone Naltrexone | [1] D05113
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
108 | 40 mg | - | - | - | - | [1] 96 96 |
109 | 40 mg GA | - | - | - | - | [2] 2 2, 13 |
110 | 40 mg glatiramer acetate | [2] Acetate Acetate, Glatiramer | - | - | - | [2] 2 2, 13 |
111 | 40 mg Glatiramer acetato | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
112 | 40 mg MSB11022 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 |
113 | 40 mg QD Alogabat | - | - | - | - | [1] 201 201 |
114 | 40 MG- SOLUZIONE INIETTABILE IN SIRINGHE PRE-RIEMPITE- USO SOTTOCUTANEO- SIRINGA PRERIEMPITA (0,4ML)- 2 SIRINGHE PRE-RIEMPITE + 2 TAMPONI IMBEVUTI DI ALCOOL | - | - | - | - | [1] 107 107 |
115 | 400 mg BIA 5-1058 | [1] BIA BIA | - | - | - | [1] 86 86 |
116 | 400 mg LX3305 QD | - | - | - | - | [1] 46 46 |
117 | 45 mg sodium nitrite inhalation solution | [1] Nitrite Nitrite | - | - | - | [1] 86 86 |
118 | 450 mg Induction/Chronic | - | - | - | - | [1] 97 97 |
119 | 5 mg Melatonin | [1] Melatonin Melatonin (Synonym: Melatonin Rapid Release Gelcaps 5 mg) | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
120 | 5 mg Montelukast | [1] Montelukast Montelukast | [1] D08229
D08229
| [1] CYSLTR1 CYSLTR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
121 | 5 mg Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 44 44 |
122 | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream | [2] Estradiol Estradiol, Lidocaine (Synonym: JOINT AND MUSCLE RELIEF 750 mg) | [3] D00105
D00105
,
D00358
,
D08127
| [7] ESR1 ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Breast cancer, Chemical carcinogenesis - receptor activation, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 💬 | [1] 226 226 |
123 | 50 mg | - | - | - | - | [1] 97 97 |
124 | 50 mg AP1189 | - | - | - | - | [1] 46 46 |
125 | 50 mg BIA 9 1067 | [1] BIA BIA | - | - | - | [1] 6 6 |
126 | 50 mg ELX/25 mg TEZ/37.5 mg IVA | - | - | - | - | [1] 299 299 |
127 | 50 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination | - | - | - | - | [1] 299 299 |
128 | 50 mg Etanercept | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
129 | 50 mg Induction/Chronic | - | - | - | - | [1] 97 97 |
130 | 50 mg LX3305 QD | - | - | - | - | [1] 46 46 |
131 | 50 mg Ongentys | [1] Opicapone Opicapone | [1] D10825
D10825
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
132 | 500 mg CK-2017357 | - | - | - | - | [2] 2 2, 11 |
133 | 500 mg LX3305 QD | - | - | - | - | [1] 46 46 |
134 | 6 mg/kg GSK2402968 | - | - | - | - | [1] 113 113 |
135 | 60 mg QD Alogabat | - | - | - | - | [1] 201 201 |
136 | 7 mg QD Alogabat | - | - | - | - | [1] 201 201 |
137 | 7 mg QD to 15 mg QD PF-06649751 | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
138 | 7 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
139 | 75 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 |
140 | 75-mg IVACAFTOR | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
141 | 750 mg metformin and 7.5 g L-citrulline daily p.o. | [2] Citrulline Citrulline, Metformin (Synonym: Metformin ER 500 mg) | [1] D04966
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 |
142 | 80 mg DR-6MP | - | - | - | - | [1] 96 96 |
143 | 800 mg ibuprofen/26.6 mg famotidine | [2] Famotidine Famotidine (Synonym: Riva-famotidine 40 mg), Ibuprofen (Synonym: Ibuprofen 200 mg) | [2] D00126
D00126
,
D00318
| [3] HRH2 HRH2, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 107 107 |
144 | 9 mg/kg GSK2402968 | - | - | - | - | [1] 113 113 |
145 | 90 mg hydrocortisone acetate suppository with Sephure suppository applicator | [2] Acetate Acetate, Hydrocortisone | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
146 | 90 mg idrocortisone acetato in supposta con appli | - | - | - | - | [1] 97 97 |
147 | 90 mg idrocortisone acetato in supposta con applicatore per supposte Sephure | - | - | - | - | [1] 97 97 |
148 | 90 mg sodium nitrite inhalation solution | [1] Nitrite Nitrite | - | - | - | [1] 86 86 |
149 | [18F]FP-R01-MG-F2 | - | - | - | - | [2] 85 85, 94 |
150 | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine | [3] Clarithromycin Clarithromycin (Synonym: Clarithromycin 500 mg), Clofazimine, Rifabutin | [3] D00276
D00276
,
D00278
,
D00424
| - | - | [1] 96 96 |
151 | Abituzumab 1500 mg | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 |
152 | Abituzumab 500 mg | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 |
153 | Abrocitinib 200 mg | [1] Abrocitinib Abrocitinib | [1] D11400
D11400
| [1] JAK1 JAK1 💬 | [27] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 84 84 |
154 | Accordion Pill Carbidopa/Levodopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
155 | Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
156 | Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
157 | Accordion Pill? Carbidopa/Levodopa 50/400 mg | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
158 | Accordion Pill? Carbidopa/Levodopa 50/500 mg | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
159 | Accordion Pill¿ Carbidopa/levodopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
160 | Accordion Pill™ Carbidopa/Levodopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
161 | Accordion Pill™ Carbidopa/Levodopa 50/400 mg | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
162 | Accordion Pill™ Carbidopa/Levodopa 50/500 mg | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
163 | ACE-031 0.5 mg/kg q4wk | - | - | - | - | [1] 113 113 |
164 | ACE-031 1.0 mg/kg q2wk | - | - | - | - | [1] 113 113 |
165 | ACER-002 (celiprolol) 200 mg BID | [1] Celiprolol Celiprolol | [1] D07660
D07660
| [1] ADRB1 ADRB1 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 168 168 |
166 | Aclasta 5 mg Infusionslösung | [1] Zoledronic acid Zoledronic acid | [2] D01968
D01968
,
D08689
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
167 | ACOMPLIA 20 mg film-coated tablets | [1] Rimonabant Rimonabant | [1] D05731
D05731
| [1] CNR1 CNR1 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 193 193 |
168 | ACR16 10 mg | - | - | - | - | [1] 8 8 |
169 | ACR16 22.5 mg | - | - | - | - | [1] 8 8 |
170 | ACR16 45 mg | - | - | - | - | [1] 8 8 |
171 | Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily. | - | - | - | - | [1] 6 6 |
172 | Actonel Once a Week 35 mg film-coated tablets | [1] Risedronic acid Risedronic acid | [1] D08484
D08484
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 274 274 |
173 | Actos 15 mg | [1] Pioglitazone Pioglitazone | [1] D08378
D08378
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 2 2 |
174 | Actos 30 mg | [1] Pioglitazone Pioglitazone | [1] D08378
D08378
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 2 2 |
175 | Actos 45 mg | [1] Pioglitazone Pioglitazone | [1] D08378
D08378
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 2 2 |
176 | ACZ885 150 mg (Canakinumab) | [1] Canakinumab Canakinumab | [1] D09315
D09315
| [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 107 107 |
177 | AD 452 18 mg tablet | - | - | - | - | [1] 46 46 |
178 | AD 452 4.5 mg Tablet | - | - | - | - | [1] 46 46 |
179 | AD 452 9 mg tablet | - | - | - | - | [1] 46 46 |
180 | Adalimumab 40 mg | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
181 | Adalimumab 40 mg eow or ew | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
182 | Adalimumab 40 mg sc every other week | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 |
183 | Adalimumab 40 mg subcutaneous (SC) every other week (EOW) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
184 | Adalimumab 80 mg | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
185 | Adalimumab, Solution for Injection 40 mg/ (0.8 ml) Pre-filled Syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
186 | ADCIRCA 20 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
187 | Adderall XR 10 mg | - | - | - | - | [1] 13 13 |
188 | ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
189 | ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
190 | ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
191 | ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
192 | ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
193 | Adempas 0.125 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
194 | Adempas 0.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 86 86, 299 |
195 | Adempas 0.5 mg Film Coated Tablet | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
196 | Adempas 1 mg Film Coated Tablet | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
197 | Adempas 1.0 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 86 86, 299 |
198 | Adempas 1.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
199 | Adempas 1.5 mg Film Coated Tablet | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
200 | Adempas 2 mg Film Coated Tablet | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
201 | Adempas 2.0 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 86 86, 299 |
202 | Adempas 2.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
203 | Adempas 2.5 mg Film Coated Tablet | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
204 | Adempas® 0.5 mg film-coated tablets | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
205 | Adempas® 1.0 mg film-coated tablets | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
206 | Adempas® 1.5 mg film-coated tablets | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
207 | Adempas® 2.0 mg film-coated tablets | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
208 | Adempas® 2.5 mg film-coated tablets | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
209 | Adempas¿ 0.5 mg compressa rivestita con film | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
210 | Adempas¿ 1.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
211 | Adempas¿ 2.0 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
212 | Adempas¿ 2.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
213 | ADS-5102, 137 mg | - | - | - | - | [1] 13 13 |
214 | ADS-5102, 274 mg | - | - | - | - | [1] 13 13 |
215 | Afamelanotide (16 mg implant) | [1] Afamelanotide Afamelanotide | [1] D10511
D10511
| [1] MC1R MC1R 💬 | [2] Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 159 159 |
216 | Agalsidase beta from Biosidus 1 mg/kg | [1] Agalsidase beta Agalsidase beta | [1] D03228
D03228
| [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
217 | AIN457, 150 mg | - | - | - | - | [1] 271 271 |
218 | AIN457, 75 mg | - | - | - | - | [1] 271 271 |
219 | Alemtuzumab 0.2 mg | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [2] 65 65, 164 |
220 | Alemtuzumab 0.3 mg | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [2] 65 65, 164 |
221 | Alemtuzumab 12 mg | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [1] 13 13 |
222 | Alemtuzumab 24 mg | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [1] 13 13 |
223 | ALISERIN - 25 MG GRANULATO EFFERVESCENTE 20 BUSTINE | - | - | - | - | [1] 19 19 |
224 | Allopurinol Sandoz 100 mg, tabletten | [1] Allopurinol Allopurinol (Synonym: Novo-purol Tab 200 mg) | [1] D00224
D00224
| [1] XDH XDH 💬 | [6] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | [1] 96 96 |
225 | Alpha-1 HC 100 mg | - | - | - | - | [1] 299 299 |
226 | Alpha-1 HC 200 mg | - | - | - | - | [1] 299 299 |
227 | ALRN-5281 0.015 mg/kg | - | - | - | - | [1] 78 78 |
228 | ALRN-5281 0.05 mg/kg | - | - | - | - | [1] 78 78 |
229 | ALRN-5281 0.15 mg/kg | - | - | - | - | [1] 78 78 |
230 | ALX-0061 150 mg/mL | - | - | - | - | [1] 49 49 |
231 | Amantadine 300 mg | [1] Amantadine Amantadine | [1] D07441
D07441
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 |
232 | Ambrisentan 5 mg | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 88 88 |
233 | Ambrisentan 5 mg film-coated tablets | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
234 | AMG 827 140 mg | - | - | - | - | [1] 46 46 |
235 | AMG 827 210 mg | - | - | - | - | [2] 46 46, 96 |
236 | AMG 827 350 MG | - | - | - | - | [1] 96 96 |
237 | AMG 827 70 mg | - | - | - | - | [1] 46 46 |
238 | AMG 827 700 MG | - | - | - | - | [1] 96 96 |
239 | Amgevita 40 mg Injektionslösung im Fertigpen | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
240 | Amgevita 40 mg Injektionslösung in einer Fertigspritze | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
241 | Amifampridine Phosphate 10 MG Oral Tablet | [2] Amifampridine Amifampridine, Phosphate ion | [1] D10228
D10228
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 3 3 |
242 | Amoxicillin (Synonym: AMOXICILLIN 500 MG) | [1] Amoxicillin Amoxicillin (Synonym: Amoxicillin Capsules 250 mg) | [2] D00229
D00229
(Name: AMOXICILLIN 500 MG),
D07452
| - | - | [7] 6 6, 46, 63, 96, 97, 222, 299 |
243 | Amoxicillin and Clavulanic acid (Synonym: AMOXICILLIN 500 MG) | [2] Amoxicillin Amoxicillin (Synonym: Amoxicillin Capsules 250 mg), Clavulanic acid | [3] D00229
D00229
(Name: AMOXICILLIN 500 MG),
D07452
,
D07711
| - | - | [1] 299 299 |
244 | Amoxicillin and doxycyclin (Synonym: AMOXICILLIN 500 MG) | [2] Amoxicillin Amoxicillin (Synonym: Amoxicillin Capsules 250 mg), Doxycycline | [4] D00229
D00229
(Name: AMOXICILLIN 500 MG),
D00307
,
D07452
,
D07876
| - | - | [1] 97 97 |
245 | Amoxicillin hydrate (Synonym: AMOXICILLIN 500 MG) | [1] Amoxicillin Amoxicillin (Synonym: Amoxicillin Capsules 250 mg) | [2] D00229
D00229
(Name: AMOXICILLIN 500 MG),
D07452
| - | - | [1] 63 63 |
246 | Amoxicillin, metronidazole and doxycycline (Synonym: METRONIDAZOLE250 MG) | [3] Amoxicillin Amoxicillin (Synonym: Amoxicillin Capsules 250 mg), Doxycycline, Metronidazole (Synonym: Metronidazole 250 mg) | [5] D00229
D00229
(Name: AMOXICILLIN 500 MG),
D00307
,
D00409
(Name: METRONIDAZOLE250 MG),
D07452
,
D07876
| - | - | [1] 97 97 |
247 | Androgel 10 grams of gel containing 100 mg of testosterone | [1] Testosterone Testosterone | [1] D00075
D00075
| [1] AR AR 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 13 13 |
248 | ANHYDROUS CARBIDOPA (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
249 | Anifrolumab 1000 mg | [1] Anifrolumab Anifrolumab | [1] D11082
D11082
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 49 49 |
250 | Anifrolumab 300 mg | [1] Anifrolumab Anifrolumab | [1] D11082
D11082
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 49 49 |
251 | AP1189, 100 mg | - | - | - | - | [1] 46 46 |
252 | AP1189, 60 mg | - | - | - | - | [1] 46 46 |
253 | AP1189, 80 mg | - | - | - | - | [1] 46 46 |
254 | Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [1] D07460
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
255 | Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed | [1] Apomorphine Apomorphine | [1] D07460
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
256 | Apremilast 10 mg | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [2] 56 56, 107 |
257 | Apremilast 20 mg | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 46 46, 56, 107 |
258 | Apremilast 30 mg | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 46 46, 56, 107 |
259 | Apremilast tablet 20 mg | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 271 271 |
260 | Apremilast tablet 30 mg BID | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 271 271 |
261 | APRISO 375 mg extended-release capsules | [1] Manganese citrate Manganese citrate | - | - | - | [1] 97 97 |
262 | Aprovel (150 mg) | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
263 | Aprovel 150 mg Tablets | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
264 | APT-1011 - 3 mg | - | - | - | - | [1] 98 98 |
265 | APT-1011 3 mg HS | - | - | - | - | [1] 98 98 |
266 | AQX-1125 100 mg | [1] AQX-1125 AQX-1125 | - | - | - | [1] 226 226 |
267 | AQX-1125 200 mg | [1] AQX-1125 AQX-1125 | - | - | - | [1] 226 226 |
268 | Arava 20 mg filmdrasjerte tabletter | - | - | - | - | [1] 46 46 |
269 | Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
270 | Arbaclofen placarbil 15 mg BID | [2] Arbaclofen Arbaclofen, Arbaclofen Placarbil | [2] D08861
D08861
,
D09791
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
271 | Arbaclofen placarbil 30 mg BID | [2] Arbaclofen Arbaclofen, Arbaclofen Placarbil | [2] D08861
D08861
,
D09791
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
272 | Arbaclofen placarbil 45 mg BID | [2] Arbaclofen Arbaclofen, Arbaclofen Placarbil | [2] D08861
D08861
,
D09791
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
273 | ARC1905 20 MG/ML | - | - | - | - | [1] 301 301 |
274 | ARCOXIA 90 mg comprimidos recubiertos con película | - | - | - | - | [1] 271 271 |
275 | Aricept 10 mg | [1] Donepezil Donepezil (Synonym: Donepezil Hydrochloride 10 mg) | [1] D07869
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 13 13 |
276 | Aricept 10 mg filmdragerade tabletter | [1] Donepezil Donepezil (Synonym: Donepezil Hydrochloride 10 mg) | [1] D07869
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 13 13 |
277 | Aricept 5 mg | [1] Donepezil Donepezil (Synonym: Donepezil Hydrochloride 10 mg) | [1] D07869
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 13 13 |
278 | Aricept 5 mg filmdragerade tabletter | [1] Donepezil Donepezil (Synonym: Donepezil Hydrochloride 10 mg) | [1] D07869
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 13 13 |
279 | Aricept 5 mg-Filmtabletten | - | - | - | - | [1] 6 6 |
280 | ARICEPT 5*28 CPR 5 MG | [1] Donepezil Donepezil (Synonym: Donepezil Hydrochloride 10 mg) | [1] D07869
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 124 124 |
281 | Arikayce™ 140 mg | [1] Amikacin Amikacin | [1] D02543
D02543
| - | - | [1] 299 299 |
282 | Arikayce™ 560 mg | [1] Amikacin Amikacin | [1] D02543
D02543
| - | - | [1] 299 299 |
283 | Arikayce™ 70 mg | [1] Amikacin Amikacin | [1] D02543
D02543
| - | - | [1] 299 299 |
284 | Artamin 150 mg | - | - | - | - | [1] 171 171 |
285 | Artamin 250 mg | - | - | - | - | [1] 171 171 |
286 | ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
287 | ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
288 | Asacol 400 mg | - | - | - | - | [1] 97 97 |
289 | Asacol 400 mg (mesalamine) | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
290 | Asacol 400 mg tablet | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
291 | Asacol 800 mg (mesalamine) | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
292 | Asacol 800 mg tablet | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
293 | Asacol® 400 mg | - | - | - | - | [1] 97 97 |
294 | ASC42 10 mg | - | - | - | - | [1] 93 93 |
295 | ASC42 15 mg | - | - | - | - | [1] 93 93 |
296 | ASC42 5 mg | - | - | - | - | [1] 93 93 |
297 | Asendis 50 mg | - | - | - | - | [1] 46 46 |
298 | AT1001 150 mg | - | - | - | - | [1] 19 19 |
299 | AT2221 65 mg Formulated Capsules | - | - | - | - | [1] 256 256 |
300 | Atacicept 150 mg | [1] Atacicept Atacicept | [1] D09704
D09704
| [2] TNFSF13 TNFSF13, TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 13 13, 49 |
301 | Atacicept 25 mg | [1] Atacicept Atacicept | [1] D09704
D09704
| [2] TNFSF13 TNFSF13, TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 13 13, 66 |
302 | Atacicept 75 mg | [1] Atacicept Atacicept | [1] D09704
D09704
| [2] TNFSF13 TNFSF13, TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 |
303 | Atacicept 75 milligram (mg) | [1] Atacicept Atacicept | [1] D09704
D09704
| [2] TNFSF13 TNFSF13, TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
304 | Ataluren 1000 mg | [1] Ataluren Ataluren | [1] D09323
D09323
| - | - | [1] 113 113 |
305 | Ataluren 125 mg | [1] Ataluren Ataluren | [1] D09323
D09323
| - | - | [1] 113 113 |
306 | Ataluren 250 mg | [1] Ataluren Ataluren | [1] D09323
D09323
| - | - | [1] 113 113 |
307 | ATN-103 10 mg q4wks | - | - | - | - | [1] 46 46 |
308 | ATN-103 10 mg q8wks | - | - | - | - | [1] 46 46 |
309 | ATN-103 30 mg q4wks | - | - | - | - | [1] 46 46 |
310 | ATN-103 80 mg q4wks | - | - | - | - | [1] 46 46 |
311 | ATN-103 80 mg q8wks | - | - | - | - | [1] 46 46 |
312 | Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet | [2] Acetylcysteine Acetylcysteine, Atorvastatin | [2] D00221
D00221
,
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 63 63 |
313 | Atorvastatin tablet 20 mg | [1] Atorvastatin Atorvastatin | [1] D07474
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 46 46 |
314 | ATYR1923 1.0 mg/kg | [1] ATYR1923 ATYR1923 | - | - | - | [1] 84 84 |
315 | ATYR1923 3.0 mg/kg | [1] ATYR1923 ATYR1923 | - | - | - | [1] 84 84 |
316 | ATYR1923 5.0 mg/kg | [1] ATYR1923 ATYR1923 | - | - | - | [1] 84 84 |
317 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA | [1] Teriflunomide Teriflunomide | [1] D10172
D10172
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 13 13 |
318 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE | [1] Teriflunomide Teriflunomide | [1] D10172
D10172
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 13 13 |
319 | Aubagio 14 mg film-coated tablets | [1] Teriflunomide Teriflunomide | [1] D10172
D10172
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 13 13 |
320 | AVASTIN 25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung | [1] Bevacizumab Bevacizumab | [1] D06409
D06409
| [1] VEGFA VEGFA 💬 | [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 227 227 |
321 | Avatrombopag 20 MG | [1] Avatrombopag Avatrombopag | [1] D10306
D10306
| [1] MPL MPL 💬 | [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 60 60 |
322 | Avatrombopag 20 MG Oral Tablet | [1] Avatrombopag Avatrombopag | [1] D10306
D10306
| [1] MPL MPL 💬 | [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 60 60 |
323 | AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL | - | - | - | - | [1] 97 97 |
324 | Azathioprin-ratiopharm 25 mg | - | - | - | - | [1] 96 96 |
325 | Azathioprin-ratiopharm 50 mg Filmtabletten | - | - | - | - | [1] 96 96 |
326 | Azathioprin-ratiopharm® 25 mg Filmtabletten | - | - | - | - | [1] 44 44 |
327 | Azathioprine (Imuran) 50 mg Overencapsulated Tablet | [1] Azathioprine Azathioprine (Synonym: Riva-azathioprine 50 mg) | [1] D00238
D00238
| - | - | [1] 97 97 |
328 | Azathioprine - ratiopharm 50 mg | [1] Azathioprine Azathioprine (Synonym: Riva-azathioprine 50 mg) | [1] D00238
D00238
| - | - | [1] 96 96 |
329 | Azathioprine 25 mg | [1] Azathioprine Azathioprine (Synonym: Riva-azathioprine 50 mg) | [1] D00238
D00238
| - | - | [1] 44 44 |
330 | AZD3241 300 mg BID | - | - | - | - | [1] 6 6 |
331 | AZD3241 600 mg BID | - | - | - | - | [1] 6 6 |
332 | AZD3241 Extended release tablets 100 mg | [1] Manganese citrate Manganese citrate | - | - | - | [1] 6 6 |
333 | AZD3241 Extended release tablets 25 mg | [1] Manganese citrate Manganese citrate | - | - | - | [1] 6 6 |
334 | AZD9567 10 mg | - | - | - | - | [1] 46 46 |
335 | AZD9567 125 mg | - | - | - | - | [1] 46 46 |
336 | AZD9567 155 mg | - | - | - | - | [1] 46 46 |
337 | AZD9567 20 mg | - | - | - | - | [1] 46 46 |
338 | AZD9567 40 mg | - | - | - | - | [1] 46 46 |
339 | AZD9567 80 mg | - | - | - | - | [1] 46 46 |
340 | AZILECT 1 mg comprimidos | [1] Rasagiline Rasagiline | [2] D08469
D08469
,
D10829
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 |
341 | AZILECT® 1 mg Tabletten | [1] Rasagiline Rasagiline | [2] D08469
D08469
,
D10829
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 2 2 |
342 | Azithromycin + Metronidazole (Synonym: METRONIDAZOLE250 MG) | [2] Azithromycin Azithromycin, Metronidazole (Synonym: Metronidazole 250 mg) | [3] D00409
D00409
(Name: METRONIDAZOLE250 MG),
D06390
,
D07486
| - | - | [1] 96 96 |
343 | Azithromycin 250 mg tablets | [1] Azithromycin Azithromycin | [2] D06390
D06390
,
D07486
| - | - | [1] 299 299 |
344 | Azithromycin 500 mg film-coated tablet | [1] Azithromycin Azithromycin | [2] D06390
D06390
,
D07486
| - | - | [1] 299 299 |
345 | AZITHROMYCINE 250 mg | [1] Azithromycin Azithromycin | [2] D06390
D06390
,
D07486
| - | - | [1] 228 228 |
346 | AZLI 75 mg three times a day (TID) | - | - | - | - | [1] 299 299 |
347 | AZLI 75 mg three times daily (TID) | - | - | - | - | [1] 299 299 |
348 | AZLI 75 mg two times a day (BID)/ three times a day (TID) | - | - | - | - | [1] 299 299 |
349 | AZLI 75 mg two times a day (BID)/three times a day (TID) | - | - | - | - | [1] 299 299 |
350 | Baclofen 20 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
351 | Baclofen ER Capsules (GRS) 10 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
352 | Baclofen ER Capsules (GRS) 20 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
353 | Baclofen ER Capsules (GRS) 50 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
354 | Baclofen Tablets USP 10 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
355 | BAF312 0,25 mg tablet | - | - | - | - | [1] 13 13 |
356 | BAF312 0,5 mg tablet | - | - | - | - | [1] 50 50 |
357 | BAF312 0.25 mg | - | - | - | - | [1] 50 50 |
358 | BAF312 0.25 mg tablet | - | - | - | - | [1] 50 50 |
359 | BAF312 0.5 mg | - | - | - | - | [1] 50 50 |
360 | BAF312 0.50 mg | - | - | - | - | [1] 50 50 |
361 | BAF312 1 mg | - | - | - | - | [1] 50 50 |
362 | BAF312 1 mg tablet | - | - | - | - | [2] 13 13, 50 |
363 | BAF312 2 mg | - | - | - | - | [1] 50 50 |
364 | BAF312 2 mg tablet | - | - | - | - | [1] 50 50 |
365 | BAF312 4 mg tablet | - | - | - | - | [1] 13 13 |
366 | BAF312 5 mg tablet | - | - | - | - | [1] 50 50 |
367 | Bardoxolone methyl 10 mg | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] D09584
D09584
,
D09585
| - | - | [1] 67 67 |
368 | Bardoxolone methyl 15 mg | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] D09584
D09584
,
D09585
| - | - | [1] 67 67 |
369 | Bardoxolone methyl 20 mg | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] D09584
D09584
,
D09585
| - | - | [1] 67 67 |
370 | Bardoxolone methyl 5 mg | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] D09584
D09584
,
D09585
| - | - | [1] 67 67 |
371 | Baricitinib 2 MG | [1] Baricitinib Baricitinib | [1] D10308
D10308
| [2] JAK1 JAK1, JAK2 💬 | [35] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 53 |
372 | Baricitinib 2 MG [Olumiant] | [1] Baricitinib Baricitinib | [1] D10308
D10308
| [2] JAK1 JAK1, JAK2 💬 | [35] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 162 162 |
373 | Baricitinib 4 MG | [1] Baricitinib Baricitinib | [1] D10308
D10308
| [2] JAK1 JAK1, JAK2 💬 | [35] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
374 | Batoclimab 340 mg SC bi-weekly | [1] Batoclimab Batoclimab | [1] D11983
D11983
| [1] FCGRT FCGRT 💬 | - | [1] 11 11 |
375 | Batoclimab 340 mg SC weekly | [1] Batoclimab Batoclimab | [1] D11983
D11983
| [1] FCGRT FCGRT 💬 | - | [2] 11 11, 14 |
376 | Batoclimab 680 mg SC weekly | [1] Batoclimab Batoclimab | [1] D11983
D11983
| [1] FCGRT FCGRT 💬 | - | [1] 11 11 |
377 | Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly | [1] Batoclimab Batoclimab | [1] D11983
D11983
| [1] FCGRT FCGRT 💬 | - | [1] 14 14 |
378 | BAY 63-2521 coated tablets 0.5 mg | - | - | - | - | [2] 86 86, 88 |
379 | BAY 63-2521 coated tablets 1 mg | - | - | - | - | [2] 86 86, 88 |
380 | BAY 63-2521 coated tablets 1.5 mg | - | - | - | - | [2] 86 86, 88 |
381 | BAY 63-2521 coated tablets 2 mg | - | - | - | - | [2] 86 86, 88 |
382 | BAY 63-2521 coated tablets 2.5 mg | - | - | - | - | [2] 86 86, 88 |
383 | BAY 63-2521 IR coated tablet 1.0 mg | - | - | - | - | [1] 88 88 |
384 | BAY 63-2521 IR coated tablet 1.5 mg | - | - | - | - | [1] 88 88 |
385 | BAY 63-2521 IR coated tablet 2.0 mg | - | - | - | - | [1] 88 88 |
386 | BAY 63-2521 IR coated tablet 2.5 mg | - | - | - | - | [1] 88 88 |
387 | BAY 63-2521 IR tablet 0.5 mg | - | - | - | - | [1] 88 88 |
388 | BAY 63-2521 IR tablet 1.0 mg | - | - | - | - | [1] 88 88 |
389 | BAY 63-2521 IR tablet 1.5 mg | - | - | - | - | [1] 88 88 |
390 | BAY 63-2521 IR tablet 2.0 mg | - | - | - | - | [1] 88 88 |
391 | BAY 63-2521 IR tablet 2.5 mg | - | - | - | - | [1] 88 88 |
392 | BAY 63-2521 IR tablets 0.5 mg | - | - | - | - | [1] 86 86 |
393 | BAY 63-2521 IR tablets 1 mg | - | - | - | - | [1] 86 86 |
394 | BAY 63-2521 IR tablets 1.0 mg | - | - | - | - | [1] 86 86 |
395 | BAY 63-2521 IR tablets 1.5 mg | - | - | - | - | [1] 86 86 |
396 | BAY 63-2521 IR tablets 2.0 mg | - | - | - | - | [1] 86 86 |
397 | BAY 63-2521 IR tablets 2.5 mg | - | - | - | - | [1] 86 86 |
398 | BAY 63-2521 tablets 0.5 mg | - | - | - | - | [2] 86 86, 88 |
399 | BAY 63-2521 tablets 1 mg | - | - | - | - | [2] 86 86, 88 |
400 | BAY 63-2521 tablets 1.5 mg | - | - | - | - | [2] 86 86, 88 |
401 | BAY 63-2521 tablets 2 mg | - | - | - | - | [2] 86 86, 88 |
402 | BAY 63-2521 tablets 2.5 mg | - | - | - | - | [2] 86 86, 88 |
403 | BCD-089, 162 mg, s/c, q2w | - | - | - | - | [1] 46 46 |
404 | BCD-089, 162 mg, s/c, qw | - | - | - | - | [1] 46 46 |
405 | BCD-132, 125 mg | - | - | - | - | [1] 13 13 |
406 | BCD-132, 500 mg | - | - | - | - | [1] 13 13 |
407 | BEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongée | - | - | - | - | [1] 94 94 |
408 | Belantamab mafodotin 1.9 mg/kg (8 weeks) | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
409 | Belantamab mafodotin 2.5 mg/kg (4 weeks) | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
410 | Belantamab mafodotin 2.5 mg/kg (6 weeks) | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
411 | Belantamab mafodotin 2.5 mg/kg (8 weeks) | [1] Belantamab mafodotin Belantamab mafodotin | [1] D11595
D11595
| [10] TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 28 28 |
412 | Belimumab 1 mg/kg | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 |
413 | Belimumab 10 mg | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 222 222 |
414 | Belimumab 10 mg/kg | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 43 43, 46, 49 |
415 | Belimumab 10 mg/kg plus standard therapy | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
416 | Belimumab 100 mg SC | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
417 | Belimumab 200 mg SC | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
418 | Belimumab 200 mg/mL | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
419 | Belimumab 4 mg/kg | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 |
420 | Benazepril hydrochloride 10 milligram (mg) Tab | [1] Benazepril Benazepril | [1] D07499
D07499
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 218 218 |
421 | BENLYSTA - 120 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 120 MG 1 FLACONCINO | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 53 53 |
422 | Benlysta 400 mg powder for concentrate for solution for infusion | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 43 43, 49 |
423 | Benlysta 400 mg powder for concentrate for solution for infusions | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
424 | BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML | [1] Interferon beta-1b Interferon beta-1b | [1] D00746
D00746
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
425 | Betaloc ZOK 100, 95 mg | - | - | - | - | [1] 113 113 |
426 | Betaloc ZOK 25, 23,75 mg | - | - | - | - | [1] 113 113 |
427 | Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days | [3] Acetate Acetate, Betamethasone, Phosphate ion | [1] D00244
D00244
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 2 2 |
428 | Bezafibrat Genericon retard 400 mg | - | - | - | - | [1] 93 93 |
429 | Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy | [2] Bezafibrate Bezafibrate, Ursodeoxycholic acid (Synonym: Reltone 400 mg) | [2] D00734
D00734
,
D01366
| [2] NR1H4 NR1H4, PPARA 💬 | [11] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 94 94 |
430 | Bezafibrate 200 MG | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
431 | Bezafibrate 200 MG Oral Tablet | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
432 | Bezafibrate 400 MG | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
433 | BF 2.649 10 mg | - | - | - | - | [1] 6 6 |
434 | BF 2.649 20 mg | - | - | - | - | [1] 6 6 |
435 | BF 2.649 40 mg | - | - | - | - | [1] 6 6 |
436 | BF 2.649 5 mg | - | - | - | - | [1] 6 6 |
437 | BHT-3009 0.5 mg | - | - | - | - | [1] 13 13 |
438 | BHT-3009 1.5 mg | - | - | - | - | [1] 13 13 |
439 | BI 1015550 18 mg Film Coated Tablet | - | - | - | - | [1] 85 85 |
440 | BI 1015550 9 mg Film Coated Tablet | - | - | - | - | [1] 85 85 |
441 | BI 655066 10 mg/ml | - | - | - | - | [1] 96 96 |
442 | BI 655066 90 mg/ml | - | - | - | - | [2] 96 96, 271 |
443 | BIA 3-202 (200 mg) | [1] BIA BIA | - | - | - | [1] 6 6 |
444 | BIA 6-512 100 mg | [1] BIA BIA | - | - | - | [1] 6 6 |
445 | BIA 6-512 100 mg dose | [1] BIA BIA | - | - | - | [1] 6 6 |
446 | BIA 6-512 200 mg dose | [1] BIA BIA | - | - | - | [1] 6 6 |
447 | BIA 6-512 25 mg | [1] BIA BIA | - | - | - | [1] 6 6 |
448 | BIA 6-512 25 mg dose | [1] BIA BIA | - | - | - | [1] 6 6 |
449 | BIA 6-512 400 mg | [1] BIA BIA | - | - | - | [1] 6 6 |
450 | BIA 6-512 50 mg dose | [1] BIA BIA | - | - | - | [1] 6 6 |
451 | BIA 9-1067 15 mg | [1] BIA BIA | - | - | - | [1] 6 6 |
452 | BIA 9-1067 25 mg | [1] BIA BIA | - | - | - | [1] 6 6 |
453 | BIA 9-1067 30 mg | [1] BIA BIA | - | - | - | [1] 6 6 |
454 | BIA 9-1067 5 mg | [1] BIA BIA | - | - | - | [1] 6 6 |
455 | BIBR 796 BS, 20 mg | - | - | - | - | [1] 96 96 |
456 | BIBR 796 BS, 5 mg | - | - | - | - | [1] 96 96 |
457 | Blinded CDCA 250 mg TID | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 |
458 | BLOKIUM 50 mg comprimidos | - | - | - | - | [1] 167 167 |
459 | BMN 044 IV 6 mg/kg | - | - | - | - | [1] 113 113 |
460 | BMN 044 IV 9 mg/kg | - | - | - | - | [1] 113 113 |
461 | BMN 044 SC 6 mg/kg | - | - | - | - | [1] 113 113 |
462 | BMS-986004 1500 mg IV | - | - | - | - | [1] 63 63 |
463 | BMS-986004 225 mg IV | - | - | - | - | [1] 63 63 |
464 | BMS-986004 675 mg IV | - | - | - | - | [1] 63 63 |
465 | BMS-986004 75 mg IV | - | - | - | - | [1] 63 63 |
466 | BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL) | - | - | - | - | [1] 113 113 |
467 | BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL) | - | - | - | - | [1] 113 113 |
468 | BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL) | - | - | - | - | [1] 113 113 |
469 | BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL) | - | - | - | - | [1] 113 113 |
470 | BMS-986089-01 Injections, 15 mg/Syringe (21.4 mg/mL) | - | - | - | - | [1] 113 113 |
471 | BMS-986089-01 Injections, 35 mg/Syringe (50 mg/mL) | - | - | - | - | [1] 113 113 |
472 | BMS-986089-01 Injections, 50 mg/Syringe (71.4 mg/mL) | - | - | - | - | [1] 113 113 |
473 | BMS-986089-01 Injections, 7.5 mg/Syringe (10.7 mg/mL) | - | - | - | - | [1] 113 113 |
474 | Bosentan 125 mg | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
475 | Bosentan 62.5 mg | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
476 | BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML | - | - | - | - | [1] 299 299 |
477 | BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML | - | - | - | - | [1] 299 299 |
478 | Brensocatib 10 mg | [1] Brensocatib Brensocatib | [1] D12120
D12120
| [1] CTSC CTSC 💬 | [2] Apoptosis Apoptosis, Lysosome 💬 | [1] 299 299 |
479 | Brensocatib 25 mg | [1] Brensocatib Brensocatib | [1] D12120
D12120
| [1] CTSC CTSC 💬 | [2] Apoptosis Apoptosis, Lysosome 💬 | [1] 299 299 |
480 | Brepocitinib 25 mg | - | - | - | - | [2] 96 96, 97 |
481 | Brepocitinib 5 mg | - | - | - | - | [2] 96 96, 97 |
482 | Brivaracetam 25 mg | [1] Brivaracetam Brivaracetam | [1] D08879
D08879
| [1] SV2A SV2A 💬 | [1] ECM-receptor interaction ECM-receptor interaction 💬 | [1] 309 309 |
483 | Brivaracetam 50 mg | [1] Brivaracetam Brivaracetam | [1] D08879
D08879
| [1] SV2A SV2A 💬 | [1] ECM-receptor interaction ECM-receptor interaction 💬 | [1] 309 309 |
484 | BRV 2.5 mg | - | - | - | - | [1] 309 309 |
485 | BRV 25 mg | - | - | - | - | [1] 309 309 |
486 | BRV 50 mg | - | - | - | - | [1] 309 309 |
487 | BT-11 (1000 mg) | - | - | - | - | [1] 97 97 |
488 | BT-11 (500 mg) | - | - | - | - | [1] 97 97 |
489 | BT-11 1,000 mg | - | - | - | - | [1] 96 96 |
490 | BT-11 500 mg | - | - | - | - | [2] 96 96, 97 |
491 | BT051 200 mg | - | - | - | - | [1] 97 97 |
492 | BT051 3200 mg | - | - | - | - | [1] 97 97 |
493 | BT051 800 mg | - | - | - | - | [1] 97 97 |
494 | BTT1023 IV Infusion 20 mg/mL, 5 mL Drug Product | - | - | - | - | [1] 94 94 |
495 | Budesonide (6 mg) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
496 | Budesonide (9 mg) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
497 | Budesonide 0.5 mg compresse orodispersibili | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
498 | Budesonide 0.5 mg orodispersible tablets | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
499 | Budesonide 1 mg compresse orodispersibili | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
500 | Budesonide 1 mg orodispersible tablets | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
501 | Budesonide 1 mg orodispersible tablets (BUL 1 mg) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
502 | Budesonide 2 mg orodispersible tablets (BUL 2 mg) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
503 | Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
504 | Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
505 | Budesonide 9 mg capsules, hard (BUX-PV) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
506 | Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
507 | Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
508 | Budesonide MMX 6 mg Tablet | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
509 | Budesonide MMX® 6 mg | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
510 | Budesonide MMX® 9 mg | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
511 | Budesonide oral suspension [0.2 mg/ml] | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
512 | Budesonide-MMX® 6 mg | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
513 | Budesonide-MMX® 9 mg | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
514 | BUET 0.5 mg | - | - | - | - | [1] 98 98 |
515 | BUET 1 mg | - | - | - | - | [1] 98 98 |
516 | BUL 0.5 mg | - | - | - | - | [1] 98 98 |
517 | BUL 1 mg | - | - | - | - | [1] 98 98 |
518 | BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI | [1] Busulfan Busulfan | [1] D00248
D00248
| - | - | [2] 19 19, 65 |
519 | Bydureon 2 mg powder and solvent for prolonged-release suspension | [2] Exenatide Exenatide, Manganese citrate | [1] D04121
D04121
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 6 6 |
520 | Cabaseril, 1,0 mg Tablette | - | - | - | - | [1] 6 6 |
521 | Cabaseril, 2,0 mg Tablette | - | - | - | - | [1] 6 6 |
522 | Caffeine 100-200 mg BID | [1] Caffeine Caffeine (Synonym: Acetaminophen 325 Mg With 15 Mg Caffeine and 8 Mg Codeine Phosphate) | [2] D00528
D00528
,
D01453
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
523 | CALCIUM D3 SANDOZ - 1000 MG + 880 U.I. COMPRESSE EFFERVESCENTI 30 COMPRESSE DIVISIBILI | [1] Calcium Calcium (Synonym: Calcium With Vitamin D 200 Mg/160 Iu) | - | - | - | [1] 274 274 |
524 | Calvan® 100 mg | - | - | - | - | [1] 8 8 |
525 | Cannabidiol / Dronabinol capsule 5 mg+2,5 mg | [2] Cannabidiol Cannabidiol, Dronabinol | [2] D00306
D00306
,
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
526 | Cannabidiol capsule 5 mg | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
527 | Cannabidiol Oral Solution, is known as Epidyolex 100 mg/mL oral solution and is the approved name in the EU. Epidiolex (cannabidiol) oral solution is the approved name in the US. | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 158 158 |
528 | Cannabidiol tablet 10 mg | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 46 46, 271 |
529 | Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) | [3] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [3] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
530 | Capsules with 160 mg Teavigo (at least 94% EGCG) | [1] Epigallocatechin gallate Epigallocatechin gallate | - | - | - | [1] 13 13 |
531 | CARBIDOPA (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [7] 6 6, 13, 17, 90, 140, 164, 201 |
532 | CARBIDOPA (CD) (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
533 | CARBIDOPA (FU) (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
534 | Carbidopa 20 mg | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
535 | Carbidopa 200mg oral dose (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 |
536 | Carbidopa 27.5 mg | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
537 | Carbidopa 65 mg capsule | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
538 | Carbidopa and Levodopa 25mg/100mg (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
539 | Carbidopa and Levodopa Controlled Release Tablets (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
540 | Carbidopa and Levodopa Tablets, USP (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
541 | CARBIDOPA ANIDRA (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
542 | CARBIDOPA FU (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
543 | CARBIDOPA INN (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
544 | CARBIDOPA LEVODOPA (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
545 | CARBIDOPA MONOHYDRATE (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
546 | Carbidopa Pill (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
547 | Carbidopa, levodopa, entacapone (Synonym: CARBIDOPA TABLETS, 25 MG) | [3] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [3] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
548 | Carbidopa- Levodopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
549 | Carbidopa-4'-Monophosphate (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
550 | Carbidopa-Levodopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
551 | Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
552 | Carbidopa/l-dopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
553 | Carbidopa/l-dopa/entacapone (Synonym: CARBIDOPA TABLETS, 25 MG) | [3] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [3] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
554 | Carbidopa/levodopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
555 | Carbidopa/levodopa, as prescribed by treating physician (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
556 | Carbidopa/Levodopa, immediate release (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
557 | Carbidopa/Levodopa/Entacapone (Synonym: CARBIDOPA TABLETS, 25 MG) | [3] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [3] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
558 | Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler | [1] Aztreonam Aztreonam | [1] D00240
D00240
| - | - | [1] 299 299 |
559 | CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution | [1] Aztreonam Aztreonam | [1] D00240
D00240
| - | - | [1] 299 299 |
560 | CBD - Oral Solution, is known as Epidyolex 100 mg/ml oral solution, | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 158 158 |
561 | CC-220 0.3 mg Daily | - | - | - | - | [1] 84 84 |
562 | Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie | [1] Ceftazidime Ceftazidime | [2] D00921
D00921
,
D07654
| - | - | [1] 299 299 |
563 | Celebra (celecoxib) (Synonym: CELECOXIB 200 MG) | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
564 | Celebrex 200 mg | - | - | - | - | [1] 46 46 |
565 | Celebrex 200 mg capsule, hard | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
566 | Celebrex 200 mg Hartkapseln | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
567 | Celecoxib (Synonym: CELECOXIB 200 MG) | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [10] 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 |
568 | Celecoxib (Celebrex) (Synonym: CELECOXIB 200 MG) | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 34 34 |
569 | Celecoxib 200 milligrams (Synonym: CELECOXIB 200 MG) | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
570 | Celecoxib 200mg capsule (Synonym: CELECOXIB 200 MG) | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
571 | Celecoxib 400 milligrams (Synonym: CELECOXIB 200 MG) | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
572 | Celecoxib, Celebrex® (Synonym: CELECOXIB 200 MG) | [1] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg) | [1] D00567
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
573 | CellCept 500 mg | - | - | - | - | [1] 11 11 |
574 | CellCept 500 mg comprimidos recubiertos | - | - | - | - | [1] 35 35 |
575 | CellCept 500 mg film-coated tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] D00752
D00752
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 |
576 | CellCept 500 mg tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] D00752
D00752
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 |
577 | CellCept®500 mg comprimidos | - | - | - | - | [1] 35 35 |
578 | CellCept®500 mg tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] D00752
D00752
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 |
579 | Cenerimod 0.5 mg | [1] Cenerimod Cenerimod | [1] D11283
D11283
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 |
580 | Cenerimod 1 mg | [1] Cenerimod Cenerimod | [1] D11283
D11283
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 |
581 | Cenerimod 2 mg | [1] Cenerimod Cenerimod | [1] D11283
D11283
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 |
582 | Cenerimod 4 mg | [1] Cenerimod Cenerimod | [1] D11283
D11283
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 |
583 | Cenicriviroc 150 mg | [1] Cenicriviroc Cenicriviroc | [1] D09878
D09878
| [2] CCR2 CCR2, CCR5 💬 | [11] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 94 94 |
584 | Certican 0,5 mg Tabletten | [1] Everolimus Everolimus | [1] D02714
D02714
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 228 228 |
585 | Certican 1 mg tablets | [1] Everolimus Everolimus | [1] D02714
D02714
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 |
586 | Certolizumab Pegol (CZP) 200 mg | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
587 | Certolizumab Pegol (CZP) 400 mg | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
588 | Certolizumab Pegol 200 MG/ML [Cimzia] | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
589 | Certolizumab pegol 400 mg | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
590 | CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU | [1] Cetirizine Cetirizine (Synonym: Reactine Chewable Tablets 10 mg) | [1] D07662
D07662
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 300 300 |
591 | CF101 1 mg | - | - | - | - | [1] 46 46 |
592 | CF101 2 mg | - | - | - | - | [1] 46 46 |
593 | Chronocort® 10 mg | - | - | - | - | [1] 81 81 |
594 | Chronocort® 20 mg | - | - | - | - | [1] 81 81 |
595 | Chronocort® 5 mg | - | - | - | - | [1] 81 81 |
596 | CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 75 75 |
597 | Cialis 10 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 |
598 | Cialis 2.5 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 |
599 | CIALIS 20 mg comprimidos recubiertos con película | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
600 | Cialis 20 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 |
601 | Cialis 5 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 |
602 | Cilostazol 100 MG | [1] Cilostazol Cilostazol | [1] D01896
D01896
| [3] PDE3A PDE3A, PDE3B, TBXA2R 💬 | [14] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 |
603 | Cimzia 200 mg injeksjonsvæske, oppløsning | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
604 | Cimzia 200 mg solution for injection | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 271 |
605 | CIMZIA certolizumab pegol 200 mg/ml solution for injection | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 |
606 | CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE | - | - | - | - | [1] 299 299 |
607 | Circadin 2 mg | [1] Melatonin Melatonin (Synonym: Melatonin Rapid Release Gelcaps 5 mg) | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 90 90 |
608 | CIRCADIN 2 mg comprimidos de liberación prolongada | [1] Melatonin Melatonin (Synonym: Melatonin Rapid Release Gelcaps 5 mg) | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 90 90 |
609 | Citicolina 1000 mg/die | [1] Citicoline Citicoline | [1] D00057
D00057
| - | - | [1] 6 6 |
610 | CK-3773274 (10 - 30 mg) | - | - | - | - | [1] 58 58 |
611 | CK-3773274 (5 - 15 mg) | - | - | - | - | [1] 58 58 |
612 | CK-3773274 (5 - 20 mg) | - | - | - | - | [1] 58 58 |
613 | CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg) | - | - | - | - | [1] 58 58 |
614 | Cladribine 3.5 mg/kg | [1] Cladribine Cladribine | [1] D01370
D01370
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 |
615 | Cladribine 5.25 mg/kg | [1] Cladribine Cladribine | [1] D01370
D01370
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 |
616 | Clarium 50 mg Retardtabletten | - | - | - | - | [1] 6 6 |
617 | Clartihromycin, amoxicillin, and omeprazole (Synonym: AMOXICILLIN 500 MG) | [2] Amoxicillin Amoxicillin (Synonym: Amoxicillin Capsules 250 mg), Omeprazole (Synonym: Losec 10 mg) | [3] D00229
D00229
(Name: AMOXICILLIN 500 MG),
D00455
,
D07452
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 6 6 |
618 | Clemastine Milstein 1 mg, tabletten | [1] Clemastine Clemastine | [1] D03535
D03535
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
619 | Clonidine HCl CF 0,150 mg, tabletten | [1] Clonidine Clonidine | [1] D00281
D00281
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 78 78 |
620 | CNTO 136 100 mg | - | - | - | - | [1] 46 46 |
621 | CNTO 136 25 mg | - | - | - | - | [1] 46 46 |
622 | CNTO 136 50 mg | - | - | - | - | [1] 46 46 |
623 | CNTO 6785 100 mg | - | - | - | - | [1] 46 46 |
624 | CNTO 6785 15 mg | - | - | - | - | [1] 46 46 |
625 | CNTO 6785 200 mg | - | - | - | - | [1] 46 46 |
626 | CNTO 6785 50 mg | - | - | - | - | [1] 46 46 |
627 | CNTO 888 1 mg/kg | - | - | - | - | [1] 85 85 |
628 | CNTO 888 15 mg/kg | - | - | - | - | [1] 85 85 |
629 | CNTO 888 5 mg/kg | - | - | - | - | [1] 85 85 |
630 | Cobitolimod 250 mg | [1] Cobitolimod Cobitolimod | [1] D12275
D12275
| [1] TLR9 TLR9 💬 | [9] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 |
631 | Cobitolimod 500 mg | [1] Cobitolimod Cobitolimod | [1] D12275
D12275
| [1] TLR9 TLR9 💬 | [9] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 |
632 | COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE | [1] Colchicine Colchicine | [1] D00570
D00570
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 2 2 |
633 | Colchicine 1 MG Oral Tablet | [1] Colchicine Colchicine | [1] D00570
D00570
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 2 2 |
634 | Colistimethate 75 mg inhaled two times daily | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 |
635 | Combination Product: EGCG 300 mg + Nintedanib | [2] Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 |
636 | Combination Product: EGCG 300 mg + Pirfenidone | [2] Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 |
637 | Combination Product: EGCG 600 mg + Nintedanib | [2] Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 |
638 | Combination Product: EGCG 600 mg + Pirfenidone | [2] Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 |
639 | Combination Product: L-dopa 140 mg | [1] Levodopa Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
640 | Combination Product: L-dopa 35 mg | [1] Levodopa Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
641 | Combination Product: L-dopa 70mg/carbidopa 7mg (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
642 | Combination therapy with vigabatrin and prednisolone (Synonym: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [2] Prednisolone Prednisolone, Vigabatrin | [2] D00472
D00472
,
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [2] ABAT ABAT, NR3C1 💬 | [8] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
643 | Comparator: carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
644 | Comparator: naproxen tablet 500 mg | [1] Naproxen Naproxen (Synonym: Naprosyn 500 Mg Tablets) | [1] D00118
D00118
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
645 | Compressa effervescente 0,5 mg di budesonide per uso orodispersibile | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
646 | Compressa effervescente 1 mg di budesonide per uso orodispersibile | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
647 | COMTAN 200* 60 CPR 200 MG | [1] Entacapone Entacapone | [1] D00781
D00781
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
648 | Concentration unit: mg milligram(s) | - | - | - | - | [1] 254 254 |
649 | Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d | [1] Conjugated estrogens Conjugated estrogens | [1] D04070
D04070
| - | - | [1] 49 49 |
650 | Continuous intrajejunal infusion of levodopa-carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
651 | Controlled-release levodopa / carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
652 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
653 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
654 | COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
655 | COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
656 | Copaxone 20 mg | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
657 | Copaxone 20 mg/ml | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
658 | COPAXONE 20 mg/ml solución inyectable en jeringa precargada | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
659 | Copaxone 20 mg/ml solución para inyección en jeringa precargada | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
660 | Copaxone 20 mg/ml Solution for Injection, pre-filled syringe | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
661 | Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
662 | Copaxone 40 mg/ml | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
663 | Copaxone 40 mg/ml solution for injection, pre-filled syringe | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
664 | CORTANCYL 20 mg | [1] Prednisone acetate Prednisone acetate | [1] D08416
D08416
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 |
665 | Cortancyl ® 1 mg | [1] Prednisone acetate Prednisone acetate | [1] D08416
D08416
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
666 | Cortancyl ® 20 mg | [1] Prednisone acetate Prednisone acetate | [1] D08416
D08416
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
667 | Cortancyl ® 5 mg | [1] Prednisone acetate Prednisone acetate | [1] D08416
D08416
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
668 | Cortef 5 mg | [1] Hydrocortisone cypionate Hydrocortisone cypionate | [1] D00976
D00976
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 |
669 | CortimentMMX 9 mg | - | - | - | - | [1] 97 97 |
670 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 1 SIRINGA PRERIEMPITA | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 107 107 |
671 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 2 SIRINGHE PRERIEMPITE | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 107 107 |
672 | Cosentyx 300 mg solution for injection in pre-filled syringe | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 |
673 | Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin | [2] Tetracosactide Tetracosactide, Vigabatrin | [2] D00284
D00284
,
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [2] ABAT ABAT, MC2R 💬 | [12] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 | [1] 145 145 |
674 | Cosyntropin Injectable Suspension, 1 mg/mL | [1] Tetracosactide Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 145 145 |
675 | COZAAR 50 mg comprimidos recubierto con pelicula | [1] Losartan Losartan (Synonym: LOSARTAN POTASSIUM 50 mg) | [1] D08146
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 179 179 |
676 | COZAAR INICIO 12,5 mg comprimidos recubiertos con pelicula | [1] Losartan Losartan (Synonym: LOSARTAN POTASSIUM 50 mg) | [1] D08146
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 167 167 |
677 | CP-690,500 5 mg | - | - | - | - | [1] 97 97 |
678 | CP-690,550 10 mg | - | - | - | - | [1] 97 97 |
679 | CR845 1.0 mg | - | - | - | - | [1] 93 93 |
680 | Cuprior 150 mg | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [1] 171 171 |
681 | Cuprior 150 mg film-coated tablets | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [1] 171 171 |
682 | Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg | [1] Turmeric Turmeric | - | - | - | [1] 299 299 |
683 | Cuvitru 200 mg/ml solution for subcutaneous injection | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
684 | CV-MG01 | [1] CV-MG01 CV-MG01 | - | - | - | [1] 11 11 |
685 | Cyclophosphamidum 500 mg | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [1] 44 44 |
686 | Cyclosporine 5 mg/kg bid days 0-14 | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 38 38, 39 |
687 | Cápsulas de Laquinimod 0.6 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
688 | D-penicillamine 250 mg | [1] Penicillamine Penicillamine | [1] D00496
D00496
| - | - | [1] 171 171 |
689 | D.3.6.2.1 - valore: 45 / 0.45 mg/ml | - | - | - | - | [1] 97 97 |
690 | D.3.6.2.1 - valore: 5 o 10 mg/kg | - | - | - | - | [1] 97 97 |
691 | D9421-C capsule 3 mg | - | - | - | - | [1] 96 96 |
692 | Dacepton 5 mg/ml | - | - | - | - | [1] 6 6 |
693 | Dacepton 5 mg/ml infuusioneste, liuos | - | - | - | - | [1] 6 6 |
694 | Dalfampridine ER, 10 Mg Oral Tablet, Extended Release | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
695 | Dapagliflozin 10 MG [Farxiga] | [1] Dapagliflozin Dapagliflozin | [1] D08897
D08897
| [1] SLC5A2 SLC5A2 💬 | - | [2] 86 86, 88 |
696 | Dazucorilant 150 mg | - | - | - | - | [1] 2 2 |
697 | Dazucorilant 300 mg | - | - | - | - | [1] 2 2 |
698 | DB adalimumab 40 mg eow | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
699 | DB adalimumab 40 mg ew | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
700 | DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
701 | Decortin 20 mg | - | - | - | - | [1] 96 96 |
702 | Decortin 5 mg | - | - | - | - | [1] 96 96 |
703 | Decortin H 1 mg | - | - | - | - | [1] 97 97 |
704 | Decortin H 50 mg | - | - | - | - | [1] 97 97 |
705 | Defanyl 50 and 100 mg | - | - | - | - | [1] 46 46 |
706 | Deferiprone 600 mg delayed release tablet | [1] Deferiprone Deferiprone | [1] D07416
D07416
| - | - | [1] 6 6 |
707 | Deferiprone 80 mg/mL oral solution | [1] Deferiprone Deferiprone | [1] D07416
D07416
| - | - | [1] 120 120 |
708 | Deferiprone 80 mg/mL oral solution (Ferriprox) | [1] Deferiprone Deferiprone | [1] D07416
D07416
| - | - | [1] 120 120 |
709 | Deflazacort 6 mg Tablets | [1] Deflazacort Deflazacort | [1] D03671
D03671
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
710 | Dehydroepiandrosterone 100 and 400 mg | [1] Prasterone Prasterone | [1] D08409
D08409
| [3] AR AR, ESR1, ESR2 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 113 113 |
711 | DEPAKINE CHRONO 500 mg | - | - | - | - | [1] 233 233 |
712 | DEPAKINE CHRONO® 500 mg | - | - | - | - | [1] 233 233 |
713 | Depot leuprolide acetate 3.75 mg | [2] Acetate Acetate, Leuprolide | - | - | - | [1] 51 51 |
714 | Desmopressine nasal spray 10 mg/ml, flacon 60 doses | [1] Desmopressin Desmopressin | [1] D00291
D00291
| [2] AVPR2 AVPR2, F8 💬 | [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 225 225 |
715 | Desmotabs® 0,2 mg Tabletten | - | - | - | - | [1] 6 6 |
716 | Dexamethasone 0,1 mg Tablets | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
717 | Dexamethasone 1,5 mg Tablets | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
718 | Dexamethasone 4 mg JENAPHARM | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
719 | Dexamethasone Oral, 10 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
720 | Dexamethasone Oral, 20 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
721 | Dexamethasone sodium phosphate 250 mg/ 10 ml | [2] Dexamethasone Dexamethasone, Phosphate ion | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
722 | Dexamethasone sodium phosphate 250 mg/10 ml solution | [2] Dexamethasone Dexamethasone, Phosphate ion | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 299 299 |
723 | Dexamethasone, 40 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
724 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg | [3] Dextromethorphan Dextromethorphan (Synonym: Dextromethorphan Hbr 15 mg), Quinidine, Sulfate ion | [2] D03742
D03742
,
D08458
| [11] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | [22] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [2] 2 2, 13 |
725 | Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg | [3] Dextromethorphan Dextromethorphan (Synonym: Dextromethorphan Hbr 15 mg), Quinidine, Sulfate ion | [2] D03742
D03742
,
D08458
| [11] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | [22] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [2] 2 2, 13 |
726 | Digoxin 0.25 mg | [1] Digoxin Digoxin | [1] D00298
D00298
| [4] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | [18] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 |
727 | Dimethyl fumarate 240 mg | [1] Dimethyl fumarate Dimethyl fumarate | [1] D03846
D03846
| [1] KEAP1 KEAP1 💬 | [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [1] 13 13 |
728 | Diosminex, 500 mg, tabletki powlekane | - | - | - | - | [1] 265 265 |
729 | Diovan 160 mg | [1] Valsartan Valsartan | [1] D00400
D00400
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
730 | Diovan 40 mg | [1] Valsartan Valsartan | [1] D00400
D00400
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
731 | Diovan 80 mg | [1] Valsartan Valsartan | [1] D00400
D00400
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
732 | Dipyridamole Tab 25 MG | [1] Dipyridamole Dipyridamole | [1] D00302
D00302
| [2] PDE4A PDE4A, PDE5A 💬 | [6] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 224 224 |
733 | Docosahexaenoic acid administration: 50 mg/kg/day during 12 months | [1] Doconexent Doconexent | - | - | - | [1] 299 299 |
734 | Dolutegravir 50 MG | [1] Dolutegravir Dolutegravir | [1] D10066
D10066
| - | - | [1] 265 265 |
735 | Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO] | [1] Lamivudine Lamivudine | [1] D00353
D00353
| - | - | [1] 265 265 |
736 | Doptelet 20 mg film-coated tablets | [1] Avatrombopag Avatrombopag | [1] D10306
D10306
| [1] MPL MPL 💬 | [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 63 63 |
737 | Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] | [2] Tenofovir Tenofovir, Tenofovir disoproxil | [1] D06074
D06074
| - | - | [1] 265 265 |
738 | Dose of 60 mg/kg alpha1-proteinase inhibitor | [1] Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | [1] 231 231 |
739 | Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor | [1] Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | [1] 231 231 |
740 | Doxycycline 100 mg Capsules | [1] Doxycycline Doxycycline | [2] D00307
D00307
,
D07876
| - | - | [1] 89 89 |
741 | DoxyHEXAL® tabs 100 mg Tabletten | - | - | - | - | [1] 28 28 |
742 | Dronabinol 25 mg/ml, oral drops | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
743 | Dronabinol capsule 2,5 mg | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
744 | Dronabinol capsule 2.5. mg | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 46 46, 271 |
745 | Droxidopa 100 MG [Northera] | [1] Droxidopa Droxidopa | [1] D01277
D01277
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
746 | Duodopa LD/CD 20/5 mg/mL | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
747 | Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
748 | Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
749 | E5501 40 mg 2 x 20-mg tablets, orally, fasted | - | - | - | - | [1] 63 63 |
750 | E5501 40 mg 2 x 20-mg tablets, orally, with food | - | - | - | - | [1] 63 63 |
751 | E5501 40mg 2 x 20-mg tablets, orally, fasted | - | - | - | - | [1] 63 63 |
752 | E6011 10 mg/kg | - | - | - | - | [1] 96 96 |
753 | E6011 15 mg/kg | - | - | - | - | [1] 96 96 |
754 | E6011 2 mg/kg | - | - | - | - | [1] 96 96 |
755 | E6011 5 mg/kg | - | - | - | - | [1] 96 96 |
756 | Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml | - | - | - | - | [1] 96 96 |
757 | EDS-EP dose range of ~14-22 mg DSP/infusion | - | - | - | - | [1] 65 65 |
758 | EDS-EP dose range of ~5-10 mg DSP/infusion | - | - | - | - | [1] 65 65 |
759 | Efexor XL 75 mg | - | - | - | - | [1] 46 46 |
760 | Efexor XL 75 mg (venlafaxine) | [1] Venlafaxine Venlafaxine | [1] D08670
D08670
| [2] SLC6A2 SLC6A2, SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 |
761 | Efgartigimod concentrate for solution for infusion 20 mg/mL | - | - | - | - | [1] 11 11 |
762 | Efmody 10 mg modified release hard capsules | [2] Hydrocortisone Hydrocortisone, Manganese citrate | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
763 | Efmody 5 mg modified release hard capsules | [2] Hydrocortisone Hydrocortisone, Manganese citrate | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
764 | Efzofitimod 3 mg/kg | - | - | - | - | [1] 84 84 |
765 | Efzofitimod 5 mg/kg | - | - | - | - | [1] 84 84 |
766 | EGB 761 (r) 120 mg | - | - | - | - | [1] 18 18 |
767 | EGb 761 120 mg | - | - | - | - | [1] 18 18 |
768 | EHP-101 25 mg BID | - | - | - | - | [1] 13 13 |
769 | EHP-101 25 mg OD | - | - | - | - | [1] 13 13 |
770 | EHP-101 50 mg BID | - | - | - | - | [1] 13 13 |
771 | EHP-101 50 mg OD | - | - | - | - | [1] 13 13 |
772 | Elafibranor 120 mg | [1] Elafibranor Elafibranor | [1] D11208
D11208
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [2] 93 93, 94 |
773 | Elafibranor 80 mg | [1] Elafibranor Elafibranor | [1] D11208
D11208
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [2] 93 93, 94 |
774 | Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening | [3] Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | [3] D09916
D09916
,
D11041
,
D11507
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
775 | Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM] | [1] Elosulfase alfa Elosulfase alfa | [1] D10333
D10333
| [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 |
776 | Eltrombopag 12.5 mg | [1] Eltrombopag Eltrombopag | - | - | - | [1] 60 60 |
777 | Eltrombopag 25 mg | [1] Eltrombopag Eltrombopag | - | - | - | [1] 60 60 |
778 | Empagliflozin 10 MG | [1] Empagliflozin Empagliflozin | [1] D10459
D10459
| [1] SLC5A2 SLC5A2 💬 | - | [2] 58 58, 97 |
779 | Empagliflozin 25 MG | [1] Empagliflozin Empagliflozin | [1] D10459
D10459
| [1] SLC5A2 SLC5A2 💬 | - | [1] 72 72 |
780 | EMSELEX 15 mg Retardtabletten | [1] Darifenacin Darifenacin (Synonym: Darifenacin 15 mg) | [1] D03654
D03654
| [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 13 13 |
781 | EMSELEX 7,5 mg Retardtabletten | [1] Darifenacin Darifenacin (Synonym: Darifenacin 15 mg) | [1] D03654
D03654
| [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 13 13 |
782 | EnalHexal®, 5 mg | - | - | - | - | [1] 113 113 |
783 | ENBREL - 50 MG POLV SOLUZ INIET SOTTOC. POLV. FLAC VETRO SOLV. SIRI. VET. SOLV 1 ML (50 MG/ML) 12 FLAC+12 SIRI. PRE+12 AGHI+12 ADAT PER FLAC+24 TAMP. PRE INIEZ | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
784 | ENBREL - 50 MG SOLUZIONE INIETTABILE IN SIRINGA (VETRO DA 1 ML) PRERIEMPITA - USO SOTTOCUTANEO 12 SIRINGHE PRERIEMPITE + 24 TAMPONI IMBEVUTI DI ALCOL | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
785 | Enbrel 25 mg | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
786 | ENBREL 25 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte. | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
787 | Enbrel 25 mg powder and solvent for solution for injection | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
788 | ENBREL 25 mg/ml polvo y disolvente para solución inyectable para uso pediátrico | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 |
789 | Enbrel 50 mg | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
790 | Enbrel 50 mg powder and solvent for solution for injection | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
791 | ENBREL 50 mg solución inyectable en jeringas precargadas | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 |
792 | Enbrel 50 mg solution for injection in pre-filled syringe | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
793 | Enbrel® 50 mg Solution for Injection in Pre-filled Syringe | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
794 | Encapsulated Baclofen 20 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
795 | Encorton, 5 mg, tablets | - | - | - | - | [1] 46 46 |
796 | ENDOPROST - 0.05 MG/0.5 ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FIALA | - | - | - | - | [1] 51 51 |
797 | Endoxan® 500 mg | - | - | - | - | [1] 44 44 |
798 | Entacapone and carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone | [2] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [2] COMT COMT, DDC 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
799 | Entocort EC® 3 mg | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
800 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 |
801 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
802 | ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 |
803 | Entyvio 300 mg | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 |
804 | Epidiolex 100 mg/mL Oral Solution | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 140 140, 144 |
805 | Epratuzumab 100 mg | [1] Epratuzumab Epratuzumab | [1] D04036
D04036
| [1] CD22 CD22 💬 | [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | [1] 49 49 |
806 | Epratuzumab 1200 mg | [1] Epratuzumab Epratuzumab | [1] D04036
D04036
| [1] CD22 CD22 💬 | [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | [1] 49 49 |
807 | Epratuzumab 400 mg | [1] Epratuzumab Epratuzumab | [1] D04036
D04036
| [1] CD22 CD22 💬 | [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | [1] 49 49 |
808 | Epratuzumab 600 mg | [1] Epratuzumab Epratuzumab | [1] D04036
D04036
| [1] CD22 CD22 💬 | [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | [1] 49 49 |
809 | Equfina 50 mg | - | - | - | - | [1] 6 6 |
810 | ER tablet 100 mg AZD3241 | - | - | - | - | [1] 6 6 |
811 | ER tablet 25 mg AZD3241 | - | - | - | - | [1] 6 6 |
812 | Ergocalciferol 1.25 mg tablet | [1] Ergocalciferol Ergocalciferol (Synonym: Calcium Mg and Zn Capsules With Vitamin D) | [1] D00187
D00187
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 46 46 |
813 | ESBRIET - 267 MG - CAPSULA RIGIDA - USO ORALE - FLACONE (HDPE) 270 CAPSULE | [1] Pirfenidone Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 |
814 | Esbriet 267 MG Oral Capsule | [1] Pirfenidone Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 |
815 | ESIDREX-R 25 mg | - | - | - | - | [1] 235 235 |
816 | Esomeprazole 20 mg | [1] Esomeprazole Esomeprazole | [1] D07917
D07917
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 46 46 |
817 | Estradiol 2 mg | [1] Estradiol Estradiol | [1] D00105
D00105
| [2] ESR1 ESR1, ESR2 💬 | [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 299 299 |
818 | Etanercept 50 mg sc day 0 and day 3 | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 38 38, 39 |
819 | Etoricoxib 60 mg | [1] Etoricoxib Etoricoxib | [1] D03710
D03710
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
820 | Etoricoxib 90 mg | [1] Etoricoxib Etoricoxib | [1] D03710
D03710
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
821 | EXCL-100, 600 MG Oral Tablet | - | - | - | - | [1] 85 85 |
822 | Exelon 1,5 mg Hartkapseln | [1] Rivastigmine Rivastigmine | [1] D03822
D03822
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 5 5 |
823 | Exelon 3,0 mg Hartkapseln | [1] Rivastigmine Rivastigmine | [1] D03822
D03822
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 5 5 |
824 | Exelon 4.6 mg/24 h transdermal patch | [1] Rivastigmine Rivastigmine | [1] D03822
D03822
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 6 6 |
825 | Exelon 6,0 mg Hartkapseln | [1] Rivastigmine Rivastigmine | [1] D03822
D03822
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 5 5 |
826 | Exelon 9.5 mg/24 h transdermal patch | [1] Rivastigmine Rivastigmine | [1] D03822
D03822
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 6 6 |
827 | EXN-32 (CARBIDOPA E LEVODOPA) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
828 | Experimental: Seladelpar / MBX-8025 200 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
829 | Experimental: Seladelpar / MBX-8025 50 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
830 | Fabrazyme (agalsidase beta) 1 mg/kg | [1] Agalsidase beta Agalsidase beta | [1] D03228
D03228
| [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
831 | FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO | [1] Agalsidase beta Agalsidase beta | [1] D03228
D03228
| [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
832 | Fabrazyme 35 mg | [1] Agalsidase beta Agalsidase beta | [1] D03228
D03228
| [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
833 | Fabrazyme 5 mg | [1] Agalsidase beta Agalsidase beta | [1] D03228
D03228
| [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
834 | Famotidine 20 MG | [1] Famotidine Famotidine (Synonym: Riva-famotidine 40 mg) | [1] D00318
D00318
| [1] HRH2 HRH2 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | [1] 86 86 |
835 | FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14) | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
836 | Fampyra 10 mg prolonged-release tablets | [2] Dalfampridine Dalfampridine, Manganese citrate | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
837 | Ferriprox 500 mg | [1] Deferiprone Deferiprone | [1] D07416
D07416
| - | - | [1] 6 6 |
838 | Fingolimod 0.5 mg | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
839 | Fingolimod 1.25 mg | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
840 | Fipamezole hydrochloride 30 mg oral disintegrating tablets | [1] Fipamezole Fipamezole | - | - | - | [2] 6 6, 17 |
841 | Fipamezole hydrochloride 60 mg oral disintegrating tablets | [1] Fipamezole Fipamezole | - | - | - | [2] 6 6, 17 |
842 | Fipamezole hydrochloride 90 mg oral disintegrating tablets | [1] Fipamezole Fipamezole | - | - | - | [2] 6 6, 17 |
843 | Firategrast 150 mg | [1] Firategrast Firategrast | [1] D06590
D06590
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
844 | Firategrast 300 mg | [1] Firategrast Firategrast | [1] D06590
D06590
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
845 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | [1] Amifampridine Amifampridine | [1] D10228
D10228
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 3 3, 11 |
846 | Fixed dose combination Ciprofloxacin/Celecoxib (Synonym: CELECOXIB 200 MG) | [2] Celecoxib Celecoxib (Synonym: Celecoxib 400 mg), Ciprofloxacin | [2] D00186
D00186
,
D00567
(Name: CELECOXIB 200 MG) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 2 2 |
847 | FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML | [1] Fludarabine Fludarabine | [1] D07966
D07966
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 19 19 |
848 | FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML | [1] Fludarabine Fludarabine | [1] D07966
D07966
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 65 65 |
849 | Fludarabine phosphate 30 mg | [2] Fludarabine Fludarabine, Phosphate ion | [1] D07966
D07966
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 164 |
850 | Fludarabine phosphate 40 mg | [2] Fludarabine Fludarabine, Phosphate ion | [1] D07966
D07966
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 164 |
851 | Fluimucil® 600 mg effervescent tablets | - | - | - | - | [1] 85 85 |
852 | Foliglurax 10 mg (treatment A) | [1] Foliglurax Foliglurax | - | - | - | [1] 6 6 |
853 | Foliglurax 30 mg (treatment B) | [1] Foliglurax Foliglurax | - | - | - | [1] 6 6 |
854 | FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE | - | - | - | - | [1] 13 13 |
855 | Formistin 10 mg | - | - | - | - | [1] 13 13 |
856 | Fortecortin Inject 40 mg Amp. | - | - | - | - | [1] 65 65 |
857 | Fostamatinib 100 mg | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
858 | Fostamatinib 100 mg tablet | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
859 | Fostamatinib 150 mg | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
860 | Fostamatinib 150 mg bid | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 61 61 |
861 | Fostamatinib 150 mg tablet | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
862 | Fostamatinib 50 mg blue film-coated tablet | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
863 | Fostamatinib Disodium tablet 100 mg | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
864 | Fostamatinib Disodium tablet 150 mg | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
865 | FT011 100 mg | - | - | - | - | [1] 51 51 |
866 | FT011 200 mg | - | - | - | - | [1] 51 51 |
867 | GA 20 mg/mL | - | - | - | - | [1] 13 13 |
868 | GA 40 mg/mL | - | - | - | - | [1] 13 13 |
869 | GA Depot 40 mg | - | - | - | - | [1] 13 13 |
870 | GA Depot 80 mg | - | - | - | - | [1] 13 13 |
871 | Gaboxadol monohydrate 0.5 mg | [1] Gaboxadol Gaboxadol | [1] D04282
D04282
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 201 201 |
872 | Gaboxadol monohydrate 0.5 mg (intended commercial formulation) | [1] Gaboxadol Gaboxadol | [1] D04282
D04282
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 201 201 |
873 | Gaboxadol monohydrate 0.5 mg capsule | [1] Gaboxadol Gaboxadol | [1] D04282
D04282
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 201 201 |
874 | Gaboxadol monohydrate 2 mg | [1] Gaboxadol Gaboxadol | [1] D04282
D04282
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 201 201 |
875 | Gaboxadol monohydrate 2 mg (intended commercial formulation) | [1] Gaboxadol Gaboxadol | [1] D04282
D04282
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 201 201 |
876 | Gaboxadol monohydrate 2 mg capsule | [1] Gaboxadol Gaboxadol | [1] D04282
D04282
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 201 201 |
877 | Gaboxadol monohydrate 5 mg | [1] Gaboxadol Gaboxadol | [1] D04282
D04282
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 201 201 |
878 | Gaboxadol monohydrate 5 mg (intended commercial formulation) | [1] Gaboxadol Gaboxadol | [1] D04282
D04282
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 201 201 |
879 | Gammanorm 165 mg/mL | - | - | - | - | [1] 65 65 |
880 | GAZYVARO - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 1000MG/40ML - 1 FLACONCINO | [1] Obinutuzumab Obinutuzumab | [1] D09321
D09321
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 |
881 | GBT440 300 mg capsule | - | - | - | - | [1] 85 85 |
882 | GBT440 300 mg tablet | - | - | - | - | [1] 85 85 |
883 | GCK 100 mg | - | - | - | - | [1] 46 46 |
884 | GCK 200 mg | - | - | - | - | [1] 46 46 |
885 | GCK 300 mg | - | - | - | - | [1] 46 46 |
886 | GED-0507-34-Levo 160 mg | [1] GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1] 97 97 |
887 | GED-0507-34-Levo 80 mg | [1] GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1] 97 97 |
888 | Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg | - | - | - | - | [1] 299 299 |
889 | Genotonorm Kabipen 5.3 mg polvo y disolvente para sol. inyectable (Marca internacional Genotropin) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
890 | Genotonorm Kabipen 5.3 mg polvo y disolvente para solución inyectable (Marca internacional Genotropin) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
891 | Genotonorm Miniquick 0,2 mg | - | - | - | - | [1] 193 193 |
892 | Genotropin 12 mg | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
893 | GENOTROPIN 12 mg powder and solvent for solution for injection. | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
894 | Genotropin 12 mg/ml | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
895 | Genotropin 5 mg/ml | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
896 | Genotropin 5.3 mg in injection system Genotropin pen | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
897 | Genotropin miniquick 0.5 mg, injection | - | - | - | - | [1] 78 78 |
898 | Gernebcin 80 mg | - | - | - | - | [1] 299 299 |
899 | GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
900 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
901 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
902 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
903 | GILENYA 0,5 mg cápsulas duras | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 14 14 |
904 | Gilenya 0,5 mg Hartkapseln | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
905 | Glatiramer Acetate (GA) 40 mg | [2] Acetate Acetate, Glatiramer | - | - | - | [1] 13 13 |
906 | Glatiramer acetate 20 mg | [2] Acetate Acetate, Glatiramer | - | - | - | [1] 13 13 |
907 | Glatiramer acetate 20 mg, with mitoxantrone | [3] Acetate Acetate, Glatiramer, Mitoxantrone | [1] D08224
D08224
| [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [1] 13 13 |
908 | Glatiramer Acetate 20 mg/0.5 mL | [2] Acetate Acetate, Glatiramer | - | - | - | [1] 13 13 |
909 | Glatiramer acetate 40 mg | [2] Acetate Acetate, Glatiramer | - | - | - | [1] 13 13 |
910 | Glentek 50 mg compresse rivestite con film | - | - | - | - | [1] 18 18 |
911 | Glentek 50 mg film-coated tablets | - | - | - | - | [1] 18 18 |
912 | GLIVEC 100 mg comprimidos recubiertos con película | [1] Imatinib Imatinib (Synonym: Imatinib mesylate 400 mg) | [1] D08066
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [2] 34 34, 86 |
913 | Glivec 100 mg Filmtabletten | [1] Imatinib Imatinib (Synonym: Imatinib mesylate 400 mg) | [1] D08066
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [2] 51 51, 86 |
914 | Glivec 100 mg Hartkapsel | [1] Imatinib Imatinib (Synonym: Imatinib mesylate 400 mg) | [1] D08066
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 86 86 |
915 | GLIVEC 400 mg comprimidos recubiertos con película | [1] Imatinib Imatinib (Synonym: Imatinib mesylate 400 mg) | [1] D08066
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 34 34 |
916 | Glivec® 100 mg Filmtabletten | [1] Imatinib Imatinib (Synonym: Imatinib mesylate 400 mg) | [1] D08066
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 86 86 |
917 | GLPG1690 600 mg QD | - | - | - | - | [1] 85 85 |
918 | GLPG2222 100 mg | - | - | - | - | [1] 299 299 |
919 | GLPG2222 150 mg q.d. | - | - | - | - | [1] 299 299 |
920 | GLPG2222 200 mg | - | - | - | - | [1] 299 299 |
921 | GLPG2222 300 mg q.d. | - | - | - | - | [1] 299 299 |
922 | GLPG2222 400 mg | - | - | - | - | [1] 299 299 |
923 | GLPG2222 50 mg | - | - | - | - | [1] 299 299 |
924 | GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.) | - | - | - | - | [1] 299 299 |
925 | GM-CSF, fosfomycin and metronidazole (Synonym: METRONIDAZOLE250 MG) | [2] Fosfomycin Fosfomycin, Metronidazole (Synonym: Metronidazole 250 mg) | [2] D00409
D00409
(Name: METRONIDAZOLE250 MG),
D04253
| - | - | [1] 97 97 |
926 | GNR-055 1.0-2.0-3.0 mg/kg | - | - | - | - | [1] 19 19 |
927 | GNR-055 2.0 mg/kg | - | - | - | - | [1] 19 19 |
928 | GNR-055 3.0 mg/kg | - | - | - | - | [1] 19 19 |
929 | Golimumab 1 mg per kg | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
930 | Golimumab 100 mg | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 |
931 | Golimumab 100 mg injections | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
932 | Golimumab 2 mg per kg | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
933 | Golimumab 2 mg/kg IV | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
934 | Golimumab 200 mg | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
935 | Golimumab 4 mg per kg | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
936 | Golimumab 400 mg | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
937 | Golimumab 50 mg | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 |
938 | Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
939 | Golimumab 50 mg injections | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
940 | Golimumab 50 mg SC | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
941 | Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53] | [1] Golodirsen Golodirsen | [1] D11707
D11707
| [1] DMD DMD 💬 | [4] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 |
942 | Group 2 ustekinumab 130 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
943 | Group 3: ustekinumab approximately 6 mg/kg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
944 | GS-4997 18 mg | - | - | - | - | [1] 86 86 |
945 | GS-4997 2 mg | - | - | - | - | [1] 86 86 |
946 | GS-4997 6 mg | - | - | - | - | [1] 86 86 |
947 | GS-6615 3 mg | - | - | - | - | [1] 58 58 |
948 | GS-6615 3 mg Pink | - | - | - | - | [1] 58 58 |
949 | GS-6615 3 mg White | - | - | - | - | [1] 58 58 |
950 | GS-6615 6 mg | - | - | - | - | [1] 58 58 |
951 | GS-6615 6 mg White | - | - | - | - | [1] 58 58 |
952 | GS-9674 100 mg | - | - | - | - | [1] 93 93 |
953 | GS-9674 30 mg | - | - | - | - | [1] 93 93 |
954 | GSK1605786 500 mg | - | - | - | - | [1] 96 96 |
955 | GSK2330672/linerixibat 40 mg | - | - | - | - | [1] 93 93 |
956 | GSK2402968 6 mg/kg/week | - | - | - | - | [1] 113 113 |
957 | GSK2586184 100 mg | - | - | - | - | [1] 49 49 |
958 | GSK2586184 200 mg | - | - | - | - | [1] 49 49 |
959 | GSK2586184 400 mg | - | - | - | - | [1] 49 49 |
960 | GSK2586184 50 mg | - | - | - | - | [1] 49 49 |
961 | GSK2618960 2 mg/kg | - | - | - | - | [1] 53 53 |
962 | GSK2982772 60 mg | - | - | - | - | [1] 46 46 |
963 | GSK962040 (25 mg tablet) | - | - | - | - | [1] 6 6 |
964 | Guselkumab 100 mg | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 37 37 |
965 | GWP42003-P 10 mg/kg/day Dose | - | - | - | - | [1] 140 140 |
966 | GWP42003-P 20 mg/kg/day Dose | - | - | - | - | [2] 140 140, 144 |
967 | GWP42003-P 5 mg/kg/day Dose | - | - | - | - | [1] 140 140 |
968 | GYLENIA 0,5 mg | - | - | - | - | [1] 13 13 |
969 | HBM9161 Injection (340 mg) | - | - | - | - | [1] 11 11 |
970 | HBM9161 Injection (680mg and 340 mg) | - | - | - | - | [1] 11 11 |
971 | Hemay007 1200 mg QD group | - | - | - | - | [1] 46 46 |
972 | Hemay007 600 mg QD group | - | - | - | - | [1] 46 46 |
973 | Hemay007 800 mg QD group | - | - | - | - | [1] 46 46 |
974 | High Dose Aspirin (1300 mg/day) | [1] Acetylsalicylic acid Acetylsalicylic acid (Synonym: Asa 80 mg) | [1] D00109
D00109
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 |
975 | HMPL-004 1800 mg/day | - | - | - | - | [1] 97 97 |
976 | HMPL-004 2400 mg/day | - | - | - | - | [1] 97 97 |
977 | Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten | [1] Somatotropin Somatotropin | - | - | - | [1] 193 193 |
978 | Humatrope® 6 mg, powder and solvent for solution for injection | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
979 | Humira (adalimumab) 40 mg in 0.4 ml s.c. injection | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
980 | Humira (adalimumab) 40 mg s.c. injection | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
981 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER | - | - | - | - | [2] 56 56, 97 |
982 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
983 | Humira 20 mg solution for injection in pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
984 | Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
985 | Humira 40 mg injekcní roztok v predplnené injekcní stríkacce | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
986 | Humira 40 mg injeksjonsvæske, oppløsning, i ferdigfylt sprøyte | - | - | - | - | [1] 46 46 |
987 | HUMIRA 40 mg solución inyectable en jeringa precargada | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 |
988 | Humira 40 mg solution for injection in pre-filled pen | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
989 | Humira 40 mg solution for injection in pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 |
990 | Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
991 | Humira 40 mg solution for injection in pre-filled syringes | - | - | - | - | [1] 97 97 |
992 | Humira 40 mg/0.8 ml solution for injection | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
993 | Humira 40 mg/0.8 ml solution for injection for paediatric use | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
994 | Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
995 | Humira, 40 mg solution for injection in pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
996 | Humira® 40 mg Injektionslösung in Fertigspritze | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
997 | Humira® 40 mg solution for injection in pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
998 | Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
999 | Hydrochlorothiazide 25 mg | [1] Hydrochlorothiazide Hydrochlorothiazide (Synonym: Metoprolol Tartrate and Hydrochlorothiazide 100 mg-50 mg) | [1] D00340
D00340
| [1] SLC12A3 SLC12A3 💬 | - | [1] 67 67 |
1000 | Hydrocortison 100 mg (Pfizer®) in 2 ml solvent | - | - | - | - | [1] 83 83 |
1001 | Hydrocortisone tablet 2.5 mg | [1] Hydrocortisone Hydrocortisone | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
1002 | Hydrokortison APL kapsel 2,5 mg | - | - | - | - | [1] 83 83 |
1003 | Hydrokortison Glostrup 5 mg | - | - | - | - | [1] 78 78 |
1004 | Hydroxychloroquine Sulfate 100 milligram (mg) Tab | [2] Hydroxychloroquine Hydroxychloroquine, Sulfate ion | [1] D08050
D08050
| - | - | [1] 218 218 |
1005 | HyQvia 100 mg/ml solution for infusion for subcutaneous use | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
1006 | Ibuprofen Sandoz 400 mg Filmtabletten | [1] Ibuprofen Ibuprofen (Synonym: Ibuprofen 200 mg) | [1] D00126
D00126
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 |
1007 | Idebenone 150 mg film-coated tablets | [1] Idebenone Idebenone | [1] D01750
D01750
| - | - | [1] 113 113 |
1008 | IdeS (0.25 mg/kg) | [1] Imlifidase Imlifidase | [1] D11470
D11470
| - | - | [1] 64 64 |
1009 | IdeS (0.50 mg/kg) | [1] Imlifidase Imlifidase | [1] D11470
D11470
| - | - | [1] 64 64 |
1010 | Idursulfase IT (1 mg) | [1] Idursulfase Idursulfase | [1] D04499
D04499
| [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 |
1011 | Idursulfase IT (10 mg) | [1] Idursulfase Idursulfase | [1] D04499
D04499
| [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 |
1012 | Idursulfase IT (30 mg) | [1] Idursulfase Idursulfase | [1] D04499
D04499
| [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 |
1013 | IGSC 20% 150 mg/kg | - | - | - | - | [1] 65 65 |
1014 | Immediate release carbidopa/levodopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1015 | Immediate Release carbidopa/levodopa 10/100 mg | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1016 | Immediate Release carbidopa/levodopa 25/100 mg | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1017 | Imnovid 1 mg hard capsules | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 |
1018 | IMU-838 (30 mg/day) | - | - | - | - | [1] 13 13 |
1019 | IMU-838 (45 mg/day) | - | - | - | - | [1] 13 13 |
1020 | Imurel 25 mg | - | - | - | - | [1] 96 96 |
1021 | INCB050465 0.3 mg | [1] Parsaclisib Parsaclisib | [1] D11437
D11437
| [1] PIK3CD PIK3CD 💬 | [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 35 35 |
1022 | INCB050465 1 mg | [1] Parsaclisib Parsaclisib | [1] D11437
D11437
| [1] PIK3CD PIK3CD 💬 | [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 |
1023 | INCB050465 1.0 mg | [1] Parsaclisib Parsaclisib | [1] D11437
D11437
| [1] PIK3CD PIK3CD 💬 | [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 35 35 |
1024 | INCB050465 2.5 mg | [1] Parsaclisib Parsaclisib | [1] D11437
D11437
| [1] PIK3CD PIK3CD 💬 | [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 |
1025 | INCRELEX 10 mg/ml | [1] Mecasermin Mecasermin | [1] D03297
D03297
| [2] GHR GHR, IGF1R 💬 | [33] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 78 78 |
1026 | INCRELEX 10 mg/ml, solución inyectable | [1] Mecasermin Mecasermin | [1] D03297
D03297
| [2] GHR GHR, IGF1R 💬 | [33] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 78 78 |
1027 | Infigratinib 0.016 mg/kg | [1] Infigratinib Infigratinib | [1] D11589
D11589
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬 | [21] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 |
1028 | Infigratinib 0.032 mg/kg | [1] Infigratinib Infigratinib | [1] D11589
D11589
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬 | [21] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 |
1029 | Infigratinib 0.064 mg/kg | [1] Infigratinib Infigratinib | [1] D11589
D11589
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬 | [21] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 |
1030 | Infigratinib 0.128 mg/kg | [1] Infigratinib Infigratinib | [1] D11589
D11589
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬 | [21] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 |
1031 | Infigratinib 0.25 mg/kg | [1] Infigratinib Infigratinib | [1] D11589
D11589
| [3] FGFR1 FGFR1, FGFR2, FGFR3 💬 | [21] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | [1] 276 276 |
1032 | INFLECTRA - 100 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 1 FLACONCINO | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 56 56 |
1033 | Inflectra 100 mg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
1034 | Inflectra 100 mg powder for concentrate for solution for infusion | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
1035 | Infliximab (Remicade): 100 mg of lyophilized infliximab | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1036 | Infliximab 10 mg/kg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 |
1037 | Infliximab 20 mg/kg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1038 | Infliximab 3 mg/kg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
1039 | Infliximab 5 mg/kg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
1040 | Infliximab 5 mg/kg body weight infused over 2 hours | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1041 | Infliximab 5 mg/kg every 6 weeks | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1042 | Infliximab 7 mg/kg every 8 weeks | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1043 | INS1007 10 mg oral tablet | - | - | - | - | [1] 299 299 |
1044 | INS1007 25 mg oral tablet | - | - | - | - | [1] 299 299 |
1045 | INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE | [1] Etravirine Etravirine | [1] D04112
D04112
| - | - | [1] 18 18 |
1046 | Intravenous (i.v.) methylprednisolone 1000 mg, total 9 | [1] Methylprednisolone Methylprednisolone (Synonym: Depo-medrol 40 mg/ml) | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 |
1047 | Intravenous Dexamethasone 1 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1048 | Iohexol Inj 300 milligrams per milliliter (MG/ML) | [1] Iohexol Iohexol | [1] D01817
D01817
| - | - | [1] 67 67 |
1049 | IPN60130 10 mg capsules | - | - | - | - | [1] 272 272 |
1050 | IPN60130 50 mg capsules | - | - | - | - | [1] 272 272 |
1051 | IPX054 100 mg | - | - | - | - | [1] 6 6 |
1052 | IPX054 150 mg | - | - | - | - | [1] 6 6 |
1053 | IPX054 200 mg | - | - | - | - | [1] 6 6 |
1054 | IPX054 250 mg | - | - | - | - | [1] 6 6 |
1055 | IPX054 300 mg | - | - | - | - | [1] 6 6 |
1056 | IPX056 10 mg | - | - | - | - | [1] 13 13 |
1057 | IPX056 20 mg | - | - | - | - | [1] 13 13 |
1058 | IPX056 30 mg | - | - | - | - | [1] 13 13 |
1059 | IPX056 35 mg | - | - | - | - | [1] 13 13 |
1060 | IPX056 40 mg | - | - | - | - | [1] 13 13 |
1061 | IPX056-10 mg | - | - | - | - | [1] 13 13 |
1062 | IPX056-20 mg | - | - | - | - | [1] 13 13 |
1063 | IPX056-25 mg | - | - | - | - | [1] 13 13 |
1064 | IPX056-30 mg | - | - | - | - | [1] 13 13 |
1065 | IPX056-35 mg | - | - | - | - | [1] 13 13 |
1066 | IPX056-40 mg | - | - | - | - | [1] 13 13 |
1067 | IPX066 145 mg | - | - | - | - | [1] 6 6 |
1068 | IPX066 145 mg LD | - | - | - | - | [1] 6 6 |
1069 | IPX066 195 mg | - | - | - | - | [1] 6 6 |
1070 | IPX066 195 mg LD | - | - | - | - | [1] 6 6 |
1071 | IPX066 245 mg | - | - | - | - | [1] 6 6 |
1072 | IPX066 245 mg LD | - | - | - | - | [1] 6 6 |
1073 | IPX066 95 mg | - | - | - | - | [1] 6 6 |
1074 | IPX066 95 mg LD | - | - | - | - | [1] 6 6 |
1075 | IPX203 140 mg | - | - | - | - | [1] 6 6 |
1076 | IPX203 180 mg | - | - | - | - | [1] 6 6 |
1077 | IPX203 210 mg | - | - | - | - | [1] 6 6 |
1078 | IPX203 270 mg | - | - | - | - | [1] 6 6 |
1079 | IPX203 280 mg | - | - | - | - | [1] 6 6 |
1080 | IPX203 350 mg | - | - | - | - | [1] 6 6 |
1081 | IR CD-LD (carbidopa-levodopa) tablets (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1082 | Iron supplement 300-600 mg/day | [1] Iron Iron (Synonym: Iron Chelate 25 mg) | - | - | - | [2] 96 96, 97 |
1083 | ISIS 443139 10 mg | - | - | - | - | [1] 8 8 |
1084 | ISIS 443139 120 mg | - | - | - | - | [1] 8 8 |
1085 | ISIS 443139 30 mg | - | - | - | - | [1] 8 8 |
1086 | ISIS 443139 60 mg | - | - | - | - | [1] 8 8 |
1087 | ISIS 443139 90 mg | - | - | - | - | [1] 8 8 |
1088 | Isosorbide Dinitrate 20 mg | [1] Isosorbide dinitrate Isosorbide dinitrate | [1] D00516
D00516
| - | - | [1] 113 113 |
1089 | Isosorbide Dinitrate 40 mg | [2] Isosorbide Isosorbide, Isosorbide dinitrate | [2] D00347
D00347
,
D00516
| - | - | [1] 113 113 |
1090 | Isosorbide Dinitrate 60 mg | [1] Isosorbide dinitrate Isosorbide dinitrate | [1] D00516
D00516
| - | - | [1] 113 113 |
1091 | Isosorbide Dinitrate 80 mg | [2] Isosorbide Isosorbide, Isosorbide dinitrate | [2] D00347
D00347
,
D00516
| - | - | [1] 113 113 |
1092 | Istradefylline 20 mg | [1] Istradefylline Istradefylline | [1] D04641
D04641
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
1093 | Istradefylline 20 mg or 40 mg | [1] Istradefylline Istradefylline | [1] D04641
D04641
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
1094 | Istradefylline 40 mg | [1] Istradefylline Istradefylline | [1] D04641
D04641
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
1095 | ITF2357 10 mg/mL | - | - | - | - | [1] 113 113 |
1096 | Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally. | [2] Itraconazole Itraconazole, Terbinafine | [2] D00350
D00350
,
D02375
| - | - | [1] 96 96 |
1097 | Ivacaftor 150 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1098 | Ivacaftor 150 mg or 250 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1099 | Ivacaftor 25 mg/75 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1100 | Ivacaftor 75 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1101 | Ivacaftor 75 mg/150 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1102 | JINARC - 15 MG +45 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28X15 MG + 28 X 45 MG) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1103 | JINARC - 15 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1104 | JINARC - 30 MG + 60 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 60 MG) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1105 | JINARC - 30 MG +90 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 90 MG) | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1106 | JINARC - 30 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1107 | Jinarc 15 mg tablets, Jinarc 45 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1108 | Jinarc 30 mg Tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1109 | Jinarc 30 mg tablets, 90 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1110 | Jinarc 30 mg tablets, Jinarc 60 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1111 | JNJ-38518168 (10 mg) | - | - | - | - | [1] 46 46 |
1112 | JNJ-38518168 (3 mg) | - | - | - | - | [1] 46 46 |
1113 | JNJ-38518168 (30 mg) | - | - | - | - | [1] 46 46 |
1114 | JNJ-38518168 50-mg Over Encapsulated Tablet | - | - | - | - | [1] 46 46 |
1115 | JNJ-38518168-AEK - Over Encapsulated Tablet - 50 mg | - | - | - | - | [1] 46 46 |
1116 | JNJ-38518168-ZBQ - film-coated tablet - 10 mg | - | - | - | - | [1] 46 46 |
1117 | JNJ-38518168-ZBQ - film-coated tablet - 3 mg | - | - | - | - | [1] 46 46 |
1118 | JNJ-38518168-ZBQ - film-coated tablet - 30 mg | - | - | - | - | [1] 46 46 |
1119 | JNJ-39758979 (10 mg) | - | - | - | - | [1] 46 46 |
1120 | JNJ-39758979 (100 mg) | - | - | - | - | [1] 46 46 |
1121 | JNJ-39758979 (30 mg) | - | - | - | - | [1] 46 46 |
1122 | JNJ-39758979 (300 mg) | - | - | - | - | [1] 46 46 |
1123 | JNJ-39758979-AAC - enteric coated tablet - 10 mg | - | - | - | - | [1] 46 46 |
1124 | JNJ-39758979-AAC - enteric coated tablet - 100 mg | - | - | - | - | [1] 46 46 |
1125 | JNJ-39758979-AAC - enteric coated tablet - 30 mg | - | - | - | - | [1] 46 46 |
1126 | JNJ-40346527-AAC - capsule - 50 mg | [1] JNJ-40346527 JNJ-40346527 | - | - | - | [1] 46 46 |
1127 | JNJ-54781532 150 mg once daily | - | - | - | - | [1] 97 97 |
1128 | JNJ-54781532 25 mg once daily | - | - | - | - | [1] 97 97 |
1129 | JNJ-54781532 75 mg once daily | - | - | - | - | [1] 97 97 |
1130 | JNJ-54781532 75 mg twice daily | - | - | - | - | [1] 97 97 |
1131 | JNJ-54781532-AAD-10 mg | - | - | - | - | [1] 97 97 |
1132 | JNJ-54781532-AAD-30 mg | - | - | - | - | [1] 97 97 |
1133 | JNJ-54781532-AAD-5 mg | - | - | - | - | [1] 97 97 |
1134 | Jorveza 0.5 mg compresse orodispersibili | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
1135 | Jorveza 0.5 mg orodispersible tablets | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
1136 | Jorveza 1 mg compresse orodispersibili | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
1137 | Jorveza 1 mg orodispersible tablets | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
1138 | Jyseleca 100 mg film-coated tablets | [1] Filgotinib Filgotinib | [1] D10871
D10871
| [1] JAK1 JAK1 💬 | [27] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
1139 | Jyseleca 200 mg film-coated tablets | [1] Filgotinib Filgotinib | [1] D10871
D10871
| [1] JAK1 JAK1 💬 | [27] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
1140 | Kalydeco 150 mg film-c | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1141 | Kalydeco 150 mg film-coated tablets | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1142 | Kesimpta 20 mg Injektionslösung im Fertigpen | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
1143 | Kesimpta 20 mg solution for injection in pre-filled pen | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
1144 | KIOVIG 100 mg/ml solution for infusion | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 14 14, 65 |
1145 | KN019, 10 mg/kg | - | - | - | - | [1] 46 46 |
1146 | KVD824 300 mg Compresse a rilascio modificato | - | - | - | - | [1] 65 65 |
1147 | KVD824 300 mg Modified Release Tablets | [1] Manganese citrate Manganese citrate | - | - | - | [1] 65 65 |
1148 | KVD900 100 mg Film Coated Tablet | - | - | - | - | [1] 65 65 |
1149 | KVD900 300 mg | - | - | - | - | [1] 65 65 |
1150 | KVD900 300 mg Film Coated Tablet | - | - | - | - | [1] 65 65 |
1151 | KVD900 600 mg | - | - | - | - | [1] 65 65 |
1152 | KW-0761 0.3 mg/kg IV | - | - | - | - | [1] 26 26 |
1153 | Lamotrigin ”Nordic Prime 100 mg | - | - | - | - | [1] 114 114 |
1154 | Lamotrigin ”Nordic Prime 25 mg | - | - | - | - | [1] 114 114 |
1155 | Lamotrigin ”Nordic Prime 50 mg | - | - | - | - | [1] 114 114 |
1156 | Lansoprazole, amoxicillin, clarithromycin (Synonym: AMOXICILLIN 500 MG) | [3] Amoxicillin Amoxicillin (Synonym: Amoxicillin Capsules 250 mg), Clarithromycin (Synonym: Clarithromycin 500 mg), Lansoprazole | [4] D00229
D00229
(Name: AMOXICILLIN 500 MG),
D00276
,
D00355
,
D07452
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 222 222 |
1157 | Laquinimod Capsulas 0.6 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
1158 | Laquinimod Capsules 0.3 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
1159 | Laquinimod capsules 0.5 mg | [1] Laquinimod Laquinimod | - | - | - | [2] 8 8, 96 |
1160 | Laquinimod Capsules 0.6 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
1161 | Laquinimod Cápsulas 0.5 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 96 96 |
1162 | Laquinimod Tablets 0.3 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
1163 | LCI699, 1 mg | - | - | - | - | [1] 75 75 |
1164 | LCI699, 10 mg | - | - | - | - | [1] 75 75 |
1165 | LCI699, 20 mg | - | - | - | - | [1] 75 75 |
1166 | LCI699, 5 mg | - | - | - | - | [1] 75 75 |
1167 | LCZ696 100 mg | - | - | - | - | [1] 58 58 |
1168 | LCZ696 200 mg | - | - | - | - | [1] 58 58 |
1169 | LCZ696 50 mg | - | - | - | - | [1] 58 58 |
1170 | Leflunomide 20 mg Tablets (Geneva Pharmaceutical) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
1171 | Leflunomide 20 mg+prednisone 0.5mg/kg/d | [2] Leflunomide Leflunomide, Prednisone | [2] D00473
D00473
,
D00749
| [2] DHODH DHODH, NR3C1 💬 | [4] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬 | [1] 66 66 |
1172 | LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [1] 13 13 |
1173 | Lenabasum 20 mg | - | - | - | - | [2] 51 51, 299 |
1174 | Lenabasum 20 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
1175 | Lenabasum 5 mg | - | - | - | - | [2] 51 51, 299 |
1176 | Lenabasum 5 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
1177 | Leqvio 284 mg solution for injection in pre-filled syringe | [1] Inclisiran Inclisiran | [1] D11931
D11931
| [1] PCSK9 PCSK9 💬 | [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 |
1178 | Letairis 10 mg | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
1179 | Letairis 5 mg | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
1180 | Leuprolide acetate 11.25 mg | [2] Acetate Acetate, Leuprolide | - | - | - | [1] 76 76 |
1181 | Leuprolide acetate 30 mg | [2] Acetate Acetate, Leuprolide | - | - | - | [1] 76 76 |
1182 | Leuprolide Acetate 45 mg | [2] Acetate Acetate, Leuprolide | - | - | - | [1] 76 76 |
1183 | LEVODOPA / BENSERAZIDE 200 + 50 MG | [2] Benserazide Benserazide, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1184 | Levodopa / carbidopa solution (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1185 | Levodopa 100 mg / benserazide 25 mg | [2] Benserazide Benserazide, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1186 | Levodopa 100 mg A CAP | [1] Levodopa Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1187 | Levodopa 125 mg A CAP | [1] Levodopa Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1188 | Levodopa 150 mg A CAP | [1] Levodopa Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1189 | Levodopa 75 mg A CAP | [1] Levodopa Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1190 | Levodopa and carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1191 | Levodopa and carbidopa SC solution (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1192 | Levodopa and carbidopa solution for SC administration (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1193 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1194 | Levodopa carbidopa intestinal gel (LCIG) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1195 | Levodopa, carbidopa, entacapone (Synonym: CARBIDOPA TABLETS, 25 MG) | [3] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [3] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1196 | Levodopa, carbidopa, ODM-104 (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1197 | Levodopa-Carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [2] 6 6, 90 |
1198 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1199 | Levodopa-carbidopa Immediate Release (LC-IR) Tablets (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1200 | Levodopa-Carbidopa Intestinal Gel (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1201 | Levodopa-Carbidopa Intestinal Gel (LCIG) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1202 | Levodopa-Carbidopa Multilayer Extended Release Tablet (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1203 | Levodopa-Carbidopa XL tablet (M) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1204 | Levodopa-carbidopa-entacapone (Synonym: CARBIDOPA TABLETS, 25 MG) | [3] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [3] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1205 | Levodopa/benserazide 100/25 mg | [2] Benserazide Benserazide, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1206 | LEVODOPA/CARBIDOPA (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [2] 6 6, 164 |
1207 | Levodopa/Carbidopa (4:1) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 201 201 |
1208 | Levodopa/Carbidopa (LD/CD) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1209 | Levodopa/Carbidopa (Sinemet) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1210 | Levodopa/carbidopa 100/25 (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1211 | Levodopa/Carbidopa Hydrate (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1212 | Levodopa/Carbidopa Solution (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1213 | Levodopa/Carbidopa(200mg/50mg) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1214 | Levodopa/carbidopa/entacapone (Synonym: CARBIDOPA TABLETS, 25 MG) | [3] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [3] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1215 | LEVOFOLENE 4 MG 30 CPR | [1] Levoleucovorin Levoleucovorin | - | - | - | [1] 13 13 |
1216 | Linerixibat (GSK2330672) 40 mg | - | - | - | - | [1] 93 93 |
1217 | Linerixibat (GSK2330672) 45 mg | - | - | - | - | [1] 93 93 |
1218 | Liposomal Cyclosporine A 10 mg | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 |
1219 | Liposomal Cyclosporine A 5 mg | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 |
1220 | LiRIS 400 mg | - | - | - | - | [1] 226 226 |
1221 | LiRIS® 400 mg | - | - | - | - | [1] 226 226 |
1222 | LJN452, 0,01 mg | - | - | - | - | [1] 93 93 |
1223 | LJN452, 0,03 mg | - | - | - | - | [1] 93 93 |
1224 | LJN452, 0,1 mg | - | - | - | - | [1] 93 93 |
1225 | Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) | [4] Acetate Acetate, Estradiol, Ethinylestradiol, Norethisterone | [3] D00105
D00105
,
D00182
,
D00554
| [3] ESR1 ESR1, ESR2, PGR 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [2] 46 46, 49 |
1226 | Lojuxta 10 mg hard capsules | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
1227 | Lojuxta 20 mg hard capsules | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
1228 | Lojuxta 5 mg hard capsules | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
1229 | Loratadina STADA 10 mg | [1] Loratadine Loratadine (Synonym: ALLERGY RELIEF 10 mg) | [1] D00364
D00364
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 89 89 |
1230 | Losartan Bluefish 50 mg | [2] Bluefish Bluefish, Losartan (Synonym: LOSARTAN POTASSIUM 50 mg) | [1] D08146
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
1231 | Losec Capsules 20 mg | [1] Omeprazole Omeprazole (Synonym: Losec 10 mg) | [1] D00455
D00455
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 46 46 |
1232 | Lovastatin 60 MG | [1] Lovastatin Lovastatin | [1] D00359
D00359
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 34 34 |
1233 | Low Dose Aspirin (162 mg/day) | [1] Acetylsalicylic acid Acetylsalicylic acid (Synonym: Asa 80 mg) | [1] D00109
D00109
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 |
1234 | Lutein (10 or 30 mg/day) capsules | [1] Lutein Lutein | - | - | - | [1] 90 90 |
1235 | LX3305 250 mg capsule | - | - | - | - | [1] 161 161 |
1236 | LY3337641 20 mg | - | - | - | - | [1] 46 46 |
1237 | LY3337641 5 mg | - | - | - | - | [1] 46 46 |
1238 | M2591 25 mg QD | - | - | - | - | [1] 46 46 |
1239 | M2951 50 mg BID | - | - | - | - | [1] 46 46 |
1240 | M2951 75 mg QD | - | - | - | - | [1] 46 46 |
1241 | MABCAMPATH 10 mg/ml concentrado para solución para perfusión | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [1] 13 13 |
1242 | MABTHERA - 1 FIALA 500 MG 50 ML | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 14 14, 53 |
1243 | MABTHERA - 2 FIALE 100 MG 10 ML | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 19 19, 65 |
1244 | MabThera 100 mg concentrate for solution for infusion | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 |
1245 | MabThera 500 mg | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
1246 | MabThera 500 mg (10 mg/ml) concentrate for solution for infusion | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
1247 | MabThera 500 mg (10mg/ml) | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
1248 | MABTHERA 500 mg concentrado para solución para perfusión | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
1249 | MabThera 500 mg concentrate for solution for infusion | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 46 46, 222 |
1250 | MabThera 500 mg Konzentrat zur Herstellung einer Infusionslösung | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
1251 | MabThera®, 100 mg Concentrado para solución para perfusión | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
1252 | MabThera®, 100 mg concentrate for solution for infusion | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
1253 | Macitentan 10 mg | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 86, 88 |
1254 | Macitentan 10 mg tablet, once daily. | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1255 | Macitentan 3 mg | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
1256 | Macitentan 37.5 mg | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1257 | Macitentan 75 mg | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1258 | Madopar 125 mg T, tablets | - | - | - | - | [1] 6 6 |
1259 | Madopar 125 mg, orodispersible tablet | - | - | - | - | [1] 6 6 |
1260 | Madopar 200+50 mg | - | - | - | - | [1] 6 6 |
1261 | Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride) | [2] Benserazide Benserazide, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1262 | Magnesium sulfate (Synonym: Conclyte-Mg (TN)) | [3] Magnesium gluconate Magnesium gluconate, Magnesium sulfate (Synonym: MgSO4), Sulfate ion | [2] D01108
D01108
(Name: Conclyte-Mg (TN)),
D04835
| - | - | [3] 11 11, 296, 297 |
1263 | Masitinib 100 mg Tablets | [1] Masitinib Masitinib | [1] D10229
D10229
| [1] KIT KIT 💬 | [11] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | [1] 2 2 |
1264 | Masitinib 200 mg Tablets | [1] Masitinib Masitinib | [1] D10229
D10229
| [1] KIT KIT 💬 | [11] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | [1] 2 2 |
1265 | Masitinib 3 mg | [1] Masitinib Masitinib | [1] D10229
D10229
| [1] KIT KIT 💬 | [11] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | [1] 46 46 |
1266 | Masitinib 6.0 mg | [1] Masitinib Masitinib | [1] D10229
D10229
| [1] KIT KIT 💬 | [11] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | [1] 46 46 |
1267 | MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE | [1] Cladribine Cladribine | [1] D01370
D01370
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 |
1268 | MAVENCLAD 10 mg tablets | [1] Cladribine Cladribine | [1] D01370
D01370
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 |
1269 | Mavenclad tabletter 10 mg | [1] Cladribine Cladribine | [1] D01370
D01370
| [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 |
1270 | Mavrilimumab 10 mg | [1] Mavrilimumab Mavrilimumab | [1] D09930
D09930
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 |
1271 | Mavrilimumab 100 mg | [1] Mavrilimumab Mavrilimumab | [1] D09930
D09930
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 |
1272 | Mavrilimumab 150 mg | [1] Mavrilimumab Mavrilimumab | [1] D09930
D09930
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 |
1273 | Mavrilimumab 30 mg | [1] Mavrilimumab Mavrilimumab | [1] D09930
D09930
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 |
1274 | Mavrilimumab 50 mg | [1] Mavrilimumab Mavrilimumab | [1] D09930
D09930
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 |
1275 | Mayzent 0,25 mg Filmtabletten | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1276 | Mayzent 0.25 mg fi | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1277 | Mayzent 2 mg film-coated tablets | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1278 | Mayzent 2 mg Filmtabletten | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1279 | MBS2320 20 mg | - | - | - | - | [1] 46 46 |
1280 | MBS2320 40 mg | - | - | - | - | [1] 46 46 |
1281 | MBS2320 5 mg | - | - | - | - | [1] 46 46 |
1282 | MBX-8025 50 mg (Dose Escalation Period 1) | - | - | - | - | [1] 79 79 |
1283 | MBX-8025 50 mg or 100 mg (Dose Escalation Period 2) | - | - | - | - | [1] 79 79 |
1284 | MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3) | - | - | - | - | [1] 79 79 |
1285 | MD1003 100 mg capsule | - | - | - | - | [1] 20 20 |
1286 | MEDI-551 100 MG-IV | - | - | - | - | [1] 13 13 |
1287 | MEDI-551 30 MG-IV | - | - | - | - | [1] 13 13 |
1288 | MEDI-551 300 MG-SC | - | - | - | - | [1] 13 13 |
1289 | MEDI-551 60 MG-SC | - | - | - | - | [1] 13 13 |
1290 | MEDI-551 600 MG-IV | - | - | - | - | [1] 13 13 |
1291 | MEDI-570 0.03 MG | - | - | - | - | [1] 49 49 |
1292 | MEDI-570 0.1 MG | - | - | - | - | [1] 49 49 |
1293 | MEDI-570 0.3 MG | - | - | - | - | [1] 49 49 |
1294 | MEDI-570 1 MG | - | - | - | - | [1] 49 49 |
1295 | MEDROL - 4 MG COMPRESSE 30 COMPRESSE | - | - | - | - | [1] 56 56 |
1296 | Medrol 4 mg tablets | [1] Methylprednisolone Methylprednisolone (Synonym: Depo-medrol 40 mg/ml) | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1297 | Medrol A 16 mg tablets | [1] Methylprednisolone Methylprednisolone (Synonym: Depo-medrol 40 mg/ml) | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1298 | Melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d | [2] Eflornithine Eflornithine, Melarsoprol | [2] D00832
D00832
,
D07883
| [1] ODC1 ODC1 💬 | [3] Arginine and proline metabolism Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬 | [1] 65 65 |
1299 | Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d | [2] Melarsoprol Melarsoprol, Nifurtimox | [2] D00832
D00832
,
D00833
| - | - | [1] 65 65 |
1300 | Meloxicam 0.125 mg/kg | [1] Meloxicam Meloxicam | [1] D00969
D00969
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
1301 | Meloxicam 0.25 mg/kg | [1] Meloxicam Meloxicam | [1] D00969
D00969
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
1302 | Mepolizumab 100 mg | [1] Mepolizumab Mepolizumab | [1] D04923
D04923
| [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [1] 98 98 |
1303 | Mepolizumab 300 mg | [1] Mepolizumab Mepolizumab | [1] D04923
D04923
| [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [1] 98 98 |
1304 | Mesalazine (3,600 mg) | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1305 | Mesalazine - TID 1000 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1306 | Mesalazine - TID 2x 500 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1307 | Mesalazine 1000 mg gastro-resistant tablets | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1308 | Mesalazine 500 mg gastro-resistant tablets (Salofa | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1309 | Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg) | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1310 | Mesalazine EC 500 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
1311 | Metalcaptase® 150 mg gastro-resistant tablet | - | - | - | - | [1] 171 171 |
1312 | Metalcaptase® 300 mg gastro-resistant tablet | - | - | - | - | [1] 171 171 |
1313 | Metex 10 mg/ml Injektionslösung, Fertigspritze | - | - | - | - | [1] 46 46 |
1314 | Metex 2,5 mg Tabletten | - | - | - | - | [1] 44 44 |
1315 | Metex 50 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte | - | - | - | - | [1] 46 46 |
1316 | Metex® 50 mg/ml Injektionslösung, Fertigspritze | - | - | - | - | [1] 46 46 |
1317 | MetFORMIN 1000 Mg Oral Tablet | [1] Metformin Metformin (Synonym: Metformin ER 500 mg) | [1] D04966
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 13 13 |
1318 | Metformin 500 Mg Oral Tablet, up to 4 tablets a day | [1] Metformin Metformin (Synonym: Metformin ER 500 mg) | [1] D04966
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 13 13 |
1319 | Metformin 500 mg TID Oral Tablet | [1] Metformin Metformin (Synonym: Metformin ER 500 mg) | [1] D04966
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 97 97 |
1320 | METFORMINA - 500 30 COMPRESSE 500 MG | [1] Metformin Metformin (Synonym: Metformin ER 500 mg) | [1] D04966
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 |
1321 | Metformine Sandoz 850 mg filmomhulde tabletten | [1] Metformin Metformin (Synonym: Metformin ER 500 mg) | [1] D04966
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 81 81 |
1322 | Methotrexat 2,5 mg Tabletten medac | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1323 | Methotrexat HEXAL® 2,5 mg Tabletten | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1324 | METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
1325 | Methotrexate 10 mg | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1326 | Methotrexate 10 mg tablets | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1327 | Methotrexate 2.5 mg | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 |
1328 | METHOTREXATE 2.5 mg tablets | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1329 | Methotrexate 25 mg | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 |
1330 | METHOTREXATE HOSPIRA 2,5 mg tablety | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1331 | METHOTREXATE HOSPIRA 2.5 mg tablety | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1332 | Methotrexate Lederle 2.5 mg Tablets | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1333 | Methotrexate Pfizer 2,5 mg tabletter | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1334 | Methotrexate Sodium Tablets 2.5 mg | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1335 | Methotrexate tablets 2.5 mg | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1336 | Methotrexate® 2.5 mg tablets | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1337 | Methylphenidate modified release 20 mg | [1] Methylphenidate Methylphenidate | [1] D04999
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
1338 | Methylphenidate modified release 30 mg | [1] Methylphenidate Methylphenidate | [1] D04999
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
1339 | Methylphenidate modified release 40 mg | [1] Methylphenidate Methylphenidate | [1] D04999
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
1340 | Methylprednisolone 1250 mg/24h x3 days | [1] Methylprednisolone Methylprednisolone (Synonym: Depo-medrol 40 mg/ml) | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
1341 | Methylprednisolone bolus IV 15 mg/kg/d for 3 days. | [1] Methylprednisolone Methylprednisolone (Synonym: Depo-medrol 40 mg/ml) | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 |
1342 | METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO | - | - | - | - | [1] 300 300 |
1343 | METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL | [1] Metoclopramide Metoclopramide | [1] D00726
D00726
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 |
1344 | MetoHEXAL® Succ ® 23,75 mg Retardtabletten | - | - | - | - | [1] 113 113 |
1345 | MetoHEXAL® Succ ® 47,5 mg Retardtabletten | - | - | - | - | [1] 113 113 |
1346 | MetoHEXAL® Succ ® 95 mg Retardtabletten | - | - | - | - | [1] 113 113 |
1347 | Metoject 10 mg/ml | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 50 50 |
1348 | METOJECT 10 mg/ml, solution injectable en seringue pré-remplie | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 |
1349 | Metopirone 250 mg capsules | [1] Metyrapone Metyrapone | [1] D00410
D00410
| [1] CYP11B1 CYP11B1 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | [1] 75 75 |
1350 | Metopirone 250 mg capsules/ Cormeto | [1] Metyrapone Metyrapone | [1] D00410
D00410
| [1] CYP11B1 CYP11B1 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | [1] 75 75 |
1351 | Metopirone 250 mg capsules/Cormeto | [1] Metyrapone Metyrapone | [1] D00410
D00410
| [1] CYP11B1 CYP11B1 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | [1] 75 75 |
1352 | Metoprolol tartrate 50 mg | [1] Metoprolol Metoprolol (Synonym: Lopresor SR 200 mg) | [1] D02358
D02358
| [1] ADRB1 ADRB1 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 |
1353 | METOTREXATO SANDOZ - 2.5 MG COMPRESSE 50 COMPRESSE IN FLACONE PP | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1354 | METOTREXATO-LEDERLE 2,5 MG COMPRIMIDOS | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1355 | METRONIDAZOLE (Synonym: METRONIDAZOLE250 MG) | [1] Metronidazole Metronidazole (Synonym: Metronidazole 250 mg) | [1] D00409
D00409
(Name: METRONIDAZOLE250 MG) | - | - | [7] 46 46, 51, 63, 94, 96, 97, 291 |
1356 | Metronidazole capsule 50 mg | [1] Metronidazole Metronidazole (Synonym: Metronidazole 250 mg) | [1] D00409
D00409
(Name: METRONIDAZOLE250 MG) | - | - | [1] 97 97 |
1357 | Metronidazole Oral (Synonym: METRONIDAZOLE250 MG) | [1] Metronidazole Metronidazole (Synonym: Metronidazole 250 mg) | [1] D00409
D00409
(Name: METRONIDAZOLE250 MG) | - | - | [1] 96 96 |
1358 | Mexiletine 167 mg | [1] Mexiletine Mexiletine | [1] D08215
D08215
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 113 113 |
1359 | Mezavant 1200 mg magensaftresistente Retardtabletten | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1360 | Mezavant XL 1200 mg gastro-resistant prolonged release tablets | [2] Manganese citrate Manganese citrate, Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1361 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets | [2] Manganese citrate Manganese citrate, Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1362 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets. | [2] Manganese citrate Manganese citrate, Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1363 | Mg | - | - | - | - | [5] 6 6, 13, 51, 63, 111 |
1364 | Mg++ | - | - | - | - | [1] 6 6 |
1365 | MG-O-1002 | - | - | - | - | [1] 11 11 |
1366 | MG-S-2525 | - | - | - | - | [1] 85 85 |
1367 | MG01CI extended-release tablet | [1] Manganese citrate Manganese citrate | - | - | - | [1] 206 206 |
1368 | MGlu5 antagonist | - | - | - | - | [1] 206 206 |
1369 | Midazolam 3 mg | [1] Midazolam Midazolam (Synonym: Apo-midazolam Injectable 1 mg/ml) | [1] D00550
D00550
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 96 96 |
1370 | Migalastat HCl 150 mg | [1] Migalastat Migalastat | [1] D10359
D10359
| - | - | [1] 19 19 |
1371 | Minocycline 100 mg Film-coated Tablets | [1] Minocycline Minocycline (Synonym: Riva-minocycline 50 mg) | [1] D05045
D05045
| - | - | [1] 13 13 |
1372 | MK-8457 100 mg | - | - | - | - | [1] 46 46 |
1373 | MN-08 24 mg/day | - | - | - | - | [1] 86 86 |
1374 | MN-08 60 mg/day | - | - | - | - | [1] 86 86 |
1375 | Monomethyl fumarate 190 mg | [1] Monomethyl fumarate Monomethyl fumarate | [1] D11492
D11492
| - | - | [1] 13 13 |
1376 | Moxifloxacin 400 mg | [1] Moxifloxacin Moxifloxacin | [1] D08237
D08237
| - | - | [1] 86 86 |
1377 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - F | [1] Plerixafor Plerixafor | [1] D08971
D08971
| [1] CXCR4 CXCR4 💬 | [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 19 19 |
1378 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 24 MG/1.2 ML 1 FLACONCINO | [1] Plerixafor Plerixafor | [1] D08971
D08971
| [1] CXCR4 CXCR4 💬 | [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 65 65 |
1379 | MTX HEXAL 2,5 mg Tabletten | - | - | - | - | [1] 46 46 |
1380 | Mycophenolate mofetil orally 1000 mg twice a day (BID) | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] D00752
D00752
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 222 222 |
1381 | Myfortic 180 mg | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 162 162 |
1382 | Myfortic 180 mg Filmtabletten | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 162 162 |
1383 | Myozyme 50 mg powder for concentrate for solution for infusion | [1] Alglucosidase alfa Alglucosidase alfa | [1] D03207
D03207
| [1] GAA GAA 💬 | [4] Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1] 256 256 |
1384 | Nabilone 0.25 mg | [1] Nabilone Nabilone | [1] D05099
D05099
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 6 6 |
1385 | Nanogam 100 mg/ml | - | - | - | - | [1] 65 65 |
1386 | Nanogam® 50 mg/ml | - | - | - | - | [1] 65 65 |
1387 | Naprosyn 500 mg | [1] Naproxen Naproxen (Synonym: Naprosyn 500 Mg Tablets) | [1] D00118
D00118
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
1388 | Naproxen 10 mg/kg | [1] Naproxen Naproxen (Synonym: Naprosyn 500 Mg Tablets) | [1] D00118
D00118
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
1389 | Naproxen 500 mg tablets (PN 200 minus omeprazole) | [2] Naproxen Naproxen (Synonym: Naprosyn 500 Mg Tablets), Omeprazole (Synonym: Losec 10 mg) | [2] D00118
D00118
,
D00455
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 |
1390 | Natalizumab 300 MG in 15 ML Injection | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
1391 | ND0612 (Levodopa/Carbidopa solution) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1392 | Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection | [3] Testosterone Testosterone, Testosterone undecanoate, Undecanoic acid | [2] D00075
D00075
,
D06087
| [1] AR AR 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 13 13 |
1393 | Nebivolol 5 mg | [1] Nebivolol Nebivolol | [1] D05127
D05127
| [1] ADRB1 ADRB1 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 |
1394 | NEUPRO 2 mg/24 h parche transdérmico | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1395 | Neupro 2 mg/24 h transdermal patch | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1396 | NEUPRO 4 mg/24 h parche transdérmico | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1397 | Neupro 4 mg/24 h transdermal patch | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1398 | NEUPRO 6 mg/24 h parche transdérmico | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1399 | Neupro 6 mg/24 h transdermal patch | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1400 | NEUPRO 8 mg/24 h parche transdérmico | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1401 | Neupro 8 mg/24 h transdermal patch | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1402 | Neupro® 8 mg/24 h | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1403 | Neurontin 300 mg hard capsule | [1] Gabapentin Gabapentin | [1] D00332
D00332
| [5] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [1] 13 13 |
1404 | Nicorette 15 mg/ 16 h | [1] Nicotine Nicotine | [1] D03365
D03365
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [8] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬 | [1] 6 6 |
1405 | Nicorette 5 mg/ 16 h | [1] Nicotine Nicotine | [1] D03365
D03365
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [8] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬 | [1] 6 6 |
1406 | Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY) | [1] Nicotine Nicotine | [1] D03365
D03365
| [16] CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | [8] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬 | [1] 6 6 |
1407 | Nicotinell 17,5 mg/24-Stunden-Pflaster | - | - | - | - | [1] 6 6 |
1408 | Nicotinell 35 mg/24-Stunden-Pflaster | - | - | - | - | [1] 6 6 |
1409 | Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d | [2] Eflornithine Eflornithine, Nifurtimox | [2] D00833
D00833
,
D07883
| [1] ODC1 ODC1 💬 | [3] Arginine and proline metabolism Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬 | [1] 65 65 |
1410 | Nilotinib 150 MG | [1] Nilotinib Nilotinib | [1] D08953
D08953
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 8 8 |
1411 | Nilotinib 50 mg | [1] Nilotinib Nilotinib | [1] D08953
D08953
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 86 86 |
1412 | Nintedanib 150 mg and 100 mg soft capsules | [1] Nintedanib Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 227 227 |
1413 | Nitisinone 10 mg Tablet High Compritol | [1] Nitisinone Nitisinone | [1] D05177
D05177
| [1] HPD HPD 💬 | [5] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 241 241 |
1414 | NNC0195-0092 10 mg/1.5 ml PDS290-10 | - | - | - | - | [1] 78 78 |
1415 | NNC0195-0092 15 mg/1.5 ml PDS290-15 | - | - | - | - | [1] 78 78 |
1416 | NNC0195-0092 5 mg/1.5 ml PDS290-10 | - | - | - | - | [1] 78 78 |
1417 | NNC0195-0092 DP 6.7 mg ml 3 ml cartridge | - | - | - | - | [1] 78 78 |
1418 | NNC0195-0092 PDS290 10 mg-1.5 ml | - | - | - | - | [1] 78 78 |
1419 | NNC0195-0092 PDS290 10 mg/1.5 ml | - | - | - | - | [1] 78 78 |
1420 | Norditropin FlexPro 10 mg | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1421 | Norditropin FlexPro 10 mg/1.5 ml | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1422 | Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen | [1] Somatotropin Somatotropin | - | - | - | [1] 195 195 |
1423 | Norditropin FlexPro 5 mg/1.5 mL | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1424 | Norditropin NordiFlex® 10 mg/1.5 ml | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1425 | Norditropin SimpleXx 10 mg | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1426 | Norditropin SimpleXx 15 mg/1.5 ml | [1] Somatotropin Somatotropin | - | - | - | [1] 3 3 |
1427 | Norditropin® SimpleXx® 5 mg/1.5ml | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1428 | Norucholic acid (NCA) 500 mg | [1] norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | [1] 93 93 |
1429 | Norvir 100 mg film-coated tablets | - | - | - | - | [1] 299 299 |
1430 | NovoNorm 0.5 mg | - | - | - | - | [1] 299 299 |
1431 | NovoNorm 1 mg | - | - | - | - | [1] 299 299 |
1432 | NovoNorm 2 mg | - | - | - | - | [1] 299 299 |
1433 | NOXAFIL - 40 mg/ml oral suspension | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 299 299 |
1434 | NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 299 299 |
1435 | NOXAFIL - oral suspension 40 mg/ml | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 299 299 |
1436 | Noxafil 100 mg | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 299 299 |
1437 | Noxafil 100 mg Tablets Gastro-Resistant | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 299 299 |
1438 | Noxafil 40 mg/ml oral solution | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 65 65 |
1439 | Nucala 100 mg powder for solution for injection | [1] Mepolizumab Mepolizumab | [1] D04923
D04923
| [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 45 |
1440 | NutropinAq 10 mg/2 ml | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1441 | NutropinAq 10 mg/2 ml (30 UI) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1442 | NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1443 | NX-13 250 mg | - | - | - | - | [1] 97 97 |
1444 | Obeticholic Acid 10 MG | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
1445 | Obeticholic Acid 5 MG | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
1446 | OCA 0.1 mg | - | - | - | - | [1] 296 296 |
1447 | OCA 1,5 mg | - | - | - | - | [1] 94 94 |
1448 | OCA 5 mg | - | - | - | - | [1] 94 94 |
1449 | Ocrelizumab 300 mg | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
1450 | Ocrelizumab 600 mg | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
1451 | Ocrevus 300 mg, solution à diluer pour perfusion | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
1452 | Ocrrelizumab 300 mg | - | - | - | - | [1] 13 13 |
1453 | Octagam 50 mg/ml | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 13 13 |
1454 | OCTAGAM 50 mg/ml oldatos infúzió | - | - | - | - | [1] 65 65 |
1455 | Octreotide a azione pronta 0,1 mg | [1] Octreotide Octreotide | [1] D00442
D00442
| [1] SSTR2 SSTR2 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 227 227 |
1456 | ODM-101 105mg Carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1457 | ODM-101 65mg Carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1458 | ODM-109 capsule 1 mg | - | - | - | - | [1] 2 2 |
1459 | ODSH at 0.125 mg/kg/h | - | - | - | - | [1] 210 210 |
1460 | ODSH at 0.250 mg/kg/h | - | - | - | - | [1] 210 210 |
1461 | ODSH at 0.375 mg/kg/h | - | - | - | - | [1] 210 210 |
1462 | Ofev 100 mg capsule | [1] Nintedanib Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 |
1463 | Ofev 150 mg capsule | [1] Nintedanib Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 |
1464 | OL adalimumab 40 mg | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1465 | OligoG (60 mg/ml) | - | - | - | - | [1] 299 299 |
1466 | OligoG CF-5/20 - 17.5 mg | - | - | - | - | [1] 299 299 |
1467 | OligoG CF-5/20, 17,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | [1] 299 299 |
1468 | OligoG CF/20 - 27.5 mg | - | - | - | - | [1] 299 299 |
1469 | OligoG CF/20 - 37.5 mg | - | - | - | - | [1] 299 299 |
1470 | OligoG CF/20, 27,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | [1] 299 299 |
1471 | OligoG CF/20, 37,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | [1] 299 299 |
1472 | Olokizumab 120 mg | [1] Olokizumab Olokizumab | [1] D12487
D12487
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
1473 | Olokizumab 240 mg | [1] Olokizumab Olokizumab | [1] D12487
D12487
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
1474 | Olokizumab 60 mg | [1] Olokizumab Olokizumab | [1] D12487
D12487
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
1475 | Olokizumab 64 mg SC q2w | [1] Olokizumab Olokizumab | [1] D12487
D12487
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
1476 | Olokizumab 64 mg SC q4w | [1] Olokizumab Olokizumab | [1] D12487
D12487
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
1477 | OLUMIANT 4 mg | [1] Baricitinib Baricitinib | [1] D10308
D10308
| [2] JAK1 JAK1, JAK2 💬 | [35] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
1478 | Omaveloxolone Capsules, 10 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1479 | Omaveloxolone Capsules, 150 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1480 | Omaveloxolone Capsules, 160 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1481 | Omaveloxolone Capsules, 2.5 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1482 | Omaveloxolone Capsules, 20 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1483 | Omaveloxolone Capsules, 300 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1484 | Omaveloxolone Capsules, 40 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1485 | Omaveloxolone Capsules, 5 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1486 | Omaveloxolone Capsules, 80 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
1487 | Omeprazole 40 mg | [1] Omeprazole Omeprazole (Synonym: Losec 10 mg) | [1] D00455
D00455
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 96 96 |
1488 | OMNIPAQUE - 300 MG I/ML SOLUZIONE INIETTABILE FLACONE IN POLIPROPILENE DA 50 ML | [1] Iohexol Iohexol | [1] D01817
D01817
| - | - | [1] 222 222 |
1489 | OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 64 64, 109 |
1490 | OMS721 185 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 64 64, 109 |
1491 | OMS721 Drug Product 185 mg/mL | - | - | - | - | [1] 109 109 |
1492 | Ondansetron 8 mg film-coated tablets | [1] Ondansetron Ondansetron | [1] D00456
D00456
| [5] HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | [2] Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | [1] 6 6 |
1493 | Ongentys 50 mg capsule rigide | [1] Opicapone Opicapone | [1] D10825
D10825
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
1494 | Ongentys 50 mg hard capsules | [1] Opicapone Opicapone | [1] D10825
D10825
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
1495 | Open-Label CDCA 250 mg TID | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 |
1496 | Opicapone 50 mg | [1] Opicapone Opicapone | [1] D10825
D10825
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
1497 | Opicapone 50 mg hard capsules | [1] Opicapone Opicapone | [1] D10825
D10825
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
1498 | OPS-2071 150 mg | - | - | - | - | [1] 96 96 |
1499 | OPS-2071 300 mg | - | - | - | - | [1] 96 96 |
1500 | OPS-2071 600 mg | - | - | - | - | [1] 96 96 |
1501 | Opsumit 10 Mg Tablet | - | - | - | - | [1] 51 51 |
1502 | Optinate 5 mg filmcoated tablets | - | - | - | - | [1] 274 274 |
1503 | Oral levodopa and carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1504 | Oral Levodopa/Carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1505 | Oral Methylprednisolone 625 mg/24h x3 days | [1] Methylprednisolone Methylprednisolone (Synonym: Depo-medrol 40 mg/ml) | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
1506 | Orencia 125 mg | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 |
1507 | ORENCIA 125 mg solution for injection | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 |
1508 | ORENCIA 125 mg solution for injection in pre-filled syringe | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [3] 46 46, 49, 53 |
1509 | ORENCIA 125 mg, solution injectable en seringue préremplie | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 |
1510 | ORENCIA 250 mg polvo para concentrado para sol. para perfusión | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 |
1511 | ORENCIA® 125 mg solution for injection in pre-filled syringe | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 65 65 |
1512 | Orkambi 100 mg/125 mg film-coated tablets | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1513 | Orkambi 200 mg/125 mg film-coated tablets | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1514 | Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg | [3] Estradiol Estradiol, Ethinylestradiol, Norgestimate | [3] D00105
D00105
,
D00554
,
D05209
| [3] ESR1 ESR1, ESR2, PGR 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 299 299 |
1515 | OsrhAAT 1 mg/kg IV | - | - | - | - | [1] 231 231 |
1516 | OsrhAAT 10 mg/kg IV | - | - | - | - | [1] 231 231 |
1517 | OsrhAAT 20 mg/kg IV | - | - | - | - | [1] 231 231 |
1518 | OsrhAAT 3 mg/kg IV | - | - | - | - | [1] 231 231 |
1519 | OsrhAAT 40 mg/kg IV | - | - | - | - | [1] 231 231 |
1520 | OsrhAAT 60 mg/kg IV | - | - | - | - | [1] 231 231 |
1521 | OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [2] 56 56, 107 |
1522 | OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 107 107 |
1523 | Ovastat 1000 mg, powder for solution for infusion | [1] Treosulfan Treosulfan | [1] D07253
D07253
| - | - | [1] 65 65 |
1524 | Ovastat 5000 mg, powder for solution for infusion | [1] Treosulfan Treosulfan | [1] D07253
D07253
| - | - | [1] 65 65 |
1525 | Over-encapsulated 150 mg Irbesartan Tablets | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
1526 | Over-encapsulated 75 mg Irbesartan Tablets | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
1527 | Overencapsulated Azathioprine (Imuran) 50 mg Tablet | [1] Azathioprine Azathioprine (Synonym: Riva-azathioprine 50 mg) | [1] D00238
D00238
| - | - | [1] 97 97 |
1528 | OXN 10 mg / 5 mg PR | - | - | - | - | [1] 6 6 |
1529 | OXN 10/5 mg PR | - | - | - | - | [1] 226 226 |
1530 | OXN 20 mg / 10 mg PR | - | - | - | - | [1] 6 6 |
1531 | OXN 20/10 mg PR | - | - | - | - | [1] 226 226 |
1532 | OXN 5 mg/2.5 mg PR | - | - | - | - | [1] 6 6 |
1533 | OXN 5/2.5 mg PR | - | - | - | - | [1] 226 226 |
1534 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] D05312
D05312
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
1535 | Oxycodone/naloxone prolonged release tablets 10/5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] D05312
D05312
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
1536 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] D05312
D05312
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
1537 | Oxycodone/naloxone prolonged release tablets 20/10 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] D05312
D05312
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
1538 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] D05312
D05312
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
1539 | Oxycodone/naloxone prolonged release tablets 5/2.5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] D05312
D05312
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
1540 | Ozanimod 0.5 mg | [1] Ozanimod Ozanimod | [1] D10968
D10968
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1541 | Ozanimod 1 mg | [1] Ozanimod Ozanimod | [1] D10968
D10968
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1542 | P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), | [2] Pramipexole Pramipexole, Rasagiline | [3] D05575
D05575
,
D08469
,
D10829
| [4] DRD2 DRD2, DRD3, DRD4, MAOB 💬 | [18] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1543 | P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), | [2] Pramipexole Pramipexole, Rasagiline | [3] D05575
D05575
,
D08469
,
D10829
| [4] DRD2 DRD2, DRD3, DRD4, MAOB 💬 | [18] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1544 | PALOVAROTENE - 10 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1545 | PALOVAROTENE - 2 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1546 | PALOVAROTENE - 2.5 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1547 | PALOVAROTENE - 3 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1548 | PALOVAROTENE - 4 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1549 | PALOVAROTENE - 5 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1550 | PALOVAROTENE 1.5 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1551 | PALOVAROTENE-2 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1552 | PALOVAROTENE-3 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1553 | PALOVAROTENE-4 mg | [1] Palovarotene Palovarotene | [1] D09365
D09365
| [1] RARG RARG 💬 | - | [1] 272 272 |
1554 | Pantoprazolo 20 mg gastro-resistant tablets | - | - | - | - | [1] 65 65 |
1555 | Paracetamolo 500 mg | - | - | - | - | [1] 13 13 |
1556 | PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE | - | - | - | - | [1] 19 19 |
1557 | PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE | - | - | - | - | [1] 300 300 |
1558 | Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP | [2] Paroxetine Paroxetine, Prednisolone | [2] D00472
D00472
,
D02362
| [2] NR3C1 NR3C1, SLC6A4 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 |
1559 | Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP | [2] Paroxetine Paroxetine, Prednisolone | [2] D00472
D00472
,
D02362
| [2] NR3C1 NR3C1, SLC6A4 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 |
1560 | Parsaclisib (1 mg) | [1] Parsaclisib Parsaclisib | [1] D11437
D11437
| [1] PIK3CD PIK3CD 💬 | [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 |
1561 | Parsaclisib (2.5 mg) | [1] Parsaclisib Parsaclisib | [1] D11437
D11437
| [1] PIK3CD PIK3CD 💬 | [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 61 61 |
1562 | Part A: 100 mg/mL GSK2618960 | - | - | - | - | [1] 13 13 |
1563 | Part I - etoricoxib 60 mg | [1] Etoricoxib Etoricoxib | [1] D03710
D03710
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
1564 | Part I - etoricoxib 90 mg | [1] Etoricoxib Etoricoxib | [1] D03710
D03710
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
1565 | Part I- naproxen 1000 mg | [1] Naproxen Naproxen (Synonym: Naprosyn 500 Mg Tablets) | [1] D00118
D00118
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
1566 | Part II- etoricoxib 60 mg | [1] Etoricoxib Etoricoxib | [1] D03710
D03710
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
1567 | Part II- etoricoxib 90 mg | [1] Etoricoxib Etoricoxib | [1] D03710
D03710
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
1568 | Part II- naproxen 1000 mg | [1] Naproxen Naproxen (Synonym: Naprosyn 500 Mg Tablets) | [1] D00118
D00118
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
1569 | Pasireotide 0.6 MG/ML | [1] Pasireotide Pasireotide | [1] D10147
D10147
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 |
1570 | Pasireotide 0.9 mg | [1] Pasireotide Pasireotide | [1] D10147
D10147
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 |
1571 | PBF-999 / 160 mg | - | - | - | - | [1] 8 8 |
1572 | PBF-999 / 320 mg | - | - | - | - | [1] 8 8 |
1573 | Pelubiprofen 30 mg | [1] Pelubiprofen Pelubiprofen | [1] D01865
D01865
| - | - | [1] 46 46 |
1574 | PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE | - | - | - | - | [1] 171 171 |
1575 | Pentasa 500 mg Retardtabletten | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1576 | Pentosan polysulfate sodium 100 mg | [1] Pentosan polysulfate Pentosan polysulfate | - | - | - | [1] 226 226 |
1577 | Pentoxifylline 400 MG | [1] Pentoxifylline Pentoxifylline (Synonym: Nu-pentoxifylline-SR 400 mg) | [1] D00501
D00501
| - | - | [1] 97 97 |
1578 | Peri-neural Dexamethasone 1 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1579 | Persantin 100 mg | - | - | - | - | [1] 46 46 |
1580 | Persantin 100 mg and | - | - | - | - | [1] 46 46 |
1581 | PF-04171327 10 mg | - | - | - | - | [1] 46 46 |
1582 | PF-04171327 25 mg | - | - | - | - | [1] 46 46 |
1583 | PF-06342674 0.25 mg/kg | - | - | - | - | [1] 13 13 |
1584 | PF-06342674 1.5 mg/kg | - | - | - | - | [1] 13 13 |
1585 | PF-06342674 6.0 mg/kg | - | - | - | - | [1] 13 13 |
1586 | PF-06480605 100 mg/ml | - | - | - | - | [1] 97 97 |
1587 | PF-06649751 high dose (15 mg QD) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
1588 | PF-06649751 low dose (1 mg QD) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
1589 | PF-06649751 middle dose 1 (3 mg QD) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
1590 | PF-06649751 middle dose 2 (7 mg QD) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
1591 | PF-06650833 100 mg | [1] PF-06650833 PF-06650833 | - | - | - | [1] 46 46 |
1592 | PF-06650833 20 mg | [1] PF-06650833 PF-06650833 | - | - | - | [1] 46 46 |
1593 | PF-06651600 10 mg | [1] PF-06651600 PF-06651600 | - | - | - | [1] 97 97 |
1594 | PF-06651600 50 mg | [1] PF-06651600 PF-06651600 | - | - | - | [2] 96 96, 97 |
1595 | PF-06700841 15 mg | [1] PF-06700841 PF-06700841 | - | - | - | [1] 49 49 |
1596 | PF-06700841 25 mg | [1] PF-06700841 PF-06700841 | - | - | - | [2] 96 96, 97 |
1597 | PF-06700841 30 mg | [1] PF-06700841 PF-06700841 | - | - | - | [1] 49 49 |
1598 | PF-06700841 45 mg | [1] PF-06700841 PF-06700841 | - | - | - | [1] 49 49 |
1599 | PF-06700841 5 mg | [1] PF-06700841 PF-06700841 | - | - | - | [3] 49 49, 96, 97 |
1600 | PF-06826647 100 mg QD | - | - | - | - | [1] 97 97 |
1601 | PF-06826647 300 mg QD | - | - | - | - | [1] 97 97 |
1602 | PF-06826647 600 mg QD | - | - | - | - | [1] 97 97 |
1603 | PF-6826647 400 mg QD | - | - | - | - | [1] 97 97 |
1604 | Pimozide 2 mg per day | [1] Pimozide Pimozide | [1] D00560
D00560
| [2] ADRA2A ADRA2A, DRD2 💬 | [9] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 |
1605 | Pimozide 2mg/day (current) or 4 mg/day (study initiation) | [1] Pimozide Pimozide | [1] D00560
D00560
| [2] ADRA2A ADRA2A, DRD2 💬 | [9] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 |
1606 | Pimozide 4 mg per day | [1] Pimozide Pimozide | [1] D00560
D00560
| [2] ADRA2A ADRA2A, DRD2 💬 | [9] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 |
1607 | Pioglitazone 15 mg | [1] Pioglitazone Pioglitazone | [1] D08378
D08378
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 96 96 |
1608 | Pirepemat, 100 mg | - | - | - | - | [1] 6 6 |
1609 | Pirepemat, 50 mg | - | - | - | - | [1] 6 6 |
1610 | Pirfenidone 267 MG [Esbriet] | [1] Pirfenidone Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 228 228 |
1611 | PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml | - | - | - | - | [1] 51 51 |
1612 | PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿ | - | - | - | - | [1] 51 51 |
1613 | Plaquenil 200 mg filmdrasjerte tabletter | - | - | - | - | [1] 46 46 |
1614 | Plenadren 20 mg modified-release tablets | [2] Hydrocortisone Hydrocortisone, Manganese citrate | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
1615 | Plenadren 5 mg modified-release tablets | [2] Hydrocortisone Hydrocortisone, Manganese citrate | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
1616 | Plovamer acetate 0.5 milligram (mg) | [1] Acetate Acetate | - | - | - | [1] 13 13 |
1617 | Plovamer acetate 10 mg | [1] Acetate Acetate | - | - | - | [1] 13 13 |
1618 | Plovamer acetate 20 mg | [1] Acetate Acetate | - | - | - | [1] 13 13 |
1619 | Plovamer acetate 3 mg | [1] Acetate Acetate | - | - | - | [1] 13 13 |
1620 | PN 200 tablets (500 mg naproxen and 20 mg omeprazole) | [2] Naproxen Naproxen (Synonym: Naprosyn 500 Mg Tablets), Omeprazole (Synonym: Losec 10 mg) | [2] D00118
D00118
,
D00455
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 |
1621 | Ponesimod 10 mg | [1] Ponesimod Ponesimod | [1] D11215
D11215
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1622 | Ponesimod 20 mg | [1] Ponesimod Ponesimod | [1] D11215
D11215
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1623 | Ponesimod 40 mg | [1] Ponesimod Ponesimod | [1] D11215
D11215
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1624 | Posaconazole 100 MG [Noxafil] | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 299 299 |
1625 | Posaconazole 40 MG/ML | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 299 299 |
1626 | PRALIA 60 mg Subcutaneous Injection Syringe(denosumab) | [1] Denosumab Denosumab | [1] D03684
D03684
| [1] TNFSF11 TNFSF11 💬 | [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 46 46 |
1627 | Pramipexole 0.125 mg tablets | [1] Pramipexole Pramipexole | [1] D05575
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1628 | Pramipexole 0.5 mg tablets | [1] Pramipexole Pramipexole | [1] D05575
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1629 | Prednisolene tablets BP 1 mg | - | - | - | - | [1] 46 46 |
1630 | Prednisolon 1 mg JENAPHARM | - | - | - | - | [1] 41 41 |
1631 | Prednisolon 10 mg JENAPHARM | - | - | - | - | [1] 41 41 |
1632 | Prednisolon 20 mg JENAPHARM | - | - | - | - | [1] 41 41 |
1633 | Prednisolon 5 mg JENAPHARM | - | - | - | - | [1] 41 41 |
1634 | Prednisolone 2,5 mg Tablets | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
1635 | Prednisolone 20 mg | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1636 | Prednisolone 40 mg | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1637 | Prednisolone 5 mg | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 |
1638 | Prednisolone 5 mg JENAPHARM | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
1639 | Prednisolone 5 mg Tablets | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
1640 | Prednisolone Tablets BP 1 mg | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1641 | Prednisolone Tablets USP 5 mg | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1642 | Prednison 10 mg GALEN | - | - | - | - | [1] 35 35 |
1643 | Prednison 5 mg GALEN | - | - | - | - | [1] 35 35 |
1644 | Prednison 50 mg GALEN | - | - | - | - | [1] 35 35 |
1645 | Prednison acis® 20 mg | - | - | - | - | [2] 43 43, 44 |
1646 | Prednison acis® 5 mg | - | - | - | - | [2] 43 43, 44 |
1647 | Prednison acis¿ 20 mg | - | - | - | - | [2] 43 43, 44 |
1648 | Prednison acis¿ 5 mg | - | - | - | - | [2] 43 43, 44 |
1649 | Prednison20 mg GALEN | - | - | - | - | [1] 35 35 |
1650 | Prednisone 0,5 mg/kg orally on alternate days | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 |
1651 | Prednisone 1 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1652 | Prednisone 15 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1653 | Prednisone 2 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1654 | Prednisone 3 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1655 | Prednisone 4 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1656 | Prednisone 5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 66 |
1657 | Prednisone 5 mg tablets | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
1658 | Prednisone 7.5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1659 | PREDNISONE ARROW 5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
1660 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 19 19 |
1661 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 300 300 |
1662 | PredniSONE Tablets USP, 1 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 41 41, 46 |
1663 | PredniSONE Tablets USP, 10 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
1664 | PredniSONE Tablets USP, 2.5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
1665 | PredniSONE Tablets USP, 5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 41 41, 46 |
1666 | PredniSONE Tablets, USP 10 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
1667 | PredniSONE Tablets, USP 2.5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
1668 | PredniSONE Tablets, USP 5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
1669 | PredniSONE Tablets, USP, 1 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
1670 | Preladenant 10 mg tablet | [1] Preladenant Preladenant | [1] D09717
D09717
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
1671 | Preladenant 2 mg tablet | [1] Preladenant Preladenant | [1] D09717
D09717
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
1672 | Preladenant 5 mg tablet | [1] Preladenant Preladenant | [1] D09717
D09717
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
1673 | Pridopidine (90 mg) | [1] Pridopidine Pridopidine | [1] D09953
D09953
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 8 8 |
1674 | PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML | - | - | - | - | [1] 51 51 |
1675 | Privigen 100 mg/ml, solution pour perfusion | - | - | - | - | [1] 53 53 |
1676 | PRO044 IV 6 mg/kg | - | - | - | - | [1] 113 113 |
1677 | PRO044 IV 9 mg/kg | - | - | - | - | [1] 113 113 |
1678 | PRO044 SC 6 mg/kg | - | - | - | - | [1] 113 113 |
1679 | PRO045, 0.15 mg/kg/week | [1] BMN-045 BMN-045 | - | - | - | [1] 113 113 |
1680 | PRO045, 1.0 mg/kg/week | [1] BMN-045 BMN-045 | - | - | - | [1] 113 113 |
1681 | PRO045, 3.0 mg/kg/week | [1] BMN-045 BMN-045 | - | - | - | [1] 113 113 |
1682 | PRO045, 6.0 mg/kg/week | [1] BMN-045 BMN-045 | - | - | - | [1] 113 113 |
1683 | PRO045, 9.0 mg/kg/week | [1] BMN-045 BMN-045 | - | - | - | [1] 113 113 |
1684 | PROCAPTAN - 10 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN CONTENITORE PER COMPRESSE PP | - | - | - | - | [1] 58 58 |
1685 | PROCAPTAN - 5 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN CONTENITORE PER COMPRESSE PP | - | - | - | - | [1] 58 58 |
1686 | Prolastin-C, 120 mg/kg | [1] Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | [1] 231 231 |
1687 | Prolastin-C, 60 mg/kg | [1] Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | [1] 231 231 |
1688 | Propranolol HCl CF 40 mg tablet | [1] Propranolol Propranolol | [1] D08443
D08443
| [3] ADRB1 ADRB1, ADRB2, ADRB3 💬 | [12] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
1689 | PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE | [1] Modafinil Modafinil | [1] D01832
D01832
| - | - | [1] 113 113 |
1690 | PRX-102 1 mg/kg every 2 weeks | - | - | - | - | [1] 19 19 |
1691 | PRX-102 2 mg/kg every 4 weeks | - | - | - | - | [1] 19 19 |
1692 | PT320 2.0 mg | - | - | - | - | [1] 6 6 |
1693 | PT320 2.5 mg | - | - | - | - | [1] 6 6 |
1694 | PTC518 tablet 20 mg | - | - | - | - | [1] 8 8 |
1695 | PTC518 tablet 5 mg | - | - | - | - | [1] 8 8 |
1696 | PTW-002 10 mg/g gel | - | - | - | - | [1] 36 36 |
1697 | Puerarin injection 400 mg | [1] Puerarin Puerarin | - | - | - | [1] 46 46 |
1698 | Puerarin tablet 50 mg | [1] Puerarin Puerarin | - | - | - | [1] 46 46 |
1699 | PUR 0110 Rectal Enema 1000 mg | - | - | - | - | [1] 97 97 |
1700 | PUR 0110 Rectal Enema 250 mg | - | - | - | - | [1] 97 97 |
1701 | PUR 0110 Rectal Enema 500 mg | - | - | - | - | [1] 97 97 |
1702 | Puri-Nethol 50 mg | - | - | - | - | [1] 96 96 |
1703 | PURINETHOL - 50 MG COMPRESSE25 COMPRESSE | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 96 96 |
1704 | Q4W GMA301 IV injections (1000 mg) | - | - | - | - | [1] 86 86 |
1705 | Q4W GMA301 IV injections (300 mg) | - | - | - | - | [1] 86 86 |
1706 | Q4W GMA301 IV injections (600 mg) | - | - | - | - | [1] 86 86 |
1707 | QCC374 0.015 mg | - | - | - | - | [1] 86 86 |
1708 | QCC374 0.06 mg | - | - | - | - | [1] 86 86 |
1709 | RAD001 2,5 mg | - | - | - | - | [1] 158 158 |
1710 | Radotinib HCl 50 mg | [1] Radotinib Radotinib | - | - | - | [1] 6 6 |
1711 | RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE | [1] Ranolazine Ranolazine | [1] D05700
D05700
| - | - | [1] 58 58 |
1712 | Ranibizumab injection (0.5 mg) | [1] Ranibizumab Ranibizumab | [1] D05697
D05697
| [1] VEGFA VEGFA 💬 | [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [2] 166 166, 301 |
1713 | Ranolazine 1000 MG | [1] Ranolazine Ranolazine | [1] D05700
D05700
| - | - | [1] 2 2 |
1714 | Ranolazine 1000 mg PR tablets | [1] Ranolazine Ranolazine | [1] D05700
D05700
| - | - | [1] 58 58 |
1715 | Ranolazine 500 MG | [1] Ranolazine Ranolazine | [1] D05700
D05700
| - | - | [1] 2 2 |
1716 | Ranolazine 500 mg PR tablets | [1] Ranolazine Ranolazine | [1] D05700
D05700
| - | - | [1] 58 58 |
1717 | Ranolazine 750 mg PR tablets | [1] Ranolazine Ranolazine | [1] D05700
D05700
| - | - | [1] 58 58 |
1718 | Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die | [1] Ranolazine Ranolazine | [1] D05700
D05700
| - | - | [1] 58 58 |
1719 | RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 2 2 |
1720 | RAPAMUNE 1 mg/ml oral solution | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 |
1721 | Rapamune 1 mg/ml solución oral | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 |
1722 | Raptiva 100 mg/ml powder and solvent for solution for injection | [1] Efalizumab Efalizumab | [1] D03959
D03959
| [1] ITGAL ITGAL 💬 | [12] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [7] 11 11, 13, 46, 53, 61, 95, 96 |
1723 | Rasagiline 1 mg capsule | [1] Rasagiline Rasagiline | [2] D08469
D08469
,
D10829
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1724 | Rasagiline 2 mg tablet | [1] Rasagiline Rasagiline | [2] D08469
D08469
,
D10829
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1725 | Rasagiline mesylate 1.0 mg | [1] Rasagiline Rasagiline | [2] D08469
D08469
,
D10829
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1726 | RAvPAL-PEG 0.001 mg/kg | [1] Pegvaliase Pegvaliase | [1] D11077
D11077
| [1] PAH PAH 💬 | [5] Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1] 240 240 |
1727 | RAvPAL-PEG 0.003 mg/kg | [1] Pegvaliase Pegvaliase | [1] D11077
D11077
| [1] PAH PAH 💬 | [5] Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1] 240 240 |
1728 | RAvPAL-PEG 0.01 mg/kg | [1] Pegvaliase Pegvaliase | [1] D11077
D11077
| [1] PAH PAH 💬 | [5] Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1] 240 240 |
1729 | RAvPAL-PEG 0.03 mg/kg | [1] Pegvaliase Pegvaliase | [1] D11077
D11077
| [1] PAH PAH 💬 | [5] Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1] 240 240 |
1730 | RAvPAL-PEG 0.1 mg/kg | [1] Pegvaliase Pegvaliase | [1] D11077
D11077
| [1] PAH PAH 💬 | [5] Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1] 240 240 |
1731 | RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE | [1] Idebenone Idebenone | [1] D01750
D01750
| - | - | [1] 113 113 |
1732 | RC18 160 mg | - | - | - | - | [2] 13 13, 53 |
1733 | RC18 160 mg plus MTX | - | - | - | - | [1] 46 46 |
1734 | RC18 160 mg plus standard therapy | - | - | - | - | [1] 49 49 |
1735 | RC18 240 mg | - | - | - | - | [2] 11 11, 53 |
1736 | RC18 240 mg plus standard therapy | - | - | - | - | [1] 49 49 |
1737 | RC18 80 mg plus standard therapy | - | - | - | - | [1] 49 49 |
1738 | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | - | - | - | - | [1] 79 79 |
1739 | Reldesemtiv 150 mg | [1] Reldesemtiv Reldesemtiv | [1] D11363
D11363
| [1] TNNC2 TNNC2 💬 | [1] Calcium signaling pathway Calcium signaling pathway 💬 | [1] 3 3 |
1740 | Reldesemtiv 450 mg | [1] Reldesemtiv Reldesemtiv | [1] D11363
D11363
| [1] TNNC2 TNNC2 💬 | [1] Calcium signaling pathway Calcium signaling pathway 💬 | [1] 3 3 |
1741 | REMICADE - 100 MG POLVERE PER CONCENTRATO PER INFUSIONE ENDOVENOSA 1 FLACONE VETRO 20 ML USO EV | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
1742 | Remicade 100 mg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 56 56, 96 |
1743 | Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
1744 | REMICADE 100 mg polvo para concentrado para solución para perfusión | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 271 |
1745 | Remicade 100 mg powder for concentrate for solution for infusion. | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
1746 | Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
1747 | Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning. | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
1748 | Remodulin® (treprostinil) 1 mg/ml solution for infusion | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
1749 | Remodulin® (treprostinil) 10 mg/ml solution for infusion | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
1750 | Remodulin® (treprostinil) 2.5 mg/ml solution for infusion | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
1751 | Remodulin® (treprostinil) 5 mg/ml solution for infusion | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
1752 | REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
1753 | Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
1754 | Repatha 140 mg Solution for Injection in Pre-filled Pen | [1] Evolocumab Evolocumab | [1] D10557
D10557
| [1] PCSK9 PCSK9 💬 | [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 |
1755 | Repatha 140 mg soluzione per iniezione in penna preriempita. | [1] Evolocumab Evolocumab | [1] D10557
D10557
| [1] PCSK9 PCSK9 💬 | [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 |
1756 | Repatha 420 mg solution for injection in cartridge | [1] Evolocumab Evolocumab | [1] D10557
D10557
| [1] PCSK9 PCSK9 💬 | [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 |
1757 | Repatha 420 mg soluzione per iniezione in cartuccia | [1] Evolocumab Evolocumab | [1] D10557
D10557
| [1] PCSK9 PCSK9 💬 | [1] Cholesterol metabolism Cholesterol metabolism 💬 | [1] 79 79 |
1758 | REQUIP 21 CPR 0,25 MG | [1] Ropinirole Ropinirole | [1] D08489
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1759 | REQUIP 21 CPR 0,5 MG | [1] Ropinirole Ropinirole | [1] D08489
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1760 | REQUIP 21 CPR 1 MG | [1] Ropinirole Ropinirole | [1] D08489
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1761 | REQUIP 21 CPR 2 MG | [1] Ropinirole Ropinirole | [1] D08489
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1762 | Rescue Medication CDCA 250 mg TID | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 |
1763 | REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 294 294 |
1764 | Revatio 10 mg/ml powder for oral suspension | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1765 | Revatio 20 mg | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
1766 | Revatio 20 mg film coated tablets | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1767 | Revatio 20 mg film-coated tablets | - | - | - | - | [1] 86 86 |
1768 | Revatio 20 mg Filmtabletten | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1769 | REVATIO 20 mg, comprimidos recubiertos con película | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1770 | Revatio ® 20 mg film-coated tablets | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1771 | REVOLADE - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU) 28 COMPRESSE | [1] Eltrombopag Eltrombopag | - | - | - | [1] 60 60 |
1772 | REVOLADE - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU | [1] Eltrombopag Eltrombopag | - | - | - | [1] 60 60 |
1773 | Revolade 25 mg film-coated tablets | [1] Eltrombopag Eltrombopag | - | - | - | [1] 63 63 |
1774 | Revolade 50 mg film-coated tablets | [1] Eltrombopag Eltrombopag | - | - | - | [1] 63 63 |
1775 | Revolade 75 mg | [1] Eltrombopag Eltrombopag | - | - | - | [1] 60 60 |
1776 | RhHNS-10 mg | - | - | - | - | [1] 19 19 |
1777 | RhHNS-45 mg | - | - | - | - | [1] 19 19 |
1778 | RhHNS-90 mg | - | - | - | - | [1] 19 19 |
1779 | RhuDex 100 mg (127 mg RhuDex choline salt) granules | [1] Choline Choline (Synonym: Choline Bitartrate 500 Mg - Tablet) | [1] D07690
D07690
| - | - | [1] 93 93 |
1780 | RhuDex 25 mg (31.75 mg RhuDex choline salt) granules | [1] Choline Choline (Synonym: Choline Bitartrate 500 Mg - Tablet) | [1] D07690
D07690
| - | - | [1] 93 93 |
1781 | RhuDex 50 mg (63.5 mg RhuDex choline salt) granules | [1] Choline Choline (Synonym: Choline Bitartrate 500 Mg - Tablet) | [1] D07690
D07690
| - | - | [1] 93 93 |
1782 | Rifaximin 550 MG | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 6 6 |
1783 | Rifaximin 550 MG Oral Tablet [XIFAXAN] | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 299 299 |
1784 | Rifaximin delayed release 400 mg film coated tablet | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
1785 | Rilonacept 160 mg | [1] Rilonacept Rilonacept | [1] D06635
D06635
| [2] IL1A IL1A, IL1B 💬 | [45] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 106 106 |
1786 | Rilutek 50 mg film-coated tablets | [1] Riluzole Riluzole | [1] D00775
D00775
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 2 2 |
1787 | RILUTEK 50 mg, film-coated tablets | [1] Riluzole Riluzole | [1] D00775
D00775
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 2 2 |
1788 | Riluzole (100 mg) | [1] Riluzole Riluzole | [1] D00775
D00775
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 2 2 |
1789 | Riluzole 50 MG | [1] Riluzole Riluzole | [1] D00775
D00775
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 2 2 |
1790 | Riluzole 50 MG (Part B) | [1] Riluzole Riluzole | [1] D00775
D00775
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 2 2 |
1791 | Riluzole Oral Soluble film (ROSF) 50 mg | [1] Riluzole Riluzole | [1] D00775
D00775
| [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1] 2 2 |
1792 | RILUZOLO TEVA - 50 MG COMPRESSE RIVESTITE CON FILM 90 COMPRESSE IN BLISTER AL/PVC | - | - | - | - | [1] 114 114 |
1793 | Riociguat coated tablet 0.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
1794 | Riociguat coated tablet 1.0 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
1795 | Riociguat coated tablet 1.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
1796 | Riociguat coated tablet 2.0 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
1797 | Riociguat coated tablet 2.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
1798 | Risankizumab 10 mg/ml | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1799 | Risankizumab 180 mg SC | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1800 | Risankizumab 600 mg IV | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1801 | Risankizumab 90 mg/ml | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1802 | Ritlecitinib 10 mg | - | - | - | - | [1] 97 97 |
1803 | Ritlecitinib 5 mg | - | - | - | - | [1] 97 97 |
1804 | Ritlecitinib 50 mg | - | - | - | - | [2] 96 96, 97 |
1805 | Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
1806 | RIV-TDS 13.3 mg/24 h | - | - | - | - | [1] 6 6 |
1807 | Rivaroxaban 20 mg | [1] Rivaroxaban Rivaroxaban | [1] D07086
D07086
| [1] F10 F10 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 91 91 |
1808 | Rivastigmine transdermal system 13.3 mg/24 h | [1] Rivastigmine Rivastigmine | [1] D03822
D03822
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 6 6 |
1809 | RIXATHON 500 mg | - | - | - | - | [1] 85 85 |
1810 | RO4917523 0.5 mg | - | - | - | - | [1] 206 206 |
1811 | RO4917523 1.5 mg | - | - | - | - | [1] 206 206 |
1812 | RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL) | - | - | - | - | [1] 113 113 |
1813 | RO7239361 Injections, 35 mg/Syringe (50 mg/mL) | - | - | - | - | [1] 113 113 |
1814 | RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL) | - | - | - | - | [1] 113 113 |
1815 | RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL) | - | - | - | - | [1] 113 113 |
1816 | RO7490677 160 mg/8 ml | - | - | - | - | [1] 85 85 |
1817 | RO7490677 160 mg/8mL | - | - | - | - | [1] 85 85 |
1818 | RO7490677 320 mg/16 ml (2nd generation) | - | - | - | - | [1] 85 85 |
1819 | ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 51 |
1820 | ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
1821 | RoActemra 162 mg | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 51 |
1822 | RoActemra 162 mg solution for injection in pre-filled syringe | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 |
1823 | RoActemra 162 mg solution injectable en seringue préremplie | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
1824 | RoActemra 162 mg soluzione iniettabile in siringa preriempita | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 50 50 |
1825 | RoActemra 20 mg/ml concentrado para solución para perfusión | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
1826 | RoActemra 20 mg/ml Concentrate for solution for infusion | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
1827 | RoActemra 20 mg/ml concentrate for solution for infusion. | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
1828 | ROACTEMRA 20 mg/ml, concentrado para solución para perfusión | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [3] 46 46, 107, 271 |
1829 | Rob 803 (capsules 12.5 mg) | - | - | - | - | [1] 46 46 |
1830 | Rob 803 (capsules 15 mg) | - | - | - | - | [1] 46 46 |
1831 | Rob 803 (capsules 25 mg) | - | - | - | - | [1] 46 46 |
1832 | Rob 803 (capsules 6.25 mg) | - | - | - | - | [1] 46 46 |
1833 | Rodatristat ethyl 300 mg tablet BID | - | - | - | - | [1] 86 86 |
1834 | Rodatristat ethyl 600 mg BID | - | - | - | - | [1] 86 86 |
1835 | Rokan (r) Novo 120 mg | - | - | - | - | [1] 18 18 |
1836 | Rosuvastatin 10 mg | [1] Rosuvastatin Rosuvastatin | [1] D08492
D08492
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 96 96 |
1837 | ROT-TDS 8 mg/24 h | - | - | - | - | [1] 6 6 |
1838 | RVT-101 35 mg | - | - | - | - | [1] 6 6 |
1839 | RWJ-445380 100 mg | - | - | - | - | [1] 46 46 |
1840 | RWJ-445380 200 mg | - | - | - | - | [1] 46 46 |
1841 | RWJ-445380 300 mg | - | - | - | - | [1] 46 46 |
1842 | RWJ-445380 capsule 100 mg | - | - | - | - | [1] 46 46 |
1843 | RWJ-445380 capsules 150 mg | - | - | - | - | [1] 46 46 |
1844 | RWJ-445380 Capsules 50 mg | - | - | - | - | [1] 46 46 |
1845 | Rytary 145 mg | - | - | - | - | [1] 6 6 |
1846 | Rytary 195 mg | - | - | - | - | [1] 6 6 |
1847 | SABRIL 500 mg, granules for oral solution | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 158 158 |
1848 | Safinimide 50-100 mg/day | - | - | - | - | [1] 6 6 |
1849 | SAIZEN - 1 FLACONCINO POLV. 8 MG + 1 CARTUCCIA. SOLV. INSERITI IN UN DISPOSITIVO PER LA RICOSTITUZIONE | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
1850 | Salazopyrin EN 500 mg enterotabletter | - | - | - | - | [1] 46 46 |
1851 | Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet | [2] Salbutamol Salbutamol (Synonym: Nu-salbutamol Plastic Ampules 1 mg/ml), Sulfate ion | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 111 111 |
1852 | Salbutamol WZF 4 mg | [1] Salbutamol Salbutamol (Synonym: Nu-salbutamol Plastic Ampules 1 mg/ml) | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 |
1853 | Salofalk 500 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
1854 | Salofalk Granu-Stix 500 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1855 | Salofalk® 500 mg gastro-resistant tablet | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1856 | Salofalk® 500 mg tablets | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
1857 | Samsca 15 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1858 | Samsca 30 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1859 | SAMSCA 7.5 mg oral tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
1860 | SAN-300 0.5 mg/kg QW | - | - | - | - | [1] 46 46 |
1861 | SAN-300 1.0 mg/kg QW | - | - | - | - | [1] 46 46 |
1862 | SAN-300 2.0 mg/kg QOW | - | - | - | - | [1] 46 46 |
1863 | SAN-300 4.0 mg/kg QOW | - | - | - | - | [1] 46 46 |
1864 | SAN-300 4.0 mg/kg QW | - | - | - | - | [1] 46 46 |
1865 | Sandimmun 50 mg/ml, infuusiokonsentraatti | - | - | - | - | [1] 97 97 |
1866 | SANDIMMUN NEORAL - 10 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
1867 | SANDIMMUN NEORAL - 100 MG CAPSULE MOLLI 30 CAPSULE | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
1868 | SANDIMMUN NEORAL - 25 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
1869 | SANDIMMUN NEORAL - 50 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
1870 | Sandostatin LAR 20 mg | [1] Octreotide Octreotide | [1] D00442
D00442
| [1] SSTR2 SSTR2 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 227 227 |
1871 | SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI | - | - | - | - | [1] 67 67 |
1872 | Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA] | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
1873 | Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1 | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 84 84 |
1874 | Saroglitazar Magnesium 1 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
1875 | Saroglitazar Magnesium 2 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
1876 | Saroglitazar magnesium 4 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
1877 | Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
1878 | Satralizumab (120 mg/PFS with NSD) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
1879 | Satralizumab (120 mg/vial) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
1880 | Satralizumab 120 mg | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
1881 | SB-497115-GR 50 mg | - | - | - | - | [1] 63 63 |
1882 | SC belimumab 200 mg | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
1883 | SCH 420814 10 mg | - | - | - | - | [1] 6 6 |
1884 | SCH 420814 100 mg | - | - | - | - | [1] 6 6 |
1885 | Sebelipase alfa 0.35 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
1886 | Sebelipase alfa 1 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
1887 | Sebelipase alfa 3 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
1888 | Secukinumab (150 mg) | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
1889 | Secukinumab (75 mg) | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
1890 | Secukinumab (AIN457) 150 mg s.c. | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
1891 | Secukinumab 150 mg | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 |
1892 | Secukinumab 150 mg (2 injections per dose | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 269 269 |
1893 | Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection. | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
1894 | Secukinumab 150 mg/1 mL Solution for injection | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [2] 37 37, 271 |
1895 | Secukinumab 150 mg/ml | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
1896 | Secukinumab 300 mg | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 |
1897 | Secukinumab 300 mg, s.c. | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 |
1898 | Secukinumab 75 mg/0.5 ml Solution for injection | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
1899 | Seladelpar 10 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
1900 | Seladelpar 10 mg Capsule | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
1901 | Seladelpar 10 mg or less | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
1902 | Seladelpar 5 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
1903 | Seladelpar 5 mg Capsule | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
1904 | Seladelpar 5-10 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
1905 | Selumetinib granules in sprinkle capsules for opening 5 mg | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
1906 | Selumetinib granules in sprinkle capsules for opening 7.5 mg | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
1907 | Sifalimumab 1,200 mg | [1] Sifalimumab Sifalimumab | [1] D09668
D09668
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 |
1908 | Sifalimumab 200 mg | [1] Sifalimumab Sifalimumab | [1] D09668
D09668
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 |
1909 | Sifalimumab 600 mg | [1] Sifalimumab Sifalimumab | [1] D09668
D09668
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 |
1910 | Sifrol, 0,35 mg Tablette | [1] Pramipexole Pramipexole | [1] D05575
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1911 | Sifrol, 0,70 mg Tablette | [1] Pramipexole Pramipexole | [1] D05575
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1912 | Sildenafil (50 mg) | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
1913 | Sildenafil (Revatio) 20 mg TID | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
1914 | Sildenafil 20 mg tablets | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 278 278 |
1915 | Sildenafil25 mg | - | - | - | - | [1] 17 17 |
1916 | SIMPONI - 50 MG-SOLUZIONE PER INIEZIONE IN PENNA PRERIEMPITA-USO SOTTOCUTANEO-PENNA PRERIEMPITA(VETRO) -0.5 ML 3 (3X1) PENNE PRERIEMPITE | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
1917 | Simponi 50 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte. | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
1918 | SIMPONI 50 mg solución inyectable en pluma precargada | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
1919 | SimvaHEXAL® 40 mg Filmtabletten | - | - | - | - | [1] 13 13 |
1920 | Simvastatin 20 mg | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 46 46 |
1921 | Simvastatin 40 mg | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 86 86 |
1922 | Simvastatin 40 mg film-coated tablets | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
1923 | Simvastatin 40 mg tablets | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 86 86 |
1924 | Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
1925 | Simvastatine Sandoz 40 mg filmomhulde tabletten | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
1926 | Sinemet (carbidopa/levodopa) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1927 | Sinemet (levodopa/carbidopa) (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1928 | SINEMET - 100 MG + 25 MG COMPRESSE 50 COMPRESSE DIVISIBILI | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1929 | SINEMET 100 mg + 25 mg compresse | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1930 | SINEMET 100 mg + 25 mg tablets | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1931 | Sinemet 125 mg | - | - | - | - | [1] 6 6 |
1932 | Sinemet plus (levodopa/carbidopa) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1933 | Sinemet® 100/25 mg | - | - | - | - | [1] 6 6 |
1934 | Sinemet® controlled release (Carbidopa/levodopa) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1935 | SINEMET® Plus 25 mg/100 mg Tablets | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1936 | Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg) | - | - | - | - | [1] 28 28 |
1937 | Sinvastatina Sandoz 40 mg comprimidos revestidos por película | - | - | - | - | [1] 13 13 |
1938 | Siponimod 0,25 mg | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1939 | Siponimod 0.25 mg tablet | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
1940 | Siponimod 0.5 mg tablet | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
1941 | Siponimod 1 mg | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1942 | Siponimod 1 mg tablet | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
1943 | Siponimod 2 mg | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
1944 | Siponimod 2 mg tablet | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
1945 | Sirolimus 2 MG | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 17 17 |
1946 | Sirolimus and Hydroxychloroquine 200 mg | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [2] D00753
D00753
,
D08050
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 |
1947 | Sirolimus and Hydroxychloroquine 400 mg | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [2] D00753
D00753
,
D08050
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 |
1948 | Sirukumab 100 mg | [1] Sirukumab Sirukumab | [1] D10080
D10080
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
1949 | Sirukumab 50 mg | [1] Sirukumab Sirukumab | [1] D10080
D10080
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
1950 | Sivatin 40 mg film-coated tablets | - | - | - | - | [1] 13 13 |
1951 | Sodium valproate 200 mg gastro-resistant tablets | [1] Valproic acid Valproic acid | [1] D00399
D00399
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 233 233 |
1952 | Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 |
1953 | Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 |
1954 | SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML) | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 13 13, 62, 109 |
1955 | SOLIRIS 300 mg concentrado para solución para perfusión | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 109 109 |
1956 | Soliris 300 mg concentrate for solution for infusion | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
1957 | SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML | - | - | - | - | [3] 13 13, 14, 53 |
1958 | SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML | - | - | - | - | [1] 56 56 |
1959 | SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML | - | - | - | - | [1] 56 56 |
1960 | Solu-Cortef 100 MG Injection | [2] Hydrocortisone Hydrocortisone, Hydrocortisone succinate | [2] D00088
D00088
,
D01442
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 |
1961 | Soluzione di levodopa/carbidopa (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1962 | SOM230 LAR 10 mg | - | - | - | - | [1] 75 75 |
1963 | SOM230 LAR 30 mg | - | - | - | - | [1] 75 75 |
1964 | SOM230 LAR, 20 mg | - | - | - | - | [1] 75 75 |
1965 | Somapacitan 10 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
1966 | Somapacitan 10 mg/1.5ml PDS290S | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
1967 | Somapacitan 15 mg/1.5 mL PDS290 | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 |
1968 | Somapacitan 15 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
1969 | Somapacitan 5 mg/1.5 mL PDS290 | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 |
1970 | Somapacitan 5 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
1971 | Somatuline Autogel 90 mg | [1] Lanreotide Lanreotide | - | - | - | [1] 298 298 |
1972 | Sortis 10 mg | - | - | - | - | [1] 93 93 |
1973 | Sotatercept - 45 mg/vial | [1] Sotatercept Sotatercept | [1] D09670
D09670
| [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 |
1974 | Sotatercept - 60 mg/vial | [1] Sotatercept Sotatercept | [1] D09670
D09670
| [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 |
1975 | Sporanox 10 mg/ml Oral Solution | [1] Itraconazole Itraconazole | [1] D00350
D00350
| - | - | [1] 299 299 |
1976 | SSP-004184 100 mg | - | - | - | - | [1] 284 284 |
1977 | SSP-004184 100 mg Capsule | - | - | - | - | [1] 284 284 |
1978 | SSP-004184 250 mg | - | - | - | - | [1] 284 284 |
1979 | SSP-004184 250 mg Capsule | - | - | - | - | [1] 284 284 |
1980 | SSP-004184 375 mg | - | - | - | - | [1] 284 284 |
1981 | SSP-004184 375 mg Capsule | - | - | - | - | [1] 284 284 |
1982 | SSP-004184 50 mg | - | - | - | - | [1] 284 284 |
1983 | SSP-004184 50 mg Capsule | - | - | - | - | [1] 284 284 |
1984 | SSP-004184 500 mg | - | - | - | - | [1] 284 284 |
1985 | SSP-004184 500 mg Capsule | - | - | - | - | [1] 284 284 |
1986 | SSP-004184AQ 100 mg | - | - | - | - | [1] 284 284 |
1987 | SSP-004184AQ 100 mg Capsule | - | - | - | - | [1] 284 284 |
1988 | SSP-004184AQ 200 mg | - | - | - | - | [1] 284 284 |
1989 | SSP-004184AQ 200 mg Capsule | - | - | - | - | [1] 284 284 |
1990 | SSP-004184AQ 250 mg | - | - | - | - | [1] 284 284 |
1991 | SSP-004184AQ 250 mg Capsule | - | - | - | - | [1] 284 284 |
1992 | SSP-004184AQ 375 mg | - | - | - | - | [1] 284 284 |
1993 | SSP-004184AQ 375 mg Capsule | - | - | - | - | [1] 284 284 |
1994 | SSP-004184AQ 50 mg | - | - | - | - | [1] 284 284 |
1995 | SSP-004184AQ 50 mg Capsule | - | - | - | - | [1] 284 284 |
1996 | Stalevo (levodopa/ carbidopa/ entacapone) (Synonym: CARBIDOPA TABLETS, 25 MG) | [3] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone, Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [3] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1997 | Stalevo (levodopa/carbidopa/entacapona) (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Entacapone | [2] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG),
D00781
| [2] COMT COMT, DDC 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1998 | Stalevo (levodopa/carbidopa/entacapone) (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1999 | Stalevo 100 mg/ 25 mg/ 200 mg Filmtabletten | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
2000 | Stalevo 100 mg/25 mg / 200 mg | - | - | - | - | [1] 6 6 |
2001 | Stalevo 100/25/200 mg | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
2002 | Stalevo 150/37.5/200 mg | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
2003 | STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2004 | STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2005 | STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 |
2006 | STELARA 130 mg concentrate for solution for infusion | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2007 | STELARA 90 mg solution for injection in pre-filled syringe | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2008 | STNM01 1.84 mg | - | - | - | - | [1] 97 97 |
2009 | Sublingual tizanidine 12 mg | [1] Tizanidine Tizanidine | [1] D08611
D08611
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
2010 | Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [1] 215 215 |
2011 | Sulphasalazine 500 mg En-Tabs | - | - | - | - | [1] 271 271 |
2012 | SYN115 Tablets, 60 mg | - | - | - | - | [1] 6 6 |
2013 | TA-650 10 mg/kg | - | - | - | - | [1] 46 46 |
2014 | TA-650 3 mg/kg | - | - | - | - | [1] 46 46 |
2015 | TA-650 6 mg/kg | - | - | - | - | [1] 46 46 |
2016 | TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE | - | - | - | - | [1] 14 14 |
2017 | TACHIPIRINA - 500 MG COMPRESSE20 COMPRESSE | - | - | - | - | [2] 13 13, 53 |
2018 | Tadalafil 20 MG | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 113 113 |
2019 | Tadalafil 20 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
2020 | Tadalafil 40 mg | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
2021 | Tafamidis meglumine 20 mg soft gelatin capsules | [3] Gelatin Gelatin, Meglumine, Tafamidis | [4] D00115
D00115
,
D01796
,
D06892
,
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
2022 | Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication) (Synonym: METRONIDAZOLE250 MG) | [3] Amoxicillin Amoxicillin (Synonym: Amoxicillin Capsules 250 mg), Clarithromycin (Synonym: Clarithromycin 500 mg), Metronidazole (Synonym: Metronidazole 250 mg) | [4] D00229
D00229
(Name: AMOXICILLIN 500 MG),
D00276
,
D00409
(Name: METRONIDAZOLE250 MG),
D07452
| - | - | [1] 63 63 |
2023 | Taltz (80 mg solution for injection in pre-filled syringe) | [1] Ixekizumab Ixekizumab | [1] D10071
D10071
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [2] 107 107, 271 |
2024 | Tamoxifen 40 mg daily for one year | [1] Tamoxifen Tamoxifen | [1] D08559
D08559
| [2] ESR1 ESR1, ESR2 💬 | [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 2 2 |
2025 | Targinact 10 mg/5 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate | - | - | - | [2] 6 6, 226 |
2026 | Targinact 20 mg/10 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate | - | - | - | [1] 6 6 |
2027 | Targinact 20mg/10 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate | - | - | - | [1] 226 226 |
2028 | Targinact 5 mg/2.5 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate | - | - | - | [1] 6 6 |
2029 | Targinact 5mg/2.5 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate | - | - | - | [1] 226 226 |
2030 | Tasigna 50 mg | [1] Nilotinib Nilotinib | [1] D08953
D08953
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 34 34 |
2031 | Tasigna® 150 mg | [1] Nilotinib Nilotinib | [1] D08953
D08953
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 86 86 |
2032 | Tavapadon 0.25 mg | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
2033 | Tavapadon 5 mg | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
2034 | TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE | - | - | - | - | [1] 13 13 |
2035 | Tecfidera® 120 mg | [1] Dimethyl fumarate Dimethyl fumarate | [1] D03846
D03846
| [1] KEAP1 KEAP1 💬 | [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [1] 13 13 |
2036 | Tecfidera® 240 mg | [1] Dimethyl fumarate Dimethyl fumarate | [1] D03846
D03846
| [1] KEAP1 KEAP1 💬 | [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [1] 13 13 |
2037 | Teduglutide 0.1 mg dose | [1] Teduglutide Teduglutide | [1] D06053
D06053
| [1] GLP2R GLP2R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
2038 | Teduglutide 0.2 mg | [1] Teduglutide Teduglutide | [1] D06053
D06053
| [1] GLP2R GLP2R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
2039 | Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. | [1] Teicoplanin Teicoplanin | [1] D02142
D02142
| - | - | [1] 299 299 |
2040 | Telitacicept 160 mg | - | - | - | - | [1] 53 53 |
2041 | Telitacicept 80 mg | - | - | - | - | [1] 53 53 |
2042 | TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY] | [2] Tenofovir Tenofovir, Tenofovir alafenamide | [2] D06074
D06074
,
D10428
| - | - | [1] 13 13 |
2043 | Terazosin 5 MG | [1] Terazosin Terazosin (Synonym: Riva-terazosin 2 Mg Tablets) | [1] D08569
D08569
| [3] ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | [7] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
2044 | Terguride 0.5 mg tablet | [1] Terguride Terguride | [1] D01348
D01348
| [2] DRD2 DRD2, PRL 💬 | [12] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 86 86 |
2045 | Teriflunomide 14 MG | [1] Teriflunomide Teriflunomide | [1] D10172
D10172
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 13 13 |
2046 | Teriflunomide 14 MG Oral Tablet [Aubagio] | [1] Teriflunomide Teriflunomide | [1] D10172
D10172
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 13 13 |
2047 | THALIDOMIDE CELGENE - 50 MG CAPSULA RIGIDA - USO ORALE - BLISTER (PVC/PE/ACLAR/ALU) 28 CAPSULE | [1] Thalidomide Thalidomide | [1] D00754
D00754
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
2048 | The investigational medicinal product (IMP) may be labelled as either PF-04236921 106 mg/vial, Clonal SC lyophilized form” or PF-04236921 Powder for Injection, 106 mg/vial”. Supplies labelled with either nomenclature are equivalent. | - | - | - | - | [1] 96 96 |
2049 | The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA | - | - | - | - | [1] 96 96 |
2050 | The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA. | - | - | - | - | [1] 96 96 |
2051 | Tildrakizumab 100 mg/ml | [1] Tildrakizumab Tildrakizumab | [1] D10400
D10400
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 271 271 |
2052 | TOBI 300 mg / 5 mL nebuliser solution | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2053 | TOBI 300 mg/5 ml Lösung für einen | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2054 | TOBI 300 mg/5 ml Lösung für einen Vernebler | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2055 | TOBI 300 mg/5 ml Nebuliser Solution | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2056 | TOBI 300 mg/5 ml solución para inhalación por nebulizador | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2057 | TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2058 | TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2059 | TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2060 | TOBI Podhaler 28 mg inhalációs por, kemény kapszula | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2061 | TOBI™ Podhaler™ 112 mg inhaled twice daily | - | - | - | - | [1] 299 299 |
2062 | Tobramycin solution for inhalation 300 mg | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2063 | Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution | [1] Tobramycin Tobramycin | [1] D00063
D00063
| - | - | [1] 299 299 |
2064 | Tocilizumab 162 mg | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
2065 | Tocilizumab SC 162 mg/0.9 ml disposable auto-injector (AI) | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
2066 | Tocilizumab SC 162 mg/0.9 ml pre-filled syringe with safety device (PFS) | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
2067 | Tocilizumab SC 162 mg/0.9 ml prefilled syringe with safety device (PFS) | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 51 51 |
2068 | Tofacitinib 10 mg | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 271 271 |
2069 | Tofacitinib 10 MG [Xeljanz] | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 97 97 |
2070 | Tofacitinib 2 mg | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 271 271 |
2071 | Tofacitinib 5 MG | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [4] 11 11, 40, 46, 271 |
2072 | Tofacitinib 5 MG [Xeljanz] | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 50 |
2073 | Tofacitinib 5 mg twice daily | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 84 84 |
2074 | Tolvaptan 15 mg Tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
2075 | Tolvaptan 15 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
2076 | Tolvaptan 30 mg Tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
2077 | Tolvaptan 30 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
2078 | Tolvaptan 7.5 mg Tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
2079 | Tominersen 100 mg | - | - | - | - | [1] 8 8 |
2080 | Tominersen 60 mg | - | - | - | - | [1] 8 8 |
2081 | Tozadenant (SYN115) 120 mg BID | [1] Tozadenant Tozadenant | [1] D10174
D10174
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
2082 | Tozadenant (SYN115) 180 mg BID | [1] Tozadenant Tozadenant | [1] D10174
D10174
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
2083 | Tozadenant (SYN115) 240 mg BID | [1] Tozadenant Tozadenant | [1] D10174
D10174
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
2084 | Tozadenant (SYN115) 60 mg BID | [1] Tozadenant Tozadenant | [1] D10174
D10174
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
2085 | TPI 287 2 mg/m2 | - | - | - | - | [2] 5 5, 7 |
2086 | TPI-287 20 mg/m2 | [1] TPI-287 TPI-287 | - | - | - | [2] 5 5, 7 |
2087 | TPI-287 6.3 mg/m2 | [1] TPI-287 TPI-287 | - | - | - | [2] 5 5, 7 |
2088 | TPN-101, 400 mg/day | - | - | - | - | [2] 2 2, 127 |
2089 | TRACLEER 62,5 mg comprimidos recubiertos con película | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
2090 | Trametinib (0.5 mg) | [1] Trametinib Trametinib | [1] D10175
D10175
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 2 2 |
2091 | Trametinib (1 mg) | [1] Trametinib Trametinib | [1] D10175
D10175
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 2 2 |
2092 | TransCon CNP 3.9 mg CNP-38/vial | - | - | - | - | [1] 276 276 |
2093 | Translarna 1000 mg granules for oral suspension | [1] Ataluren Ataluren | [1] D09323
D09323
| - | - | [1] 113 113 |
2094 | Translarna 125 mg granules for oral suspension | [1] Ataluren Ataluren | [1] D09323
D09323
| - | - | [1] 113 113 |
2095 | Translarna 250 mg granules for oral suspension | [1] Ataluren Ataluren | [1] D09323
D09323
| - | - | [1] 113 113 |
2096 | Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms | [1] Lansoprazole Lansoprazole | [1] D00355
D00355
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 98 98 |
2097 | Trexan inj 25 mg/ml | - | - | - | - | [1] 97 97 |
2098 | Triam 40 mg Lichtenstein | - | - | - | - | [1] 46 46 |
2099 | Triamcinolone Hexacetonide 20 MG/ML | [1] Triamcinolone Triamcinolone | [1] D00385
D00385
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 107 107 |
2100 | TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML | - | - | - | - | [1] 14 14 |
2101 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere | [1] Dulaglutide Dulaglutide | [1] D09889
D09889
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 13 13 |
2102 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. | [1] Dulaglutide Dulaglutide | [1] D09889
D09889
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 13 13 |
2103 | TVP-1012 (1 mg/day) with levodopa | [1] Levodopa Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
2104 | TYSABRI 300 mg concentrado para solución para perfusión | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
2105 | TYSABRI 300 mg concentrate for solution for infusion | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
2106 | TYSABRI 300 mg solution à diluer pour perfusion | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
2107 | ULTOMIRIS - 300 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 3 ML (100 MG / ML) - 1 FLACONCINO | [1] Ravulizumab Ravulizumab | [1] D11054
D11054
| [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
2108 | Ultomiris 1,100 mg/11 mL | [1] Ravulizumab Ravulizumab | [1] D11054
D11054
| [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 |
2109 | Ultomiris 300 mg/30 ml | [1] Ravulizumab Ravulizumab | [1] D11054
D11054
| [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 66 66 |
2110 | Urbason 40 mg | - | - | - | - | [1] 13 13 |
2111 | URBASON 40 mg comprimidos | - | - | - | - | [1] 13 13 |
2112 | Urbason® solubile forte 1000 mg | - | - | - | - | [1] 13 13 |
2113 | Ursodeoxycholic acid (UDCA) 500 mg | [1] Ursodeoxycholic acid Ursodeoxycholic acid (Synonym: Reltone 400 mg) | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 46 46 |
2114 | UrsoFalk® 250 mg tabletten. | [1] Ursodeoxycholic acid Ursodeoxycholic acid (Synonym: Reltone 400 mg) | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 96 96 |
2115 | Ursofalk® 500 mg film-coated tablets | [1] Ursodeoxycholic acid Ursodeoxycholic acid (Synonym: Reltone 400 mg) | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
2116 | Ursofalk® 500 mg Filmtabletten | [1] Ursodeoxycholic acid Ursodeoxycholic acid (Synonym: Reltone 400 mg) | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
2117 | Ustekinumab (approximately 6 mg/kg) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 49 49 |
2118 | Ustekinumab 130 mg IV | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2119 | Ustekinumab 180 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 93 93 |
2120 | Ustekinumab 3 mg/kg (IP) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2121 | Ustekinumab 4.5 mg/kg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2122 | Ustekinumab 45 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 93 93 |
2123 | Ustekinumab 6 mg/kg (IP) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2124 | Ustekinumab 90 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [3] 49 49, 93, 96 |
2125 | Ustekinumab 90 mg (SC) Group 1 | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2126 | Ustekinumab 90 mg (SC) Group 2 | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2127 | Ustekinumab 90 mg SC q12w | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2128 | Ustekinumab 90 mg SC q8w | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2129 | Ustekinumab 90 milligram (mg) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 49 49 |
2130 | Ustekinumab approximately 6 mg/kg (IV) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
2131 | UT-15C 0.25 mg | - | - | - | - | [1] 86 86 |
2132 | UT-15C 1 mg | - | - | - | - | [1] 86 86 |
2133 | UT-15C 5 mg | - | - | - | - | [1] 86 86 |
2134 | Vamorolone 0.25 mg/day/day | [1] Vamorolone Vamorolone | [1] D11000
D11000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
2135 | Vamorolone 0.25 mg/kg/day | [1] Vamorolone Vamorolone | [1] D11000
D11000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
2136 | Vamorolone 0.75 mg/day/day | [1] Vamorolone Vamorolone | [1] D11000
D11000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
2137 | Vamorolone 0.75 mg/kg/day | [1] Vamorolone Vamorolone | [1] D11000
D11000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
2138 | Vamorolone 2.0 mg/day/day | [1] Vamorolone Vamorolone | [1] D11000
D11000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
2139 | Vamorolone 2.0 mg/kg/day | [1] Vamorolone Vamorolone | [1] D11000
D11000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
2140 | Vamorolone 6.0 mg/day/day | [1] Vamorolone Vamorolone | [1] D11000
D11000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
2141 | Vamorolone 6.0 mg/kg/day | [1] Vamorolone Vamorolone | [1] D11000
D11000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 |
2142 | Vedolizumab 108 mg SC | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 |
2143 | Vedolizumab 300 mg | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 |
2144 | Vedolizumab 300 MG Injection [Entyvio] | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 |
2145 | Vedolizumab 300 mg IV | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 97 97 |
2146 | Vedolizumab IV 300 mg | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 |
2147 | Vedolizumab SC 108 mg | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
2148 | Venetoclax Oral Tablet, 200 mg | [1] Venetoclax Venetoclax | [1] D10679
D10679
| [1] BCL2 BCL2 💬 | [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | [1] 28 28 |
2149 | Venetoclax Oral Tablet, 400 mg | [1] Venetoclax Venetoclax | [1] D10679
D10679
| [1] BCL2 BCL2 💬 | [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | [1] 28 28 |
2150 | VFEND 40 mg/ml powder for oral suspension | [1] Voriconazole Voriconazole | [1] D00578
D00578
| - | - | [1] 299 299 |
2151 | VIGABATRIN (Synonym: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [2] 145 145, 158 |
2152 | Vigabatrin (Sabril) (Synonym: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 158 158 |
2153 | Vigabatrin Tablets (Synonym: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
2154 | Vigabatrin: Vigabatrin new ST formulation then Sabril® (Synonym: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
(Name: VIGABATRIN FOR ORAL SOLUTION USP, 500 MG) | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
2155 | VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE | - | - | - | - | [1] 46 46 |
2156 | VIREAD 30 CPR 245 MG | - | - | - | - | [1] 46 46 |
2157 | VOLIBRIS 10 mg comprimidos recubiertos con película | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
2158 | VOLIBRIS 5 mg comprimidos recubiertos con película | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
2159 | VX-661/ivacaftor (VX-770) 100mg/150 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
2160 | VX-661/ivacaftor 100 mg/ 150 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
2161 | VX-661/ivacaftor 100mg/150 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
2162 | VX-661/ivacaftor 50 mg/ 75 mg | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
2163 | WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
2164 | WD-1603 Carbidopa-Levodopa Extended-Release Tablets (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
2165 | WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS (Synonym: CARBIDOPA TABLETS, 25 MG) | [2] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg), Levodopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [2] D00059
D00059
,
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
2166 | XADAGO - 100 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
2167 | XADAGO - 50 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
2168 | XELJANZ 5 mg film-coated tablets | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 97 |
2169 | XGEVA - 120 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 1.7 ML 4 FLACONCINI | [1] Denosumab Denosumab | [1] D03684
D03684
| [1] TNFSF11 TNFSF11 💬 | [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 |
2170 | Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung | [1] Omalizumab Omalizumab | [1] D05251
D05251
| [1] FCER1A FCER1A 💬 | [4] Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [1] 299 299 |
2171 | XP21279 and carbidopa (experimental) (Synonym: CARBIDOPA TABLETS, 25 MG) | [1] Carbidopa Carbidopa (Synonym: Nu-levocarb - Tab 25 Mg/100 mg) | [1] D00558
D00558
(Name: CARBIDOPA TABLETS, 25 MG) | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
2172 | YONDELIS 0,25 mg polvo para concentrado para solución para perfusión | [1] Trabectedin Trabectedin | [1] D06199
D06199
| - | - | [1] 159 159 |
2173 | Yondelis 0.25 mg powder for concentrate for solution for infusion. | [1] Trabectedin Trabectedin | [1] D06199
D06199
| - | - | [1] 159 159 |
2174 | YONDELIS 1 mg polvo para concentrado para solución para perfusión | [1] Trabectedin Trabectedin | [1] D06199
D06199
| - | - | [1] 159 159 |
2175 | Yondelis 1 mg powder for concentrate for solution for infusion. | [1] Trabectedin Trabectedin | [1] D06199
D06199
| - | - | [1] 159 159 |
2176 | Zanubrutinib 80 MG | [1] Zanubrutinib Zanubrutinib | [1] D11422
D11422
| [1] BTK BTK 💬 | [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 300 300 |
2177 | ZITHOMAX 40 mg/ml ENFANTS | - | - | - | - | [1] 299 299 |
2178 | ZITHROMAX 250 mg | [1] Azithromycin Azithromycin | [2] D06390
D06390
,
D07486
| - | - | [1] 299 299 |
2179 | Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion, generic medicinal product | [1] Zoledronic acid Zoledronic acid | [2] D01968
D01968
,
D08689
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 274 274 |
2180 | Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion, generic medicinal product. | [1] Zoledronic acid Zoledronic acid | [2] D01968
D01968
,
D08689
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 274 274 |
2181 | Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion,generic medicinal product | [1] Zoledronic acid Zoledronic acid | [2] D01968
D01968
,
D08689
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 274 274 |
2182 | Zomacton 10 mg/ml | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 |
2183 | ZSP1603 12.5 mg | - | - | - | - | [1] 85 85 |
2184 | ZSP1603 25 mg | - | - | - | - | [1] 85 85 |
2185 | ZSP1603 50 mg | - | - | - | - | [1] 85 85 |
2186 | ZSP1603 7.5 mg | - | - | - | - | [1] 85 85 |
2187 | ZUGLIMET - 500 MG COMPRESSE RIVESTITE CON FILM 30 COMPRESSE IN BLISTER PVC/AL | - | - | - | - | [1] 67 67 |
2188 | ZX008 - 0.2 mg/kg/day | - | - | - | - | [1] 140 140 |
2189 | ZX008 - 0.8 mg/kg/day | - | - | - | - | [1] 140 140 |
2190 | ZX008 0.2 or 0.8 mg/kg/day | - | - | - | - | [1] 144 144 |
2191 | ZX008 0.2 to 0.8 mg/kg/day | - | - | - | - | [2] 140 140, 144 |
2192 | ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE | [1] Abiraterone Abiraterone | - | - | - | [1] 75 75 |